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ABSTRACT 
Jonathan Henry Shannahan:  Susceptibility to Libby Amphibole Induced Pulmonary Disease 
in the Cardiovascular-Compromised Subpopulation 
(Under the direction of Dr. Urmila Kodavanti) 
Human exposure to asbestos is known to cause the development of mesothelioma, asbestosis 
and lung cancer.  Asbestos toxicity is thought to be mediated through reactive oxygen species 
(ROS) production by surface available iron (Fe).   Within the lung asbestos can complex 
endogenous Fe possibly increasing toxicity.  We hypothesized that asbsestos-induced 
inflammation and injury would be greater in rat models of human cardiovascular disease 
(CVD) with Fe-overload. We characterized the baseline pulmonary disease of normotensive 
Wistar Kyoto, spontaneously hypertensive (SH), and SH heart failure (SHHF) rats.  SH and 
SHHF were found to exist with pulmonary inflammation, oxidative stress, and Fe-overload 
(SHHF>SH).  Libby amphibole (LA) was used to examine the role of Fe in asbestos-induced 
toxicity.  LA complexed Fe in an acellular system, which enhanced ROS production.  In in 
vitro and in vivo models the inflammatory response to LA decreased with increased cellular 
and fiber-complexed Fe.  The chelation of Fe from fibers and cells exacerbated LA-induced 
inflammation.  To determine the role of increased host Fe in LA-induced inflammation, and 
lung pathology WKY, SH, and SHHF were intratracheally-instilled with LA (0.0, 0.25, and 
1mg/rat).  LA-induced neutrophilic inflammation was not exacerbated although persistent 
through 1-month in CVD models compared to WKY.  SH and SHHF failed to increase 
antioxidants but increased Fe-binding proteins after LA exposure.  Progressive pulmonary 
fibrosis was noted over 3-months in all strains, whereas the accumulation of Fe in fiber-laden 
macrophages occurred primarily in SHHF.  At 3-months, only SHHF exposed to LA 
demonstrated atypical hyperplastic lesions of bronchiolar epithelial origin.  Gene expression 
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profiling at 3-months indicated baseline differences reflective of pulmonary inflammation, 
and immune dysregulation in CVD models.  Changes in genes involved in cell-cycle control 
and cancer pathways correlated with atypical hyperplasia in SHHF.  We concluded LA can 
bind Fe and produce ROS in an acellular system but this process does not exacerbate the 
inflammatory response in cells or animals.  Furthermore, in Fe-overload conditions, more Fe 
accumulates at sites of fiber deposition without enhancing the inflammatory response.  In the 
presence of baseline lung pathology, the inability to further induce inflammation in response 
to LA may predispose those with Fe-overload to proliferative lung pathology. 
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CHAPTER 1.  INTRODUCTION 
 
 
Asbestos is a well-known air pollutant associated with a number of pulmonary 
abnormalities and diseases including mesothelioma and asbestosis.  Asbestos refers to a 
group of naturally occurring fibrous minerals that are divided into different sub-classes based 
on their chemical formulas.  The serpentine family includes only chrysotile and the 
amphibole family includes tremolite, crocidolite, actinolite, richerite, and winchite.  
Chrysotile has a curly structure and is flexible; whereas the amphiboles consist of straight, 
inflexible, rod-like fibers.  Prior to the 1970s, mined fibrous asbestos minerals were widely 
used in building materials, brake shoes, electrical wiring, and insulation.  Because of the 
unique properties of asbestos minerals such as their durability, flexibility, and resistance to 
heat, electrical, and chemical damage, these materials had a variety of commercial 
applications.  However, due to a strong correlation between asbestos exposure and the health 
risk of mesothelioma and other pulmonary diseases, its use has diminished in most developed 
countries. 
 Human exposure to asbestos takes place mainly in occupational settings; however, 
since it is naturally occurring, some environmental exposure does occur.  Libby, Montana is 
currently an EPA superfund site and has been declared as the first public health emergency 
by the United States EPA.  Because of the extensive history of mining operations of 
amphibole asbestos-contaminated vermiculite, significant asbestos exposure has taken place 
in Libby.  The residents of Libby have shown orders of magnitude higher numbers of
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asbestos-related diseases, such as asbestosis, lung cancer, and mesothelioma in comparison to 
the rest of the United States (Sullivan 2007).  Furthermore epidemiological research has 
demonstrated a dose-dependent correlation between Libby amphibole (LA) exposure and 
cardiovascular disease (CVD) mortality (Larson et al. 2010), as well as an increase in the 
incidence of systemic autoimmune disease in Libby residents (Pfau et al. 2005).  Because the 
asbestos-contaminated vermiculite was shipped, processed, and used all over the country, 
primarily for insulation in the attics of homes, exposure to LA is not limited to Libby, 
Montana.  The physicochemistry of LA asbestos (Figure 1.1) is unique in that it is a complex 
mixture of different amphiboles, primarily winchite, and richterite with trace amounts of 
tremolite (Figure 1.2) (Meeker et al. 2003).  It is currently not known how the toxicity of this 
mineral fibrous mix differs from the toxicity of other well-classified asbestos materials. 
Figure 1.1 
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Figure 1.1. Scanning Electron microscope image of Libby amphibole asbestos at 10 µm 
resolution.  Image from USGS Denver Microbeam Laboratory, G.P. Meeker. 
 
 
Figure 1.2 
 
 
 
Figure 1.2.  Specific fiber types found to compose the Libby amphibole fiber mix. (Meeker et 
al. 2003). 
 
 
Chemical Formulas of Primary Fiber Components of Libby Amphibole 
 
Winchite: (CaNa)Mg4(Al,Fe3+)Si8O22(OH)2 
Richterite: Na(CaNa)(Mg,Fe2+)5[Si8O22](OH)2 
Tremolite: Ca2Mg5Si8O22(OH)2 
 
 
 In general, asbestos is known to cause pulmonary toxicity upon inhalation which 
leads to a variety of diseases.  It has been estimated that the cumulative deaths associated 
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with asbestos exposure will surpass 200,000 by the year 2030 in the United States (Nicholson 
et al. 1982).  A number of pulmonary diseases have been attributed specifically to asbestos 
exposure.  Mesothelioma, a cancer of the mesothelium, is the most well-known asbestos 
associated disease.  Mesothelioma usually arises in the pleural surface decades after exposure 
to asbestos in humans and decreases the functionality of the lung.  The mode of action by 
which asbestos causes mesothelioma is currently unknown.  The majority of mesothelioma 
cases occur in people who have been exposed occupationally to asbestos.  Furthermore, 
inhalation of asbestos fibers has been linked to increases in the development of lung tumors, 
which is enhanced upon co-exposure with tobacco smoke (Vaino and Buffetta 1994, 
Mossman and Churg 1998).  Exposure to asbestos can also cause the development of 
asbestosis leading to dyspnea, restrictive outcomes, and ultimately respiratory failure.  
Asbestosis is a chronic inflammatory condition of the lung resulting in fibrosis and is directly 
related to the biopersistence of asbestos within the lung.  
Asbestos toxicity and eventually the development of asbestos-related diseases are 
thought to be mediated through the production of reactive oxygen species (ROS).  ROS can 
cause direct cellular damage through the oxidation of lipids, proteins, and DNA.  This 
damage can activate many pathways and transcription factors which in turn cause a variety of 
gene expression changes.  Asbestos exposure is known to modify the expression of genes 
related to antioxidants, apoptosis, inflammatory cytokines, growth factors, and stress 
response (Kamp and Weitzman 1999) (Figure 1.3). 
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Figure 1.3 
Antioxidant- Mn-SOD, Ascorbate, Glutathione
Stress Response: HO-1, ferritin, transferrin, heat shock proteins
Inflammatory Cytokines: TNFα, MIP, interleukins
Apoptosis: caspases, p53
ROS Generation
Cell Damage
Signal Transduction
Transcription Factors
Gene Expression
Inhalation of Asbestos Fibers
Production of O2-, H2O2, HO-
Oxidation of DNA, Lipids, Proteins
Activation of MAP Kinase, Tyrosine Kinase, Protein Kinase C 
Activation of NFĸB, AP-1, p53
Growth Factors: TGF αand β, PDGF
 
Figure 1.3.  Effects of asbestos and generated reactive species in causing pulmonary toxicity. 
 
In general, asbestos produces ROS through 1) frustrated phagocytosis, 2) redox 
cycling of surface available transition metals, 3) complexation of endogenous iron.  
Frustrated phagocytosis is directly related to the biopersistence of asbestos and the continual 
activation of inflammatory cells.  Typically, foreign particles are removed from the lung via 
recognition and phagocytosis by alveolar macrophages.  Asbestos fibers are usually too long 
and rigid to be completely engulfed and phagocytozed by alveolar macrophages.  This 
inability of alveolar macrophages to clear fibers allows them more time within the lung to 
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induce toxicity.  Fibers often can penetrate epithelial cells and the interstitium thereby 
contributing to the inflammatory cascade as well as causing extracellular matrix turnover.  
The inability to engulf the fiber leads to the further recruitment and activation of other 
inflammatory cells and causes continual production of ROS through activation of NADPH 
oxidase.  This constant inflammation and production of ROS by inflammatory cells leads to 
damage of cells in the lung through oxidative stress.  Besides initiating an inflammatory 
response, mediators released from alveolar macrophages also stimulate proliferation, 
production of growth factors and collagen synthesis by interstitial fibroblasts.  This state of 
chronic inflammation eventually leads to thickening of the alveolar walls of the lung and 
filling of the alveolar spaces with scar tissue and fibrous connective tissue leading to fibrosis 
or asbestosis.   
Asbestos itself is able to produce ROS through the redox cycling of iron (Fe) and 
other transition metals associated with its surface.  Asbestos has been shown to generate ROS 
in cellular and acellular systems.  Researchers have demonstrated that increasing the amount 
of Fe available on the surface of the fiber leads to increased oxidative damage, such as DNA 
double strand breaks and lipid oxidation.  Furthermore chelation of Fe has been shown to 
reduce this damage in vitro and to lessen in vivo fiber-induced inflammation and DNA 
damage (Kamp 1995).  Amphiboles typically have been shown to have increased amounts of 
Fe on their surfaces compared to chrysotile which may facilitate the production of ROS and 
enhance their toxicity.  Fe on the surface of fibers is able to continually generate ROS 
through facilitating Fenton chemistry/Haber-Weiss reactions. 
Fenton Reaction:  Fe2+ + H2O2  Fe3+ + HO- + HO. 
Haber-Weiss Reaction: O2- + H2O2   Fe   HO- + HO. +O2 
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Reduction of ferric iron to ferrous iron: Fe3+ + O2-  Fe2+ + O2 
 
This output of ROS by the fiber producing an environment of oxidative stress within the lung 
that can lead to the progression of asbestos-induced diseases.  Additionally, superoxide 
produced by inflammatory cells can assist in the production of hydroxyl radicals by driving 
Fenton reaction occurring on the surface of the fibers (Figure 1.4).  Superoxide in an attempt 
to remove iron from the surface of the fiber reduces ferric iron to ferrous iron.  This allows 
for the oxidation of hydrogen peroxide by ferrous iron to highly reactive hydroxyl radicals. 
Figure 1.4 
Fe 3+ Fe 2+
Oxidative Damage:
DNA
Protein
Lipids
Alveolar Macrophage/
Neutrophil
O2-
H2O2
HO.
SOD
Catalase
SOD
H 2O
 
Figure 1.4.  Mechanism of asbestos-induced free radical production via inflammatory cell 
activation and cycling of iron associated with the surface of the fiber.  
  
 Interestingly, asbestos has demonstrated an ability to bind catalytically active Fe from 
the endogenous labile Fe pool upon deposition into the airways and thereby potentiating the 
production of ROS (Ghio et al. 2004).  At physiological pH there is a dissociation of 
hydrogens from Si-OH groups associated with the surface of asbestos leaving a net negative 
charge across the surface of the fiber allowing for ionic binding of cations.  Due to the 
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bioavailability of Fe and the high stability constant for Si-O- and Fe cations, inhaled asbestos 
becomes saturated by exogenous Fe in the lung forming ferriginous bodies (Figure 1.5).  As 
long as one of the coordination sites on this Fe remains available it is still able to redox cycle 
and produce ROS.  Through this mechanism the ability of the fiber to produce ROS is 
enhanced after inhalation.  Due to the ability of asbestos to bind endogenous Fe we believe 
that individuals existing in a state of Fe-overload may be increasingly sensitive to the toxic 
effects of asbestos.  Diseases and conditions associated with Fe-overload include thalassamia 
patients or others receiving repeated blood transfusions, diabetics, and individuals with 
cardiovascular disease (CVD). 
Figure 1.5 
 
Figure 1.5.  Scanning Electron microscope image of asbestos fiber with ferringinous bodies 
associated with its surface at a magnification of 2,000.     
 
Cardiovascular disease (CVD) is the number one cause of mortality and morbidity 
worldwide (Lopez et al. 2006, Sans et al. 1997). It is estimated that out of 300 million people 
in the United States, 80.7 million suffer from one or more forms of CVD. In the United 
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States, 35% of total deaths are attributable to CVD.  Types of CVD include atherosclerosis, 
myocardial ischemia, congestive heart failure, hypertension, cerebrovascular disease, stroke, 
angina and others.  In general, risk factors for the development of CVD include tobacco 
smoking, high blood pressure, diabetes mellitus, physical inactivity, high cholesterol, and 
obesity.  Chronic cardiopulmonary diseases are associated with common multiple systemic 
alterations, including a dysregulation of Fe homeostasis, inflammation, microvascular 
thrombosis, and oxidative stress (Blum 2009; Omiya et al. 2009).  This dysregulation of Fe 
homeostasis associated with chronic CVD is known to cause an increase in the systemic 
labile Fe pool (Kruszewski 2004).  The labile Fe pool is an intracellular chelatable pool 
composed of both ferrous and ferric ions associated with a variety of ligands.  The labile Fe 
loosely bound to ligands is able to potentially engage in reduction-oxidation, cycling which 
may be one of the factors increasing systemic oxidative stress in these individuals (Kakhlon 
and Cabantchik 2002).  Due to these alterations, this population of individuals may compose 
a sub-group that is significantly more susceptible to the negative health effects of a variety of 
pollutants including asbestos.       
Epidemiological studies have demonstrated that individuals with chronic diseases 
such as chronic obstructive pulmonary disease, diabetes, asthma, and CVD exhibit increased 
mortality and morbidity upon exposure to particulate matter.  These findings have driven 
both the development and the increased use of animal models to study variations in human 
susceptibility to inhaled pollutants.  A number of experimentally created and genetically 
predisposed rodent models have been used in the investigation of air pollution health effects 
(Nikula and Green 2000; Kodavanti and Costa 2001; Doggrell and Brown 1998).  Our 
laboratory introduced the use of the genetically predisposed spontaneously hypertensive (SH) 
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rat for understanding CVD-related susceptibility to air pollution-induced injury a decade ago 
(Kodavanti et al. 2000).  The SH rat as a model for human CVD is now accepted and 
extensively used to study air pollution health effects.  Specifically, the SH rat mimics human 
hypertension and CVD in its pathogenesis, progression, and failure mechanisms (Schmid-
Schonbein et al. 1991; Suzuki et al. 1995; Harjai 1999).  Even though the hypertension 
displayed by the SH rat is similar to human hypertension, neither the number of gene 
polymorphisms nor the mechanism by which hypertension is initiated is currently known.  
Unlike the SH rat, the spontaneously hypertensive heart failure (SHHF) rat model of human 
CVD has not been used in air pollution susceptibility studies.  The SHHF model was 
produced by breeding an obese SH rat with a non-obese SH rat and then inbreeding the 
offspring and selecting for the unique trait of congestive heart failure (McCune et al. 1990). 
The SHHF rat is a model of more severe CVD compared to SH because it presents with heart 
failure along with diastolic dysfunction in addition to hypertension (Cheng et al. 2009). The 
SHHF is known to exhibit hypertension and myocardial hypertrophy at 4 months of age or 
earlier.  By 9 months of age, the SHHF demonstrates increased left ventricular wall thickness 
and enhanced markers of inflammation, hypertrophy and stress.  Usually by approximately 
18 months of age, they begin to present with dilated heart failure (Emter et al. 2005; Heyen et 
al. 2002).  Most animal studies typically use the Wistar Kyoto (WKY) rat as the 
normotensive reference strain in conjunction with the SH or SHHF due to the WKY being 
the genetic background for both models (Okomoto and Akoto 1963). The use of the SH rat 
has generally supported epidemiological studies in that the SH rat model has demonstrated 
exacerbated cardiac outcomes, oxidative stress, and pulmonary injury/inflammation in 
response to a number of air pollutants (Yu et al. 2008; Kodavanti et al. 2002; Kodavanti et al. 
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2006; Farraj et al., 2009) compared to WKY rats without CVD.  Due to the significant 
number of individuals suffering from CVD, air pollution susceptibility in this population is of 
concern to our society.  Regulatory agencies often set standards based on the most 
susceptible group of individuals.  This has driven research to assess a variety of pollutants for 
exacerbated responses in many possible susceptible sub-populations.   
LA has been attributed to an increase in mortality and morbidity in exposed 
individuals.  Specifically, exposure to LA has been connected to incidences of autoimmune 
disease and increases in CVD mortality.  Although the toxicity of asbestos has been well 
studied, it is not known how underlying diseases alter host susceptibility to asbestos-induced 
lung injury.  Because the significant proportion of the population suffers from CVD, any 
environmental pollutant-induced risk exacerbation will be significant.  Individuals suffering 
from CVD are recognized to have increases in endogenous Fe levels, systemic inflammation, 
and oxidative stress.  Studies have established the ability of Fe to bind to asbestos fibers and 
possibly potentiate the generation of reactive oxygen species.  Due to a dysregulation of Fe 
homeostasis, individuals with CVD may demonstrate enhanced susceptibility to the toxicity 
associated with asbestos exposure. 
I hypothesize that individuals with CVD are more susceptible to the toxicity of LA 
exposure due to the ability of their endogenous Fe to bind to the fibers.  This binding of Fe to 
the fibers will enhance their ability to produce ROS leading to increased lung damage.  Due 
to this increased output of ROS, individuals with pre-existing CVD will exhibit enhanced 
inflammation, oxidative stress, and fibrosis in response to LA-exposure.
CHAPTER 2.  PULMONARY OXIDATIVE STRESS, INFLAMMATION, AND 
DYSREGULATED IRON HOMEOSTASIS IN RAT MODELS OF 
CARDIOVASCULAR DISEASE 
 
2.1 Introduction 
Cardiovascular disease (CVD) is the most prevalent global causes of mortality and 
morbidity (Lopez et al. 2006; Sans et al. 1997).  Many epidemiological studies established 
that individuals suffering from CVD have increased susceptibility to particulate matter (PM) 
(Morris et al. 1995; Pope et al. 2004; Dominici et al. 2005; Samet and Krewski 2007) and 
other air pollutants (Yang et al. 1998; Yang et al. 2004; Zhang et al. 2006).  This increased 
susceptibility may exacerbate the negative respiratory health effects of air pollution 
compared to individuals without CVD. These findings have driven both the development and 
the increased use of animal models to study human susceptibility to inhalable pollutants 
(Kodavanti et al. 2002; Ulrich et al. 2002).  A number of experimentally created and 
genetically predisposed rodent models have been used in the investigation of air pollution 
health effects (Nikula and Green 2000; Kodavanti and Costa 2001; Doggrell and Brown 
1998).  
Our lab introduced the use of the genetically predisposed spontaneously hypertensive 
(SH) rat for understanding susceptibility to air pollution-induced injury a decade ago 
(Kodavanti et al. 2000).  Specifically the SH mimic human hypertension and CVD in its 
pathogenesis, progression, and failure mechanisms (Schmid-Schonbein et al. 1991; Suzuki et 
al. 1995; Harjai 1999). As in the case of human CVD patients, neither the number of gene 
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polymorphisms nor the mechanism by which hypertension is initiated in the SH is known.  
Unlike SH, the spontaneously hypertensive heart failure (SHHF) rat has not been used in air 
pollution susceptibility studies.  The SHHF model was produced by breeding an obese SH 
with a non-obese SH and then inbreeding the offspring selecting for the unique trait of 
congestive heart failure (McCune et al. 1990). The SHHF rat is a more severe model of CVD 
compared to SH because it presents with both hypertension and heart failure with diastolic 
dysfunction (Cheng et al. 2009).  The SHHF is known to exhibit hypertension and 
myocardial hypertrophy at 4 months of age or earlier.  By 9 months of age the SHHF 
demonstrates increased left ventricular wall thickness and enhanced markers of 
inflammation, hypertrophy and stress.  Usually by approximately 18 months of age they 
begin to present with dilated heart failure (Emter et al. 2005; Heyen et al. 2002).  Studies 
generally use the Wistar Kyoto (WKY) rat as the normotensive reference strain in 
conjunction with the SH or SHHF due to the WKY being the genetic background for both 
models (Okomoto and Akoto 1963).  The use of the SH has generally supported 
epidemiological studies in that the SH rat demonstrated increased sensitivity to air pollutants, 
specifically enhanced effects including pulmonary inflammation, vascular permeability, and 
oxidative stress (Yu et al. 2008; Kodavanti et al. 2002; 2006; Farraj et al., 2009) compared to 
WKY rats.  Although SH showed increased susceptibility to air pollution induced pulmonary 
injury, the role of their underlying pulmonary disease state has not been thoroughly 
investigated.     
Chronic human CVD and pulmonary diseases share multiple risk factors including 
systemic inflammation, oxidative stress, and dysregulation of iron (Fe) homeostasis (Blum 
2009; Omiya et al. 2009).  Dysregulation of Fe homeostasis associated with chronic CVD is 
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known to increase the systemic labile Fe pool (Kruszewski 2004).  The labile Fe pool is an 
intracellular chelatable pool composed of both ferrous and ferric ions associated with a 
variety of ligands.  The Fe within this pool is able to potentially engage in reduction-
oxidation cycling (Kakhlon and Cabantchik 2002).  Therefore, this biologically available Fe 
is tightly controlled by an array of regulatory proteins.  Increases in the labile Fe pool can 
support the production of reactive oxygen species (ROS) through Fenton/Haber-Weiss 
reactions leading to oxidative stress (Kruszewski 2003).  Such oxidant generation mediates 
inflammatory and fibrotic responses.   
The healthy lung is highly sensitive to ROS due to high levels of O2 and the presence 
of atmospheric Fe. Studies demonstrated that the pulmonary toxicity associated with ambient 
PM, tobacco smoke, and asbestos exposure may be associated with to alterations in Fe 
homeostasis (Ghio and Cohen 2005; Ghio et al. 2008a; 2008b).  These alterations are likely a 
result of an accumulation of catalytically active metal in both cells and the alveolar lining 
fluid.  This endogenous Fe exacerbates Fenton reactions and thereby produces oxidative 
damage and inflammation (Ghio et al. 2004).   
It was postulated that an altered state of Fe homeostasis exists in the lungs of both SH 
and SHHF rats producing an increase in the availability of Fe.  Furthermore, it was 
postulated that both strains will have higher pulmonary baseline levels of oxidative stress and 
inflammation than WKY.  These disease complications may account for altered susceptibility 
of SH and SHHF to respirable toxicants relative to WKY.  Studies were undertaken to 
analyze proteins involved in the uptake, storage, and release of Fe to understand each 
model’s regulation of Fe homeostasis along with various markers of baseline pulmonary 
inflammation and oxidative stress.   
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2.2 Materials and Methods 
Animals.  Healthy male, 11 to 12 weeks old, WKY, SH and obese SHHF rats were purchased 
from Charles River Laboratories, Raleigh, NC; WKY 258 ± 1.38g, SH 266 ± 2.06g, SHHF 
391 ± 6.66g, HWKY 271 ± 3.3g (Values mean weight ± S.E.).  All rats were maintained in 
an isolated animal room in an Association for Assessment and Accreditation of Laboratory 
Animal Care (AALAC) approved animal facility at 21 +/- 1°C, 50 +/- 5% relative humidity, 
and 12h light/dark cycle. The rats were allowed to acclimate for 4 weeks during their blood 
pressure and breathing parameters measurements.  Rats were housed together in pairs 
according to strain in polycarbonate cages containing beta chips bedding.  Animals received 
standard (5001) Purina rat chow (Brentwood, MO) and water ad libitum.  The protocol for 
this study was approved by the Environmental Protection Agency’s (EPA) Animal Care and 
Use Committee. 
 
Measurements of Blood Pressure, Heart Rate, and Breathing Parameters. 
Systolic blood pressure and heart rate measurements were monitered using tail cuff 
plethysmography (IITC, Inc., Life Sciences Instruments, Woodland Hills, CA.).  
Unanesthetized rats were restrained in plastic holding tubes and acclimated for 5 min prior to 
measurement of blood pressure in a temperature controlled chamber (32°C).  The monitoring 
system uses an automatic scanner, pump, sensing cuff and amplifier to determine the 
animal’s heart rate and compute blood pressure.  Three measurements of systolic blood 
pressure were taken without interfering movements from each rat, and were averaged by the 
software.  These measurements were performed three times per week and repeated over a 
three week period.     
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 Barometric plethysmography using a whole body plethysmograph system (Buxco 
Electronics, Inc., Sharon, CT) was used to acquire data on breathing parameters for all 
animals (Wichers et al. 2004; Kodavanti et al. 2005).  This instrument provided continuous 
monitoring of many breathing parameters including breathing frequency (F), tidal volume 
(TV), minute ventilation (MV), peak expiratory flow (PEF), peak inspiratory flow (PIF), 
inspiratory time (TI), expiratory time (TE), pause (Pau), and enhanced pause (Penh).   
 
Necropsy, Sample Collection, and Analysis.  Rats were weighed and anesthetized at 14 to 15 
weeks of age; WKY 289 ± 3.47g, SH 292 ± 2.89g, SHHF 525 ± 6.28g, HWKY 295 ± 6.84g 
(Values mean weight ± S.E.). with an overdose of Euthasol (Virbac AH, Inc., Fort Worth, 
TX)(50-100 mg/kg, ip), and exsanguinated via the abdominal aorta.  Blood was then 
removed from the vasculature of the lung by perfusion of Ca2+/Mg2+ free phosphate buffered 
saline (PBS) via the pulmonary artery. Upon weighing the hearts, it was noted 4 WKY rats 
presented with non-pathologic cardiac hypertrophy (heart weights >1.3g).  All other WKY 
rats demonstrated heart weights of approximately 1g and were considered to exist without 
cardiac hypertrophy.  Spontaneously occurring non-pathogenic cardiac hypertrophy with the 
absence of hypertension was previously reported in these rats (Kuribayashi 1987; Leenen and 
Yuan 1998). It was presumed that this underlying hypertrophy may obscure evaluation of 
normal baseline values in the control group with which SH and SHHF data are compared. 
Therefore, these rats were removed from our WKY normotensive control group and used to 
create another group of hypertrophic Wistar Kyotos (HWKY).   
Left ventricular tissues were frozen in liquid nitrogen and stored at -80°C for 
ascorbate and glutathione (GSH) level analysis. The trachea was then cannulated and the left 
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lung lobes were tied off.  The right lung lobes were lavaged with Ca2+/Mg2+ free phosphate 
buffered saline (pH 7.4, at 37°C) equal to 35 ml/kg body weight (representing total lung 
capacity) x 0.6 ( right lung capacity being 60% of total lung capacity).  The lung lobes were 
lavaged three times with the same PBS aliquot.  This bronchoalveolar lavage fluid (BALF) 
was collected in tubes and kept on ice for additional analysis.  The left lung lobes were then 
removed, placed in liquid nitrogen, and stored at -80°C for real time reverse transcriptase-
polymerase reaction (RT-PCR) analysis.    
  
Cell Differential and BALF Analysis.  Aliquots of BALF were taken for total cell counts 
(Coulter Inc., Miami, FL, USA), differential cell determination, and protein analysis.    
Differential cell determination was conducted by cytospin preparation (Shandon, Pittsburgh, 
PA), and slides were stained with LeukoStat (Fisher Scientific Co., Pittsburgh, PA).  
Macrophages and neutrophils were counted under light microscopy and quantified based on 
total cell count. The remaining BALF was centrifuged at 1500g, and the supernatants were 
evaluated for the following: protein content (Coomassie plus Protein Assay Kit, Pierce, 
Rockford, IL), albumin (DiaSorin, Stillwater, MN), lactate dehydrogenase (LDH) activity 
levels (Thermo Trace Ltd., Melbourne Australia), N-acetyl glucosaminidase (NAG) activity 
(Roche Diagnostics, Indianapolis IN), γ-glutamyl transferase (GGT) activity (Thermo Trace 
Ltd., Melbourne Australia), and the Fe-binding proteins, ferritin (Kamiya Biomedical 
Company, Seattle, Wa) and transferrin (Trf) (DiaSorin, Stillwater, MN).  Total Fe-binding 
capacity (TIBC) was calculated by adding the unsaturated Fe-binding capacity (UIBC) 
(UIBC Assay, Genzyme Diagnostics, Charlottetown, Prince Edward Island, Canada) and the 
non-HEME Fe (Serum Fe-SL Assay, Genzyme Diagnostics, Charlottetown, Prince Edward 
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Island, Canada).  All assays were run using commercial kits with only slight modifications 
for use on the Konelab Arena 30 clinical analyzer (Thermo Chemical Lab Systems, Espoo 
Finland).  
One aliquot of BALF was mixed with an equal volume of 6% perchloric acid and 
vortexed.  After standing on ice for 10 min., it was centrifuged (14,000 g) for 10 min. (4°C) 
and supernatants were stored at -80°C.  Ascorbate was measured in the perchloric acid 
treated supernatants by high performance liquid chromatography (HPLC) (C-18 Bondpack 
column, Millipore Waters Chromatography, Milford, MA) using amperometric 
electrochemical detection (Bioanalytical Systems, W. Layfayette, IN).  Total GSH levels 
were measured using 5,59-dithiobis(2-nitro-benzoic) acid-glutathione disulfide reductase 
recycling assay via the Konelab clinical analyzer (Anderson 1985).   
 
Lung and Heart Tissue Analysis.  Ascorbate and GSH levels were measured in the apical 
lung lobes, and, heart (left ventricle).  Individual samples were homogenized in 3% 
perchloric acid and then centrifuged (14000 g) for 10 min (4°C).  The supernatant was then 
separated into two tubes, one for GSH analysis via the Konelab clinical analyzer, and the 
other ascorbate by using HPLC as indicated before. 
 Frozen tissue was homogenized in Tris-HCl buffer (pH 7.4) with protease inhibitors 
present.  The individual samples were then centrifuged (14000 g) for 20 min (4°C) and the 
supernatant stored at -80°C.  The supernatant was used to determine total protein content, 
ferritin, transferrin (Trf), total Fe binding capacity (TIBC), and unsaturated Fe-binding 
capacity (UIBC) using the commercially available kits and the Konelab clinical analyzer as 
stated above. 
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RNA Isolation.  Total RNA was isolated from caudal lung lobes frozen in liquid nitrogen.  
The frozen tissue was homogenized in TriReagent (Sigma, St. Louis, MO), and RNA was 
isolated by RNeasy mini kit by manufacturer’s instructions (Qiagen, Valencia, CA).  RNA 
was then dissolved in 50ul of RNase free water with RNase inhibitor present.  The quantity 
of RNA was assessed using a spectrophotometer, Nanodrop 1000 (Thermo Scientific, 
Wilmington, DE).  
 
Real-Time Quantitative PCR.  One-step RT-PCR was carried out using Platinum Quantitative 
RT-PCR ThermoScript One-Step System (Invitrogen, Carlsbad, CA) following the 
manufacturer’s instructions.  PCR was performed for β-actin (Control), macrophage 
inflammatory protein (MIP-2), tumor necrosis factor-α (TNF-α), interleukin-1α (IL-1α), 
interleukin-1β (IL-1β), heme-oxygenase-1 (HO-1), transferrin receptor-1 (TFR-1), transferrin 
receptor-2 (TFR-2), transferrin (Trf), ferritin heavy chain, ferritin light chain, and the 
divalent metal transporter-1 (DMT-1).  Primers for these mRNA were purchased from 
Applied Biosystems, Inc. (Foster City, CA). Reactions were run using 100 ng of total RNA.  
RT-PCR was conducted on an ABI Prism 7900 HT Sequence Detection System (Applied 
Biosystems, Foster City, CA).  RT-PCR conditions consisted of 20 min of reverse 
transcription at 53°C and inactivation of reverse transcriptase activity for 2 min at 95°C.  
This was followed by 40 amplification cycles at 95°C for 15 sec followed by 60°C for 45 
sec. Relative fold mRNA expression was calculated for SH and SHHF rats considering the 
normal WKY values as control.  
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Statistical Analysis.  Data are expressed as mean ± S.E. (WKY, n = 8; SH, n = 12; SHHF, n = 
11; HWKY, n = 4).  Values for SH and SHHF were compared with non-hypertrophied WKY 
rats. Sigma Stat version 3.5 (Systat Software, Inc., Point Richmond, C.A.), commercially 
available software, was used to determine statistical comparisons via a one-way analysis of 
variance followed by a post-hoc comparison using the Holm-Sidak method.  Statistical 
significance was determined when p was found to be less than or equal to 0.05 between 
WKY and SH or SHHF rats.  
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2.3  Results 
2.3.1  Cardiophysiology and breathing parameters 
Both the SH and SHHF rat models exhibited increases in heart rate and blood 
pressure compared to WKY (Figure 2.1) consistent with presence of underlying CVD.  
HWKY had significantly increased heart weights compared to the normal WKY.  Since 
HWKY rats are not obese, their heart weights normalized for body weights showed an 
increase compared to WKY demonstrating their hypertrophic cardiac condition (Figure 2.1).  
However, because age-matched obese SHHF rats had increased body weight due to high 
amounts of body fat, despite their hearts being larger than non-hypertrophied WKY or SH 
hearts, heart to body weight ratio failed to indicate their hypertrophic condition (Figure 2.1).  
HWKY with hypertrophied hearts did not present with altered blood pressure when 
compared to non-hypertrophied rats, but did have elevated heart rates.  Variations in 
breathing parameters were observed between the groups (Figure 2.2).  Most notably, MV was 
significantly greater in both models of CVD which collaborated with elevation in F and slight 
increases in TV.  HWKY, however, demonstrated significant differences in MV from control 
WKY (Figure 2.2).  TI and TE were also significantly shorter in both SH and SHHF rats 
relative to WKY.   
2.3.2  Pulmonary inflammation, vascular leakage, and injury 
SHHF demonstrated significant increases in total protein in BALF when compared to 
WKY (Figure 2.3).  The concentration of total protein in BALF of SH rats was higher than 
BALF protein in WKY rats which is consistent with our previous studies (Kodavanti et al. 
2000; 2001).  Interestingly, a significant increase was observed in total protein in the 
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HWKYs compared to healthy WKY.  Albumin levels agreed with this rise in total protein.  
NAG activity, a marker of macrophage activation, was significantly elevated in SHHF 
compared to WKY and SH (Figure 2.3).  Baseline levels of LDH activities in BALF were 
also significantly higher in the SHHF than the other strains. 
 There were no markedly significant differences between the total cells present in the 
CVD models and the healthy WKY, but HWKY demonstrated an increased number of total 
cells (Figure 2.4).  This divergence in total cells between the WKY and HWKY can be 
accounted for by higher numbers of alveolar macrophages present in the HWKY as there was 
no difference in neutrophils compared to WKY; however, both the SH and SHHF had 
increased numbers of neutrophils in their BALF (Figure 2.4). 
2.3.3  Antioxidants in BALF, lung, and heart   
Analysis of glutathione in the BALF was attempted, but our assay was not sensitive 
enough to accurately detect such low amounts.  Glutathione concentrations in the lung 
homogenates were similar between SH and WKY, while GSH in the SHHF rats was 
significantly reduced (Figure 2.5).  BALF ascorbate was higher  per given volume of BALF 
in SHHF than WKY, perhaps due to markedly increased proteins in BALF  (Figure 2.5), but 
ascorbate was significantly lower in the lungs of the SHHF when compared to the WKY and 
SH.  No significant differences in antioxidant levels (GSH, and ascorbate) were observed 
between the HWKY and the WKY groups. Although the levels of GSH in the hearts did not 
differ between the 4 groups of rats, the levels of ascorbate was significantly higher in SHHF 
relative to WKY, SH, or HWKY. 
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2.3.4  Fe-binding proteins and capacities in BALF 
A number of Fe-regulatory proteins and Fe-binding capacities were analyzed in the 
BALF to evaluate the potential homeostatic mechanisms within the alveolar lining and lung 
tissue which may be altered as a result of CVD (Figure 2.6). Ferritin, an intracellular Fe 
storage protein, was significantly increased in BALF of both SHHF and HWKY compared to 
WKY.  Trf, an extracellular Fe transporter, was found to be significantly higher in the BALF 
of SH and SHHF compared to WKY.  HWKY seemed to display a quantitative decrease in 
Trf in their BALF compared to WKY.  BALF from SH demonstrated no significant changes 
in UIBC and TIBC when compared to WKY, which complements with increased amounts of 
Trf present in the BALF.  SHHF demonstrated significant decreases in UIBC and TIBC in 
the BALF compared to SH even though they had significantly higher amounts of ferritin and 
Trf (Figure 2.6).  The SHHF exhibited no marked differences when compared to WKY in 
TIBC in BALF.  This could be due to the fact that the Fe regulatory proteins in the BALF of 
the SHHF are already saturated with Fe, thus accounting for the decreased UIBC but similar 
TIBC when compared to the WKY.  No markedly significant differences occurred between 
WKY and HWKY in respect to Fe-binding capacities.  
2.3.5  Fe-binding proteins and capacities in Lung Tissue  
Lung levels of Trf and ferritin proteins were analyzed to evaluate their regulation of 
Fe in the lung and potentially determine the source of these proteins in BALF. Lung tissue 
levels of ferritin were decreased in SHHF compared to WKY, while levels of Trf were 
markedly increased (Figure 2.7).  Trf levels were also quantitatively increased in SH 
compared to WKY.  However, the UIBC was below the detection limit in SHHF, further 
supporting the hypothesis that the available Fe-binding proteins within the lungs of SHHF 
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were already occupied with non-Heme Fe.  Fe-binding proteins and Fe-binding capacities did 
not differ markedly between HWKY and WKY (Figure 2.7). 
2.3.6  Expression of mRNA markers of inflammation, oxidative stress, and Fe 
homeostasis  
Baseline differences in mRNA markers of inflammation, oxidative stress, and Fe 
homeostasis were analyzed determine pathological complications of the respiratory system 
secondary to CVD and Fe homeostasis dysregulation.  SH showed no significant changes in 
macrophage inflammatory protein-2 (MIP-2) and tumor necrosis factor α (TNF-α) compared 
to WKY (Figure 2.8) which corroborated with increased presence of neutrophils in BALF 
(Figure 2.4).  SHHF showed even greater increases in both MIP-2 and TNF-α relative to 
WKY (Figure 2.8). The lung mRNA expression of IL-1α, and IL-1β in SHHF rats was not 
statistically different from WKY or SH.  HO-1, an inducible marker of oxidative stress, was 
found at significantly higher levels in the lungs of SHHF compared to WKY and SH.  Levels 
of Trf mRNA were markedly higher in SH than in the WKY and SHHF, but SHHF had lower 
mRNA for both transferrin receptor 1 (TRF-1) and 2 (TRF-2).  The SHHF model exhibited 
no marked differences in mRNA expression in both ferritin light and heavy chain mRNA 
when compared to WKY.  The HWKY did not demonstrate any significant variations from 
control WKY in the expression of mRNA for any of the markers. 
 25
Figure 2.1 
 
Figure 2.1.  Body weight, heart weight, heart weight normalized to body weight, baseline 
blood pressure, and heart rate in 14-15 week-old healthy male WKY and cardiovascular 
compromised SH, SHHF and HWKY rats.  Cardiovascular function was assessed by heart 
rate and blood pressure measurements using tail cuff technique.  Values are mean ± S.E. 
(WKY (n =8); HWKY (n = 4); SH (n = 12); SHHF (n = 11)). * Indicates significant 
difference from WKY (control) (p<0.05), # Indicates significant difference between SH and 
SHHF (p<0.05). 
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Figure 2.2 
 
Figure 2.2.  Strain-related differences in breathing parameters among male WKY, HWKY, 
SH and SHHF rats.   Breathing parameters were assessed by whole body plethysmography 
using Buxco System. Pulmonary function illustrated by minute volume a calculated volume 
(Tidal volume x Frequency).  Values are mean ± S.E. (WKY (n =8); HWKY (n = 4); SH (n = 
12); SHHF (n = 11)). * Indicates significant difference from WKY (control) (p<0.05), # 
Indicates significant difference between SH and SHHF (p<0.05). 
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Figure 2.3 
 
Figure 2.3.  BALF concentrations levels of protein, albumin, and LDH, NAG and GGT 
activities in WKY, HWKY, SH and SHHF rats.   Values are mean ± S.E. (WKY (n =8); 
HWKY (n = 4); SH (n = 12); SHHF (n = 11)). * Indicates significant difference from WKY 
(control) (p<0.05), # Indicates significant difference between SH and SHHF (p<0.05). 
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Figure 2.4 
 
Figure 2.4.  Inflammatory cells (macrophages and neutrophils) in BALF of rat models of 
CVD.   Values are mean ± S.E. (WKY (n =8); HWKY (n = 4); SH (n = 12); SHHF (n = 11)). 
* Indicates significant difference from WKY (control) (p<0.05), # Indicates significant 
difference between SH and SHHF (p<0.05). 
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Figure 2.5 
 
Figure 2.6.  Markers of Fe homeostasis in the BALF of rat models of CVD.   Unsaturated Fe-
binding capacity (UIBC) is a measurement of the capacity of the tissue components to bind 
non-heme free Fe.  TIBC (total Fe-binding capacity), a calculated value (UIBC + non-HEME 
Fe), is a measurement of all the Fe currently bound within the BALF and the Fe capable of 
binding.    Values are mean ± S.E. (WKY (n =8); HWKY (n = 4); SH (n = 12); SHHF (n = 
11)). * Indicates significant difference from WKY (control) (p<0.05), # Indicates significant 
difference between SH and SHHF (p<0.05).  
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Figure 2.6 
 
Figure 2.6.  Markers of Fe homeostasis in homogenates of lung tissue from rat models of 
CVD.    Unsaturated Fe-binding capacity (UIBC) is a measurement of the capacity of the 
tissue components to bind non-heme free Fe.  TIBC (total Fe-binding capacity), a calculated 
value (UIBC + non-HEME Fe), is a measurement of all the Fe currently bound within the 
lung tissue homogenate and the Fe capable of binding.    Values are mean ± S.E. (WKY (n 
=8); HWKY (n = 4); SH (n = 12); SHHF (n = 11)). * Indicates significant difference from 
WKY (control) (p<0.05), # Indicates significant difference between SH and SHHF (p<0.05). 
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Figure 2.7 
 
Figure 2.7.  Baseline lung, cardiac and BALF glutathione and ascrobate in WKY, HWKY, 
SH and SHHF rats.   Values are mean ± S.E. (WKY (n =8); HWKY (n = 4); SH (n = 12); 
SHHF (n = 11)). * Indicates significant difference from WKY (control) (p<0.05), # Indicates 
significant difference between SH and SHHF (p<0.05). 
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Figure 2.8 
 
Figure 2.8.  Relative mRNA levels for markers of inflammation. Fe homeostasis, and 
oxidative stress in the lungs of WKY, HWKY, SH and SHHF rats.   Real-time reverse 
transcriptase PCR was used for analysis.  MIP-2 (Macrophage Inflammatory Protein-2), Tnf-
α (Tumor Necrosis Factor-α), IL-1α (Interleukin-1α), IL-1β (Interleukin-1β), HO-1 (Heme 
Oxygenase-1), DMT1 (Divalent Metal Transporter 1),   Trf (Transferrin), TFR-1 (Transferrin 
Receptor-1), TFR-2 (Transferrin Receptor-2), Ferritin Light Chain, and Ferritin Heavy 
Chain. Values are mean ± S.E. (WKY (n =8); HWKY (n = 4); SH (n = 12); SHHF (n = 11)). 
* Indicates significant difference from WKY (control) (p<0.05), # Indicates significant 
difference between SH and SHHF (p<0.05). 
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2.4  Discussion 
Rodent models of human CVD are increasingly being utilized to understand variations in 
human susceptibility to air pollution exposures (Kodavanti et al. 2005; Kodavanti and Costa 
2001).  The use of CVD models in these studies requires comprehensive characterization of 
baseline pulmonary pathobiology in order to elucidate the mechanisms of susceptibility 
variations.  In the current study, it was postulated that two animal models of human CVD, the 
SH and SHHF rat, would have underlying pulmonary dysregulation of Fe homeostasis, 
elevated levels of oxidative stress and inflammation compared to healthy WKY.  Our data 
supports this hypothesis in that both rat models displayed pulmonary abnormalities 
secondary to their CVD that are characterized by a baseline pulmonary dysregulation of Fe 
homeostasis that may influence their susceptibility to air pollution-induced injuries.  
Furthermore, the pulmonary tissues of the SH and more so of the SHHF exist in a state of 
increased inflammation and oxidative stress compared to the WKY.  Previous studies showed 
that SH are more susceptible than WKY to lung injury and airway inflammation induced by 
PM, tobacco smoke and sulfur dioxide (Yu et al. 2008; Kodavanti et al. 2002; 2006). Our 
study points to possible contributions of these underlying host abnormalities in their 
susceptibility to pulmonary injury from air pollutants.  Our study also provides evidence that 
the SHHF rats exists with a dysregulation of Fe homeostasis and diminished antioxidant 
compensation, which may further enhance their susceptibility to injury from air pollution 
compared to both the WKY and SH rat strains.   
A number of host physiological factors either regulated at gene transcription level or 
post transcriptionally, influence susceptibility to subsequent environmental exposure.  
Although the etiology and genetic factors which play a role in CVD predisposition in these 
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models may not exactly mimic human disease, both the SH and SHHF exhibit unique CVD 
pathobiologies that have been considered relevant to human conditions and responsive to 
broad based therapies.  The pulmonary complications, secondary to CVD in SH and SHHF 
models were also observed at physiological and biochemical levels in our study.  For 
example, the SH and SHHF rats demonstrated alterations in breathing patterns (Figure 2.2), 
which is consistent with alterations of pulmonary function in humans after exercise-induced 
increases in blood pressure (Fomina et al. 2007).  
 Numerous studies showed the SH to display systemic oxidative stress and 
inflammation that mirrors what is seen in the human condition (Turi et al. 2003; Gómez-
Amores et al. 2007; Lassègue and Griendling 2004).  No studies have investigated, in details, 
the pulmonary disease secondary to CVD. (Our study provides evidence that these rats have 
oxidative stress and inflammation within their lungs as evidenced by increased levels of HO-
1 (Figure 2.8) and decreased antioxidants (Figure 2.5) secondary to their systemic 
hypertension.  Weakening of the antioxidant response due to a chronic disease such as CVD 
may cause one to be increasingly susceptible to inhalable pollutant exposure (Scapellato and 
Lotti 2007).  The enhanced inflammation in the lung and the reduced levels of antioxidants 
are consistent with reported increases in mediators of inflammation and carbonyl content in 
various tissues in SH (Sun et al. 2006). 
SH rats have shown to be more susceptible than WKY rats to increased inflammation 
and cardiac abnormalities following exposure to a high concentration of inhaled particulate 
matter, tobacco smoke and sulfur dioxide, however, no air pollution studies have been done 
using SHHF rats (Kodavanti et al., 2002;  2006; Yu et al., 2008).  Because of much greater 
pulmonary disease and compromised compensatory response in SHHF relative to SH, it is 
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likely that they might not be able to produce as greater an inflammatory response as WKY to 
inhaled pollutants, however, they might have more sustained toxicity and oxidative stress.  
Severe forms of cardiac disease might allow one to look at the failed compensatory 
mechanisms that are responsible for increased cardiopulmonary mortality, shown in 
epidemiological studies of air pollution. 
Rats with experimentally induced heart failure were shown to have increased 
oxidative stress and the expression of HO-1 in the lung (Lam et al. 2005).  In our study, the 
genetically predisposed SHHF rat model demonstrated alterations in Fe homeostasis 
characterized by lower levels of ferritin (Figure 2.7), and decreased Fe-binding capacity 
within the alveolar lining (Figure 2.6) and the lung tissue (Figure 2.7). These deficiencies 
were corroborated with decreased lung mRNA expression for ferritin in SHHF, but not SH 
(Figure 2.8).  SHHF, despite having lower lung tissue levels than WKY, had increased 
ferritin in their BALF.  The cause for this difference is unknown but because circulating 
ferritin levels are generally lower than tissue levels in rats (Othman et al., 2008), vascular 
leackage might not fully account for increase seen in SHHF rats.  It is likely that increased 
pulmonary cell injury in SHHF might also contribute to increased BALF ferritin.  
Additionally, decreased clearance of iron-bound ferritin from the airways of the SHHF, 
might also account for an increase in BALF ferritin.  Overall, the actual mechanisms by 
which Fe metabolism is altered in the lung are not clear, but may involve increase in 
pulmonary capillary pressure due to existent diastolic dysfunction (Cheng et al. 2009), sheer 
stress-induced hemolysis, and altered microvascular thrombotic mechanisms.  Thus, our data 
supports the presence of oxidative stress and dysregulated Fe homeostasis in SHHF having 
both hypertension and heart failure. 
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There were strain differences in the expression pattern in the markers of Fe 
homeostasis dysregulation and pulmonary pathology between SH and SHHF rats. The SH, in 
general, showed milder complications. The Fe-binding capacity in SH was not fully saturated 
suggesting that the SH may still be able to accommodate exogenous Fe from air pollutants 
(Figure 2.7).  The SH lung was also capable of inducing much greater Trf expression than 
SHHF rats, suggesting that the lung of SH might not be as severely compromised as that of 
SHHF rats (Figure 2.8).  The SH might possess greater compensatory reserve. However, the 
SHHF lung based on their more severely dysregulated iron binding capacity and decreased 
lung ferrrtin might be more vulnerable to oxidative damage and injury following air pollution 
exposure.  
Previous studies have demonstrated the ability of Fe to complex with inhalable PM 
and fibers (Ghio et al. 2004; Weinrach et al. 2005).  The availability of Fe to bind to inhaled 
particulates or fibers may promote Fenton-like reactions within the reducing environment of 
the alveolar lining.  Based on the baseline pulmonary dysregulation of Fe homeostasis in SH 
and SHHF rats, it was postulated that these host factors may play roles increasing their 
susceptibility to air pollutants. Reactive species generated from the above mechanism then go 
on to damage DNA or oxidize proteins and lipids within the lung.  Our data demonstrate a 
modification of Fe homeostasis in both strains that is consistent with the dysregulation of Fe 
seen in human CVD (Tuomainen et al. 1998; Salonen et al. 1992).   
The elevated levels of oxidative stress and inflammation in this study are likely 
influenced by decreases in pulmonary antioxidants in SHHF and SH relative to WKY. It is 
difficult to ascertain from this study if lower level of antioxidants in the lungs are due to their 
increased utilization in combating existent oxidative stress or reduced production.  However, 
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diminished antioxidants likely contribute to a rise in oxidative stress, which also leads to 
increases in inflammation.  Both the SH and the SHHF showed deficiencies in lung levels of 
ascorbate and glutathione (Figure 2.5) that is in agreement with the systemic antioxidant 
deficiencies in CVD patients (Videan et al. 2009; Shih and Lusis 2009).   
 Upon necropsy during our study a subset was found within the WKY control group 
suffered from cardiac hypertrophy in absence of increase in blood pressure (Figure 2.1).  Our 
data demonstrate that these rats, due to their hypertrophy, displayed increased vascular 
leakage in their lungs compared to non-hypertrophic WKY (Figure 2.3).  The associated 
increases in neutrophils and ferritin in the BALF (Figure 2.4), but lack of rise in ferritin in 
the lung of the HWKY compared to the WKY (Figure 2.7), may relate to its vascular origin 
from enhanced leakage.  The vascular leakage in the HWKY was not as severe as seen in the 
SHHF.  It was noted during necropsy that the hypertrophic hearts in most HWKY rats were 
due to enlarged right but not left ventricles.  This might explain the lack of an increase in 
systemic blood pressure in HWKY but likely increased pressure in the pulmonary capillaries 
resulting in pulmonary vascular leakage.  The spontaneous cardiac hypertrophy in this strain 
was noted by other investigators (Kuribayashi 1987; Leenen and Yuan 1998) but the 
mechanisms are unknown. Separation of HWKY from normal WKY allowed us to precisely 
compare WKY, SH and SHHF.  This separation also allowed us to understand the role of 
non-pathogenic cardiac hypertrophy in secondary pulmonary complications.  The vascular 
leakage produced by the cardiac hypertrophy may influence the susceptibility of this model 
and cause the HWKY to be an inadequate control for these studies.  
In conclusion, our study provides the characterization of the underlying baseline 
pulmonary disease of two rat models of human CVD. Data showed increased oxidative 
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stress, inflammation, and dysregulation of Fe homeostasis in two rat models of CVD.  The 
degree of alterations in the SH model represent effects observed in hypertensive humans with 
mild cardiovascular complications, and the SHHF represents a more compromised diseased 
population with susceptibility to heart failure. Results demonstrated that SHHF rats have 
severely compromised antioxidant compensatory response and diminished Fe-binding 
capacities in the lung that is associated with oxidative stress and pulmonary vascular leakage 
at baseline. Overall, this study provides the characterization of pulmonary disease secondary 
to CVD in SH and SHHF, and lays the foundation for their use in understanding variations in 
air pollution health effects.
CHAPTER 3.  THE ROLE OF IRON IN LIBBY AMPHIBOLE-INDUCED ACUTE 
LUNG INJURY AND INFLAMMATION 
 
3.1  Introduction 
 
 Asbestos has been studied for decades for its ability to induce diseases such as 
asbestosis, mesothelioma, and lung cancer in humans after inhalation exposure (Mossman et 
al., 1990).  Although the mining and the use of asbestos contaminated materials have been 
banned in most developed countries, the health issues continue to emerge because of the long 
latency of the disease and perhaps persistent environmental exposures.  Miners in the town of 
Libby, Montana exposed to fibers during the mining of Libby amphibole (LA)-contaminated 
vermiculite exhibit increased incidences of asbestos-related diseases (Peipins et al., 2003, 
Sullivan, 2007).  Environmental exposure levels in the vicinity of the mine were also 
elevated during mining operations possibly contributing to non-occupational exposures and 
asbestos-related diseases in non-mine workers (Muravov et al., 2005, Whitehouse et al., 
2008, Vinikoor et al., 2010).  LA contains a mixture of winchite, richterite, tremolite and 
other minerals of prismatic, acicular, and asbestiform morphologies (Meeker et al., 2003). 
 The biological effects of asbestos are associated with the production of reactive 
oxygen species (ROS) and corresponding cellular injury by the oxidation of lipids, proteins, 
and DNA after exposure (Sanchez et al., 2009).  This cellular damage alters host 
antioxidants, and induces apoptosis, inflammatory cytokine release, growth factor gene 
expression, and a stress response (Kamp and Weitzman, 1999).  Cellular damage caused by 
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inhalation of asbestos can lead to the development of asbestos-related diseases.  Amphibole 
asbestos fibers are known to be extremely biopersistent within the lung causing chronic 
oxidative stress and persistent active inflammation (McDonald, 1998, Dostert et al., 2008, 
Cheng et al., 1999).  The persistent inflammation leads to increased pulmonary damage and 
contributes to the development of chronic pulmonary diseases.  Rigid fiber physicochemistry 
and biopersistence are thought to be necessary for the progression of asbestos-related chronic 
diseases.  
Iron (Fe) is a ubiquitous component of inhalable particulates and fibrous materials; 
therefore its influence on the inflammation induced by these materials has been a topic of 
interest.  Surface complexed Fe has the ability to produce ROS by providing a redox site for 
Fenton reactions to occur on the surface of asbestos fibers (Ghio et al., 2008).  Furthermore, 
increases in the amount of Fe associated with the surface of asbestos fibers have been shown 
in vivo due to complexation of endogenous Fe (Ghio et al., 2004, Gibbs et al., 1994). Fe also 
has the ability to complex the fibers in vitro in an acellular system (Shen et al., 2000).  This 
fiber-associated Fe has been postulated to redox cycle enhancing the ROS generation and 
possibly contributing to toxicity and asbestos-related diseases (Governa et al., 1999, Ghio et 
al., 2006).  Gazzano et al. (2007) demonstrated that chrysotile asbestos loaded with Fe 
stimulates DNA strand breaks and lipoperoxidation while impairing redox metabolism, and 
damages cell integrity in vitro, while Fe itself has no effect on these parameters.  Chelation of 
Fe from the surface of amosite has been shown to reduce DNA strand breaks in vitro 
(Gilmour et al., 1997, Kamp et al., 1995a).  Chelation of endogenous Fe in vivo has also been 
shown to reduce pulmonary inflammation and fibrosis after asbestos exposure (Kamp et al., 
1995b).  
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Because the binding of endogenous Fe to asbestos fibers can increase ROS 
production and its toxicity, individuals with Fe-overload might be increasingly sensitive to 
asbestos-induced injury.  Systemically disrupted Fe homeostasis and Fe-overload has been 
noted in individuals with underlying cardiovascular disease due to increased degradation of 
heme as a result of disruption of red blood cells under sheer stress (Blum, 2009, Kruszewski, 
2004).  In rodent models of cardiovascular disease, such as spontaneously hypertensive (SH) 
and SH heart failure (SHHF) rats, we have recently shown that Fe binding proteins are 
increased and binding capacities have been altered in the lungs in comparison to healthy 
Wistar Kyoto rats (Shannahan et al., 2010). We have further shown that LA-induced 
inflammation is more persistent in SH and SHHF rats which is associated with persistent 
increases in Fe binding proteins (Shannahan et al., 2011a).  
We hypothesized that, as with other fibers, Libby amphibole (LA) will bind Fe, and 
increase the inflammogenic activity of fibers in vitro and the acute lung injury and 
inflammation in vivo.  In order to address this hypothesis, we examined the ability of LA to 
bind exogenous Fe in an acellular system and evaluated Fe-related alterations in the 
production of ROS.  Furthermore, we studied the role of Fe in the acute inflammogenic 
response in vitro, using human bronchiolar epithelial cells, and in vivo, using SH rats by 
modulating fiber-associated Fe concentrations.              
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3.2  Materials and Methods 
 
Libby Amphibole.  The Libby amphibole (LA) sample was collected from the Rainy Creek 
Complex near Libby, Montana in 2007 by the United States Geological Survey (Meeker et 
al., 2003).  The sample was size fractionated by water elutriation as described previously 
(Webber et al., 2008) in order to isolate a rat respirable fraction (PM2.5) using a settling 
velocity of 3.4 x 10-4 cm s-1.  Transmission Electron microscopy showed 97.8% (135/138) of 
elutriated fibers with aspect ratios ≥ 5, consistent with the composition of fibers obtained 
from the PM2.5 elutriated fraction of the 2000 collection (Meeker et al., 2003, Webber et al., 
2008, Lowers and Bern, 2009). Fiber dimensions, as determined using transmission 
microscopy of the elutriated LA 2007 sample were: mean length 4.99µm ± 4.53 and width 
0.28µm ± 0.19; median length = 3.59µm, width = 0.23µm with upper and lower values of 
length being 0.52µm – 27.30µm and width 0.07µm – 1.15µm (Shannahan et al., 2011a).  The 
estimated fiber count for 1 mg LA sample was 218 x 106.  In comparison to the elutriated LA 
2007 sample used in the present study air samples from Libby Montana have been shown to 
contain fibers having a mean length of 7.64µm ± 8.40 and width 0.51µm ± 0.46, and median 
length 5.2µm and width 0.39µm with upper and lower values of length being 0.5µm – 
195µm and width 0.01µm – 10µm; with an aspect ratio of ≥ 5 (U.S. EPA 2010). The median 
fiber length being smaller than the mean length suggests that there are likely a larger 
proportion of fibers that are smaller than the mean length. 
 
LA Transition Metal Content.  We measured the concentrations of both the water and 1M 
HCl leachable metals associated with LA in order to gain insight into the surface metal 
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composition.  LA was suspended in saline at a concentration of 5 mg/ml, sonicated for 15 
min, vortexed, and mixed for 30 min. Samples were then centrifuged for 15 min at 14,000 
rpm and the supernatant removed for evaluation of saline leachable metal content. The pellets 
were then resuspended in 1M HCl, mixed for 30 min., centrifuged, and the supernatant 
removed for evaluation of the acid-leachable metal content. All elemental analysis was 
performed with inductively coupled plasma-atomic emission spectrometry (ICP-AES), 
following U.S. Environmental Protection Agency (EPA) Method 200.7 rev4.4 protocol (U.S. 
EPA 2007), using an axially-viewed, simultaneously-measured instrument (PerkinElmer 
4300DV ICP-OES, Bridgeport, CT). Fe content was evaluated at duplicate wavelengths of 
259.940 nm for reporting and 238.204 nm for confirmation.  Independently-sourced, matrix-
matched calibration (VHG Labs, Manchester, NH) and quality control (SPEX Certiprep, 
Metuchen, NJ) standards were used as specified by the analytical protocol. A standard 
reference material (NIST SRM 1643e, National Institute of Standards, Gaithersburg, MD) 
solution was included as an additional quality control standard during specified checks. Fe 
levels measured at the two wavelengths agreed within 10% for all measurements. To 
demonstrate method proficiency, duplicate samples of bulk solid standard references 
materials NIST 1648a and 1649b from NIST, Gaithersburg, MD, were digested using aqua 
regia. Average Fe recoveries were acceptable, with recoveries of 84% and 80%, respectively.  
 
Fe Binding.  LA was suspended in saline at a concentration of 5 mg/ml, sonicated for 15 min 
and vortexed.  The LA suspension was then mixed with an equal volume of ferric chloride 
(FeCl3) (Sigma Aldrich, St. Louis MO) at either 215 µg/ml or 21.5 µg/ml.  Samples were 
incubated at room temperature for 1 hr on a rotator before being centrifuged for 15 min at 
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14,000 rpm.  Supernatant was removed for ICP-AES analysis, to determine the amount of Fe 
remaining in solution.  Through subtracting the amount of Fe in the supernatant from FeCl3 
control samples lacking LA, we were able to determine the amount of Fe that associated with 
the fibers.  In order to validate these findings the pellet-associated Fe content was determined 
using ICP-AES.  The pellet was washed 3 times with double distilled water to remove non 
bound Fe before being digested with aqua regia, (3:1 hydrochloric acid:nitric acid). The 
amount of Fe bound to LA was then calculated by subtracting Fe released from digested 
control LA (4.34 µg/mg) without added FeCl3. Results from the two sets of experiments, 
involving the analysis of Fe lost from the supernatant and Fe bound to the fiber, yielded 
equivalent results with agreement within 93%. 
 
ROS Measurement.  LA was loaded with Fe as described above using 215 µg/ml of FeCl3, 
the concentration that provided significant Fe binding.  After incubation of LA with FeCl3 
and before performing the assay fibers were washed 3 times with saline to remove any non-
bound FeCl3 and resuspended in saline.  Acellular oxidant generation by LA with and 
without bound Fe was measured by analyzing thiobarbituric acid (TBA)-reactive products 
generated from the oxidation of deoxyribose.  The reaction mixture, containing 1.0 mM 
deoxyribose, 1.0 mM H2O2, 1.0 mM ascorbate, and 2.5 mg of LA was incubated in saline at 
37°C for 30 min with agitation and then centrifuged at 1200×g for 10 minutes. One ml of 
both 1.0% (w/v) TBA and 2.8% (w/v) trichloroacetic acid was added to 1.0 mL of 
supernatant, heated at 100°C for 10 min, cooled in ice, and the TBA-malondialdehyde adduct 
concentration was determined by its absorbance at 532 nm. 
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In Vitro Exposure of Respiratory Epithelial Cells to LA.  BEAS-2B cells (passages 70–80) 
were grown to 90% confluence on tissue culture 12-well plates (Costar) in keratinocyte 
growth medium (media).  In a series of experiments we examined the role of Fe in 
modulating LA induced toxicity in vitro.  Initially a dose-response experiment was 
performed to determine LA-induced cytotoxicity and to set an appropriate dose for 
subsequent studies. BEAS-2B cells were incubated with 0, 50, 100, or 200 µg LA/mL media 
and the release of lactate dehydrogenase (LDH) was measured in supernatants.   
Next we examined the toxicity of LA loaded with Fe (FeLA) compared to control LA 
fibers.   BEAS-2B cells were incubated with media, 2 µg FeCl3 without LA (2 µg of FeCl3 
contains the amount of Fe bound to 50 µg LA), 50 µg LA or 50 µg FeLA.  FeLA fibers were 
produced by the procedure described above including removal of free Fe by washing fibers 
with distilled water 3 times.  In order to further understand the role of fiber bound and 
endogenous cellular Fe, a Fe chelator, deferoxamine (DEF) was used to alter LA-induced 
toxicity.  BEAS-2B cells were incubated with media, 50 µg LA, 200 µM DEF, or 50 µg LA 
+ 200 µM DEF (LA + DEF).  Lastly an experiment was designed to understand how a state 
of intracellular excess Fe might affect LA-induced toxicity.  BEAS-2B cells were Fe-
preloaded during a 4hr pre-treatment with 100 µM ferric ammonium citrate (FAC) (Sigma 
Aldrich, St. Louis MO) or media, then cells were washed and incubated with media or 50 µg 
LA. The concentrations of LA used are consistent with previous in vitro experimentation of 
other asbestos samples using BEAS-2B cells (Wang et al., 2006a, Wang et al., 2006b) as 
well as in vitro studies examining the toxicity of LA (Duncan et al., 2010).  In all 
experiments supernatants and cells were collected 4 hours after exposure.  Cytotoxicity was 
also measured using LDH release in the supernatant normalized to a positive control (LDH 
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released from cells lysed with 1 ml of double distilled H2O) to obtain percent cell viability.  
Changes in cellular mRNA expression levels of β-actin (Control), interleukin-8 ( a rat 
homolog of macrophage inflammatory protein-2; MIP-2), heme-oxygenase-1 (HO-1), and 
ferritin heavy chain (FHC) were analyzed at 4 hrs as described below. FHC has been shown 
to be upregulated following acute insults as a result of mobilization of Fe likely via induction 
of HO-1 (Koorts and Viljoen, 2007). 
 
Animals.  Male, 11-12 week old SH rats were purchased from Charles River Laboratories, 
Raleigh, NC.  All rats were maintained in an isolated animal room within an Association for 
Assessment and Accreditation of Laboratory Animal Care (AALAC) approved animal 
facility at 21 ± 1°C, 50 ± 5% relative humidity, and 12 h light/dark cycle.  Rats were housed 
(2/cage) in polycarbonate cages containing beta chip bedding.  Animals received standard 
(5001) Purina rat chow (Brentwood, MO) and water ad libitum.  The U.S. EPA NHEERL 
Institutional Animal Care and Use Committee (IACUC) approved the protocol. 
 
Intratracheal Instillation of Libby Amphibole.  LA fibers were suspended in saline, sonicated 
for 15 minutes in a water bath, and vortex mixed in order to obtain uniform suspension of 
fibers for instillation. To assure that fibers did not settle at the bottom when removing 
suspension for instillation, the suspension was mixed prior to each instillation. Rats 
(n=8/time point) were anesthetized with isoflurane and intratracheally instilled as described 
previously (Wallenborn et al., 2009) with 300 µl saline only or containing 1 mg 
deferoxamine, 21 µg FeCl3, 0.5 mg of LA, 0.5 mg LA loaded with Fe (FeLA), or 0.5 mg LA 
+ 1 mg deferoxamine (LA + DEF).  
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Necropsy, Sample Collection, and Analysis.  Four hours or 1 day following instillation rats 
weighed 309 ± 1.46g (Values mean weight ± S.E.) and were anesthetized with an overdose of 
sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, ip).  Animals were 
exsanguinated via the abdominal aorta.   The trachea was then cannulated and the whole lung 
was lavaged with Ca2+/Mg2+ free PBS (pH 7.4, at 37°C) equal to 35 ml/kg body weight 
(representing total lung capacity).  The lung lobes were lavaged three times with the same 
PBS aliquot. The right lung lobes were then removed, placed in liquid nitrogen, and stored at 
-80°C for later RNA isolation.   
 
Cell Differential and Bronchoalveolar Lavage Fluid (BALF) Analysis.  Aliquots of BALF 
were taken for total cell counts (Coulter Inc., Miami, FL, USA), and cell differentials.    Cell 
differentials were determined on Cytospin preparations (Shandon, Pittsburgh, PA), of slides 
stained with LeukoStat (Fisher Scientific Co., Pittsburgh, PA).  Macrophages and neutrophils 
were counted under light microscopy and quantified based on total cell count of at least 300 
cells per slide. The remaining BALF was centrifuged, and cell-free BALF was evaluated for 
the following: total protein (Coomassie plus Protein Assay Kit, Pierce, Rockford, IL), 
albumin (DiaSorin, Stillwater, MN), lactate dehydrogenase (LDH) activity (Thermo Fischer 
Diagnostics, Middletown VA), N-acetyl-β-D-glucosaminidase (NAG) activity (Roche 
Diagnostics, Indianapolis IN), γ-glutamyl-transferase (GGT) activity (Thermo Fischer 
Diagnostics), ferritin (Kamiya Biomedical Company, Seattle, WA) and transferrin 
(DiaSorin).  Total Fe-binding capacity (TIBC) was calculated by adding the unsaturated Fe-
binding capacity (UIBC) (UIBC Assay, Genzyme Diagnostics, Charlottetown, Prince 
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Edward Island, Canada) and the non-heme Fe (Serum Fe-SL Assay, Genzyme Diagnostics).  
All assays were normalized for BALF analysis and run using the Konelab Arena 30 clinical 
analyzer (Thermo Chemical Lab Systems, Espoo Finland). 
 
RNA Isolation and Real-Time Quantitative PCR.  Total RNA was isolated from cells using 
RNeasy micro kits (Qiagen, Valencia, CA), and from caudal lung lobes frozen in liquid 
nitrogen using RNeasy mini kit (Qiagen).  One-step RT-PCR was carried out using Platinum 
Quantitative RT-PCR ThermoScript One-Step System (Invitrogen, Carlsbad, CA) via 
manufacturer’s instructions (Shannahan et al., 2010).  PCR was performed for β-actin 
(Control), macrophage inflammatory protein (MIP-2), heme-oxygenase-1 (HO-1), ferritin 
light chain (FLC), and ferritin heavy chain (FHC).  Human specific and rat specific primers 
for these mRNA were purchased from Applied Biosystems, Inc. (Foster City, CA). Relative 
fold mRNA expression was calculated considering, media exposed cells or saline exposed 
SH rats as controls.  
 
Statistical Analysis.  Data are expressed as mean ± S.E. (BEAS-2B cells, n=9/treatment 
group; SH rats, n = 8/ group).  Sigma Stat version 3.5 (Systat Software, Inc., Point 
Richmond, C.A.) was used to determine statistical comparisons via a one-way analysis of 
variance with exposure as the factor followed by a post-hoc comparison using the Holm-
Sidak method.  Statistical significance was determined when p was found to be less than or 
equal to 0.05 between treatment groups. 
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3.3  Results 
 
3.3.1 LA Surface Metal Content, Fe binding and Modulation of ROS Generation by Fe 
A very small quantity of water-leachable Fe was present on the surface of LA fibers 
(6.04 ± 2.96 ng Fe / mg of LA, Table 3.1). When LA fibers were incubated with 1M HCl, the 
quantity of Fe leached off from LA surface increased by ~100X, however the acid-soluble Fe 
is still very low relative to total Fe content of LA.  Silicon and magnesium, the two major 
structural elements of LA, were also detected in water and acid leachable fractions of LA. 
Levels are very low compared to total elemental content, indicating that neither water nor 1M 
HCl was significantly dissolving the amphibole structure. We observed that upon incubation 
of LA with FeCl3 additional Fe bound to the fibers, corresponding to 16.6 µg Fe / mg of fiber 
(Figure 3.1). The additional Fe was not dissociable after three washes with distilled water, 
demonstrating that Fe can chemically bond with LA which is not dissociable in aqueous 
media. Since a solution of FeCl3 at a concentration of 215 µg/ml provided a high level of Fe 
binding to the surface of LA (≈17 µg/mg of LA), all subsequent experiments utilizing Fe-
loaded LA were done at this concentration of FeCl3.   
LA was found to generate ROS that could be modulated via altering the availability 
of Fe in a cell free system (Figure 3.1).  Incubation of untreated LA in an acellular media 
produced ROS as determined by presence of TBA reactive substance.  Deferoxamine (DEF) 
reduced the potential of LA to produce ROS by approximately 50%.  Furthermore, through 
loading of LA with Fe, ROS generation was increased 3.5-fold.  This increase in ROS 
generation was also reduced to approximately 75% of untreated LA control levels in the 
presence of DEF (Figure 3.1). 
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3.3.2 Effect of Fe Binding and Removal from LA on BEAS-2B Cells 
BEAS-2B cells exhibited no changes in cytotoxicity at 4hr post LA exposure at all 
concentrations (Figure 3.2).   Cellular mRNA expression level of IL-8, a neutrophil 
chemoattractant and marker of inflammation, was elevated 4hr after LA exposure in a 
concentration-dependent manner.  Neither HO-1, a rate limiting enzyme of heme metabolism 
and a sensor of cellular ROS, nor ferritin, a Fe binding protein transcriptionally activated by 
increased HO-1, were altered due to LA exposure at any concentration.  Since LA at a 
concentration of 50 µg did not show any cytotoxicity but caused a significant increase in IL-
8, further in vitro experiments were performed using this concentration of LA.    
3.3.3 The Role of Fe Binding to LA on BEAS-2B Cell Expression of mRNA markers of 
Fe Homeostasis, Oxidative Stress, and Inflammation  
LA did not alter cellular mRNA expression levels of HO-1 or ferritin; however 
significant modifications were demonstrated in IL-8 transcriptional activation (Table 3.2).  
Exposure of BEAS-2B cells to LA caused a significant induction in IL-8 compared to cells 
incubated with media without added LA. Fe-loading of LA reduced the level of IL-8 
transcriptional activation seen without Fe-loading (Table 3.2A).  Exposure of cells to FeCl3 
alone (at the level that was bound to LA), did not significantly change IL-8 expression 
compared to media controls.  LA exposure in the presence of DEF caused greater increases in 
IL-8 expression when compared to LA incubations without DEF (Table 3.2B).  Exposure to 
DEF alone did not change IL-8 expression significantly when compared to media controls.  
Fe preloading of BEAS-2B cells significantly decreased the ability of LA to induce IL-8 
expression (Table 3.2C).  Preloading of cells with Fe alone was not found to affect IL-8 
expression.    
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3.3.4 The role of Fe in Modulating In Vivo Pulmonary Injury and Inflammation as 
Determined by Analysis of BALF  
In order to determine the role of Fe in altering the toxicity of LA, we intratracheally 
exposed rats to LA with or without Fe-loading and also in the presence of DEF. Since the 
transcriptional response was expected to occur earlier than the neutrophilic influx in the lung, 
we determined changes in transcription of target genes at 4 hr and inflammation at 4hr and 
24hr post exposure. BALF total cells collected from rats 24h post-exposure were elevated in 
LA and LA + DEF exposed animals (Figure 3.3).  FeLA however, demonstrated no 
significant changes from saline controls.  No changes were seen in alveolar macrophage 
counts but they trended to decrease in rats exposed to LA under all conditions.  Neutrophil 
counts were elevated in all LA exposure groups compared to saline controls however 
variations of neutrophilic influx occurred due to the availability of Fe.  In general BALF 
neutrophil counts were less in rats receiving FeLA than LA by itself. LA + DEF on the other 
hand caused a marked increase in BALF neutrophils when compared to LA groups without 
added DEF (LA + DEF > LA > FeLA).  
At 4hr post-exposure to LA, FeLA or LA + DEF, BALF LDH and NAG activities, 
used as the markers of lung cell cytotoxicity and alveolar macrophage activation, 
respectively, were elevated, whereas total protein, albumin, and GGT activity were 
unchanged (Data not shown).  At 24hr post exposure however, FeCl3 exposed animals 
demonstrated elevated (though not significantly) BALF total protein levels while all other 
treatments showed no changes (Figure 3.4).  BALF albumin levels followed a similar trend to 
total protein.  GGT and LDH activities at 24hr were unchanged after FeCl3 exposure and 
were increased in DEF, LA, FeLA, and LA + DEF groups compared to saline controls 
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(Figure 3.4).  Interestingly, animals exposed to FeLA demonstrated less LDH activity when 
compared to LA alone.  NAG activity was uniformly elevated at 24hr in all groups receiving 
LA (LA, FeLA, LA + DEF) compared to saline.  BALF ferritin levels were elevated at 24hr 
post-exposure to all LA treatments while transferrin levels were unaltered (Figure 3.5).  
Heme in BALF was increased due to DEF treatment while non-heme Fe levels were 
increased only in FeCl3 exposed animals (Figure 3.5). No specific pattern of differences in 
these parameters emerged between LA, FeLA and LA + DEF groups. 
3.3.5 Lung Expression of mRNA Markers of Fe Homeostasis, Oxidative Stress, and 
Inflammation 
MIP-2 was significantly elevated in all LA exposed groups at 4hr post-exposure; 
however variations in induction due to Fe modifications were evident (Figure 3.6).  FeLA 
caused an elevation in MIP-2 that was significantly less than what was observed in LA, 
whereas LA + DEF caused a significant increase in MIP-2 compared to LA (LA + DEF > LA 
> FeLA).  HO-1 mRNA expression was significantly increased in rats exposed to 21 µg 
FeCl3 while no changes were seen in any other exposure groups.  Ferritin heavy chain (FHC) 
was markedly elevated only in rats exposed to Fe-loaded LA compared to saline.  Ferritin 
light chain (FLC) was unchanged from control saline in all groups.     
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Table 3.1.  Leachable Metals Associated with LA 
 
Average Concentration ng Metal / mg of LA (std. error)  
        Fe                                     Si                                    Mg 
Saline 6.04 ± 2.96                  648.48 ± 18.79                 317.44 ± 2.75 
1M HCl                         845.23 ± 6.84             1416.40 ± 23.82               1060.26 ± 8.60 
 
LA was washed with either saline or 1 M HCl and supernatants were measured for leachable 
iron (Fe), silicon (Si), and Magnesium (Mg).  Values represent mean ± S.E. 
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Figure 3.1 
 
 
Figure 3.1.  The binding of Fe to LA and modulation of ROS generation in a cell-free 
environment.  A) The amount of Fe complexed with LA after an hour incubation with 215 
µg/ml or 21.5 µg/ml FeCl3 in an acellular system.  Values are mean ± SE (n = 6/ group).  B) 
Reactive oxygen species generation of LA, Fe-loaded LA (FeLA) (produced after incubation 
with 215 µg/ml FeCl3) and in the presence or absence of an Fe chelator, deferoxamine (DEF) 
in an acellular system.  Values mean ± SE (n= 3/group). * Indicates significant difference 
from LA controls (p<0.05).
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Figure 3.2 
 
 
Figure 3.2.  Cell viability (LDH), and mRNA expression for biomarkers of inflammation, 
oxidative stress, and Fe homeostasis in BEAS2B cells at 4 hour following LA exposure. 
Cells were exposed to 0, 50, 100 or 200 µg/cm2 of LA and LDH release in the media was 
analyzed.  Real-time reverse transcriptase PCR was used for analysis of IL-8 (Interleukin-8), 
HO-1 (Heme Oxygenase-1), and Ferritin heavy chain (FHC).  Values are mean ± SE (n = 9/ 
group). * Indicates significant difference from media controls (p< 0.05). 
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Table 3.2.  In Vitro Interventional Studies 
 
A. 
         Fe loaded LA (Relative mRNA Fold Change ± Std. error) 
      IL-8      HO-1    Ferritin 
Media 1.53 ± 0.67 1.07 ± 0.22 1.05 ± 0.14 
FeCl3 0.47 ± 0.05 0.91 ± 0.09 1.11 ± 0.14 
LA 24.45 ± 1.81 * 0.74 ± 0.04 0.97 ± 0.09 
FeLA 14.49 ± 0.60 * # 1.40 ± 0.28 1.50 ± 0.40 
 
B. 
          LA and Def Treatment (Relative mRNA Fold Change ± Std. error) 
      IL-8     HO-1     Ferritin 
Media 1.07 ± 0.18 1.04 ± 0.13 1.05 ± 0.16 
Def 1.62 ± 1.00 0.93 ± 0.13 1.02 ± 0.13 
LA 39.90 ± 11.51 * 0.77 ± 0.12 0.92 ± 0.14 
LA + Def 83.40 ± 10.69 * # 1.22 ± 0.09 1.23 ± 0.18 
 
C. 
        Fe Loaded Cells and LA Exposure (Relative mRNA Fold Change ± Std. error) 
      IL-8     HO-1     Ferritin 
Media 1.02 ± 0.10 1.08 ± 0.20 1.07 ± 0.19 
Fe loaded cells 1.88 ± 0.74 1.38 ± 0.20 1.30 ± 0.22 
LA 50.88 ± 6.54 * 0.87 ± 0.09 1.00 ± 0.09 
Fe loaded 
cells + LA 
12.61 ± 2.16 * # 0.95 ± 0.17 0.92 ± 0.23 
 
BEAS-2B cells were exposed for 4h to LA under a number of Fe manipulations and were 
examined for changes in mRNA expression of interleukin-8 (IL-8) a marker of inflammation, 
heme-oxygenase-1 (HO-1) a marker of oxidative stress, and ferritin a marker of Fe 
homeostasis. A) BEAS-2B cells were exposed to media (control), 1 µg FeCl3, 50 µg LA, or 
50 µg Fe loaded LA (FeLA). B) BEAS-2B cells were exposed to media (control), 200 µM 
deferoxamine (DEF), 50 µg LA, or 50 µg LA + DEF.  C) BEAS-2B cells were pretreated 
with 0 or 200 µM ferric ammonium chloride (FAC) in order to Fe preload cells.  Then cells 
were treated with either media (control) or 50 µg LA.  Values are mean fold change ± S.E. 
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Figure 3.3 
 
 
Figure 3.3.  The role of Fe binding and chelation in LA-induced influx of inflammatory cells 
(total cells, macrophages and neutrophils) in BALF of rats 24 h after exposure. Rats were 
instilled with saline (control), 21 µg FeCl3, 1 mg DEF, 0.5 mg of LA, 0.5 mg Fe-loaded LA 
(FeLA), or 0.5 mg LA + 1 mg DEF (LA + DEF).  Values are mean ± SE (n = 8/group). * 
Indicates significant difference from saline controls (p < 0.05). # Indicates significant 
difference from LA (p < 0.05).    
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Figure 3.4 
 
 
Figure 3.4.  The role of Fe binding and chelation in LA-induced changes in BALF protein, 
albumin and LDH, NAG and GGT activities in rats at 24 hour post exposure. Rats were 
instilled with saline (control), 21 µg FeCl3, 1 mg DEF, 0.5 mg of LA, 0.5 mg Fe-loaded LA 
(FeLA), or 0.5 mg LA + 1 mg DEF (LA + DEF).  Values are mean ± SE (n = 8/group). * 
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Indicates significant difference from saline controls (p < 0.05). # Indicates significant 
difference from LA (p < 0.05).    
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Figure 3.5 
 
 
Figure 3.5.  Markers of Fe homeostasis in the BALF of rats exposed to saline (control), 21 µg 
FeCl3, 1 mg DEF, 0.5 mg of LA, 0.5 mg Fe-loaded LA (FeLA), or 0.5 mg LA + 1 mg DEF 
(LA + DEF).   Values are mean ± SE (n = 8/group). * Indicates significant difference from 
saline controls (p < 0.05). # Indicates significant difference from LA (p < 0.05).    
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Figure 3.6 
 
 
Figure 3.6.  Relative mRNA levels for markers of inflammation, oxidative stress, and Fe 
homeostasis in the lungs of rats exposed to saline (control), 21 µg FeCl3, 1 mg DEF, 0.5 mg 
of LA, 0.5 mg Fe-loaded LA (FeLA), or 0.5 mg LA + 1 mg DEF (LA + DEF).  Real-time 
reverse transcriptase PCR was used for analysis of MIP-2 (Macrophage Inflammatory 
Protein-2), HO-1 (Heme Oxygenase-1), FHC (Ferritin Heavy Chain), and FLC (Ferritin 
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Light Chain). Values are mean ± SE (n = 8/group). * Indicates significant difference from 
saline controls (p < 0.05). # Indicates significant difference from LA (p < 0.05).    
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3.4  Discussion 
Fe complexed onto the surface of fibers after inhalation exposure is thought to increase the 
toxicity of asbestos by increasing ROS production through Fenton reactions. The purpose of 
this study was to systematically examine the role of surface complexed and endogenous Fe in 
exacerbating the toxicity of LA. We determined the presence of leachable surface metals, 
such as Fe and silicon on LA and examined the ability of LA to bind exogenous Fe and 
produce ROS in an acellular system.  Furthermore, we investigated the ability of this 
additional complexed Fe in modifying LA-induced inflammation in vitro (BEAS-2B cells) 
and in vivo (SH rats).  As has been reported with other asbestos materials, our data show that 
a significant quantity of Fe binds to LA.  In an acellular system with sufficient quantities of 
reducing equivalent present, Fe loading of LA increases the production of ROS while 
removal of the Fe using DEF reduces it. However, in vitro, Fe-loading of LA or Fe-
preloading of cells reduces the inflammogenic effect of LA as evidenced by a decrease in 
transcriptional activation of IL-8.  Furthermore, in vivo Fe loading of LA decreases the 
neutrophilic inflammation and inflammatory gene expression induced by LA while DEF 
increases this response.  Fe-loading of LA increases ferritin mRNA without inducing HO-1 
in vivo but not in cells. Thus, increased fiber-bound or cellular catalytically active Fe might 
reduce the acute inflammatory response caused by LA rather than increasing inflammation 
through ROS production. In situations where there is a deficiency of catalytically active Fe in 
cells or more readily available Fe binding sites on the surface of fibers, Fe might be released 
from cellular proteins that bind Fe tightly which can result in the activation of proteins, and 
signaling that leads to an inflammatory response. 
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 As with other asbestos fibers (Hardy and Aust, 1995), we noted that LA contained 
leachable Fe. More importantly, it is likely that because significant amount of silicon is 
present on the surface of LA (as evidenced by its leaching with 1 M HCl), it can bind 
exogenous Fe.  Silanol groups have been shown in other fiber types to mediate the 
complexation of endogenous Fe (Ghio et al., 2004).  At physiological pH deprotonation of 
the Si-OH groups leaves a net negative charge across the surface of the fiber allowing for the 
association of cations.  Due to the bioavailability of Fe and the high stability constant for Si-
O- and Fe cations, asbestos fibers could become saturated by exogenous Fe in an acellular 
system or with endogenous Fe in cellular systems.  We show that a substantial amount of Fe 
could complex LA in an acellular system.  Additionally, this Fe was able to redox cycle and 
increase ROS production in a cell free system consistent with what has been observed with 
other mineral fibers such as crocidolite and amosite (Ghio et al., 1992, Eborn and Aust, 
1995). It has been shown that loading of asbestos fibers with Fe increases asbestos-induced 
DNA strand breaks and oxidation byproducts via augmentation of ROS production (Gazzano 
et al., 2007).  The Fe chelator, phytic acid, has also been shown to reduce the production of 
ROS and DNA strand breaks in vitro in cellular incubations (Kamp et al., 1995a).   
The role of Fe in generating ROS was further demonstrated in our study by a 
reduction in ROS in the presence of a Fe chelator, DEF, in an acellular system.  DEF binds 
all six available coordination sites of Fe therefore blocking all redox active sites and 
inhibiting the production of ROS.  This ability of DEF to bind Fe at all of coordination sites 
makes it appropriate for the treatment of Fe-overload diseases and for the study of Fe 
mediated ROS production (Galanello et al., 2010, Poser et al., 2004).   
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It is likely that Fe can be released from fibers over time during the dissolution 
process, as has been shown to occur in case of crocidolite exposure of A549 cells (Fang and 
Aust, 1997). However dissolution can depend on the type of fiber, the solubility in an 
intracellular and lysosomal compartment and the duration of incubation. We observed that in 
case of LA, while a very small quantity of Fe was leached from fibers after water and 1 M 
HCl washing, a large quantity was Fe was bound in a very short time (1 h) upon incubation 
with FeCl3. We observed that additional Fe remained bound to LA upon washing with water. 
Our data show that when rats were exposed to FeLA, Fe remained bound to LA even in the 
lung. This assumption is supported by the fact that in rats instilled with FeCl3 but not in rats 
instilled with FeLA, cell-free BALF levels of non heme Fe were increased.  The short 
duration of exposure in our study does not allow us to examine the possibility that 
endogenous Fe can continue binding LA fibers over time, but our data are consistent in 
supporting the ability of LA to bind Fe.  
The evidence from our study on the role of Fe in LA-induced inflammogenic effects 
in cells and in vivo in rats show that Fe loading of LA decreases the toxicity of LA in cells, 
contrary to what has been shown to occur involving other asbestos fibers (Kamp et al., 
1995b). Since Fe remained associated with fibers after instillation of FeLA in the rat lung, 
and the inflammatory response of LA was reduced in the presence of surface complexed Fe, 
we can presume that release of Fe from LA fibers was not associated with a decrease in the 
inflammatory response. When cells were preloaded with Fe, a decrease in LA-induced 
inflammogenic effects suggests that the availability of cellular Fe to bind LA, likely in 
catalytically active form within a low molecular weight fraction of cytoplasm (Fang and 
Aust, 1997) might decrease the release of Fe from more tightly bound endogenous proteins 
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thereby causing a decrease in inflammatory response.  As DEF removes Fe from the surface 
of LA and proteins, it is likely that opened Fe binding sites on the surface of LA promotes 
more tightly bound iron to be released from proteins leading to their activation and signaling 
for inflammation.  The ability to chelate Fe from endogenous sources has been shown to 
contribute to the inflammatory response to bacteria in the lung as they utilize host Fe 
resources (Weinberg, 2009).  Recent research assessing the role of Fe in quartz-induced 
toxicity suggests that the movement of Fe is a key component in the inflammatory response 
(Ghiazza et al. 2011).  In our study using LA, a mixture of relatively short asbestos fibers, 
with different physiochemistry yielded similar results.  These studies together suggest that 
the differential inflammation induced by fibrous and non-fibrous particles, each with the 
ability to bind Fe can be inhibited by readily bioavailable cellular Fe.  
Since precise real-time measurement of ROS generation in cells and in lung in vivo is 
technically challenging, we chose to use induction of HO-1 as a marker of oxidative stress 
and IL-8/MIP-2- as markers for inflammatory response for in vitro and in vivo experiments. 
HO-1, an antioxidant, is involved in generating cellular Fe by catabolizing heme. Heme 
containing proteins are known to be susceptible to damage by ROS causing the release of Fe 
containing heme groups.  Both the release of heme and the presence of ROS cause the 
transcriptional activation of HO-1.  The release of Fe from HO-1 mediated heme catabolism 
causes the transcriptional upregulation of Fe storage proteins such as ferritin (Gozzelino et 
al., 2010).  The fiber itself and the ROS are known to induce an inflammatory cytokine 
release causing the recruitment of inflammatory neutrophils in an attempt to clear the foreign 
fiber (Haegens et al., 2007, Haegens et al., 2005).  The primary inflammogenic cytokines 
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(IL-8 in humans and MIP-2, a human analog of IL-8, in rats) are known to be induced after 
asbestos exposure (Hillegass et al., 2010, Duncan et al., 2010).   
LA was able to markedly induce IL-8 in BEAS-2B cells and MIP-2 in rat lungs.  
These LA-induced inflammogenic effects were not associated with transcriptional changes in 
HO-1 regardless of Fe loading. However, FeCl3 by itself increased HO-1 mRNA in vivo 
without inducing ferritin in the lung. It is likely that the kinetics of uptake and the 
bioavailability of Fe from the airway lining when in loosely-bound chemical form could be 
different from Fe bound to LA resulting in FeCl3 inducing HO-1. Since Fe loading of LA but 
not FeCl3 increased ferritin heavy chain mRNA in vivo, it is likely that Fe bound to LA 
triggered a compensatory response in the lung. It is not clear if this response might be 
involved in reducing the inflammatory response of LA.  BALF ferritin was increased in all 
animals receiving LA, demonstrating the ability of LA to influence host Fe homeostasis.  In 
cells or in the lung lining fluid, the availability of Fe binding proteins might function as 
antioxidants by sequestering metals. Furthermore, the lack of sufficient reducing equivalents 
in the lung lining might inhibit pro-oxidant reaction with Fe on LA surface and thus, ROS 
generation.  
The development of ferruginous bodies has been shown to occur years after fiber 
exposures in humans (Pooley, 1972, Treffry et al., 1987). No evidence exists to show that in 
animals the toxicity of asbestos is due to ferruginous bodies and not the fiber core, however, 
it has been shown that upon isolation of these bodies from a patient lung the production of 
ROS, as measured by DNA strand breaks in vitro, was increased relative to fibers without 
ferruginous bodies (Lund et al., 1994). From our study one can postulate that since in an 
acellular system Fe can rapidly bind LA fibers, it is likely that the inhibition of the acute 
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inflammatory response in vivo might relate to the availability p of Fe in its catalytically 
active form in cells and on the surface of the fibers. In a chronic condition, the presence of 
fibers with open Fe binding sites in the lung might lead to a new Fe equilibrium between 
proteins and the surface of the fibers causing bioactive Fe to be associated with fibers and 
possibly results in a decreased inflammatory response.  
 The intratracheal instillation produces an acute bolus response characterized by 
inflammation, however, if conducted at relatively less toxic levels of exposure, it can provide 
mechanistic insights and allow interventional strategies. Similar to the response from 
intratracheal instillation in our study, short-term inhalation of asbestos materials has been 
shown to induce acute inflammation (Dostert et al., 2008). As with instillation, in vitro 
exposures, although not realistic when conducted in relevant cell types allow one to examine 
the acute mechanisms involved in inflammogenic responses at a cellular level. Because the 
fiber length in the LA mix used in this study is relatively shorter than other asbestos materials 
such as amosite and crocidolite, it is likely that over time the intracellular and extracellular 
processes that control the Fe binding might be different with longer fibers. It has been shown 
that significant quantities of fibers are internalized by BEAS-2B cells during 24hr incubation 
with LA collected in 2000 (Duncan et al., 2010).  Because the LA sample used in the present 
study is similar to the LA sample of 2000, it is likely that the shorter fiber fractions are 
readily phagotytosed by alveolar macrophages. Uptake by alveolar macrophages of the LA 
sample in vivo may be responsible for mediating the inflammatory responses not airway 
epithelial cells such as used in our in vitro study.  Long-term retention of fibers in the lung 
will likely depend on the size range of different fractions of LA.  
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 In conclusion we determined that LA fibers contain surface silicon, can readily bind 
exogenous Fe in an acellular system and this binding can increase ROS production. 
However, loading of LA with Fe decreased the inflammatory response of LA both in vitro 
and in vivo.  By chelating LA-bound and endogenous host associated Fe, the toxicity of LA 
was increased suggesting that Fe in moderate concentrations inhibits the inflammatory 
response induced by fibers. Our data suggests that the deficiency of Fe in cells or on the 
surface of fibers might increase the acute inflammatory response of LA.
CHAPTER 4.  INFLAMMASOME ACTIVATION BY LIBBY AMPHIBOLE AND 
THE ROLE OF IRON  
 
4.1  Introduction 
 The inflammasome is a multiprotein complex which initiates the inflammatory 
cascade resulting in the innate immune response evident after exposures to a variety of 
pathogens (Pang and Iwasaki, 2011, Conforti-Andreoni et al., 2011, Martinon et al., 2002).  
The inflammasomes primarily functions through the cleavage and activation of caspases.  
These caspases once activated cleave and activate pro-inflammatory cytokines such as 
interleukin-1β (IL-1β) and interleukin-18 (IL-18).  IL-1β is known to not only mediate 
inflammatory response but also cellular apoptosis, proliferation, and differentiation.  IL-18 is 
known to be involved with activating cellular immunity after microbial exposure to LPS 
(Mojtahedi and Ghaderi, 2005). 
Depending on the activating signal the proteins that complex to form the 
inflammasome and the caspases that cleave IL-1β are different.  It has been shown that 
asbestos and silica can activate the NALP3 inflammasome after exposure (Cassel et al., 
2008, Dostert and Petrilli, 2008).  Furthermore NALP3 -/- mice have been shown to be 
protected from the development of fibrosis after silica exposure compared to wild type mice 
(Dostert and Petrilli, 2008, Cruz et al., 2007).  This has led researchers to postulate that the 
activation of the inflammasome may have a role in the development of asbestosis after 
asbestos exposure.  Asbestos exposure is also known to cause an up-regulation of IL-1β
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which is known to be vital to both the inflammation and fibrosis that occurs after asbestos 
exposure (Lindroos et al., 1997, Wang et al., 2004).    
 Previously our lab has demonstrated that through modifications of surface available 
iron (Fe) on Libby amphibole (LA) the inflammatory response can be altered both in vitro 
and in vivo (Shannahan et al. 2011b).  Specifically, we showed that the acute inflammatory 
response was dampened when LA was loaded with Fe while inflammation was enhanced 
when LA was treated with an Fe chelator.  These findings along with new research regarding 
the inflammasome led us to hypothesize that the availability of Fe on the surface of LA 
modifies the activation of the inflammasome.  In order to address this hypothesis we 
examined 1) LA’s ability to induce the inflammasome, and 2) the role of Fe in 
inflammasome induction.  Activation of the inflammasome pathway was assessed through 
analyzing mRNA expression changes after exposure to LA in the lungs of rats (Figure 4.1).  
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Figure 4.1. 
 
 
Figure 4.1.  A schematic of the inflammasome signaling pathway.  The SA Bioscience’s PCR 
array included all components of inflammasome pathway.  Capthesin-B is a known activator 
of the inflammasome that has been shown to be induced by other asbestos materials.  Genes 
encoding inflammasome complex proteins of included a variety of NALPs and ASC.  ASC is 
an adaptor protein containing a CARD domain that cleaves and activates caspase-1. NALP 
proteins are known to bind and activate ASC.  Specifically NALP3 has been shown to be 
activated by asbestos exposure.  The inflammasome activation causes the activation and 
release of caspase-1 which cleaves pro-IL-1 β and pro-IL-18 to their active IL-1β, and IL-18 
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forms. Activation of IL-18 is known to lead to the induction interferon-γ by activating natural 
killer (NK) and T cells.   
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4.2  Materials and Methods 
Animals.  Male, 11-12 week old SH rats were purchased from Charles River Laboratories, 
Raleigh, NC.  All rats were maintained in an isolated animal room within an Association for 
Assessment and Accreditation of Laboratory Animal Care (AALAC) approved animal 
facility at 21 ± 1°C, 50 ± 5% relative humidity, and 12 h light/dark cycle.  Rats were housed 
(2/cage) in polycarbonate cages containing beta chip bedding.  Animals received standard 
(5001) Purina rat chow (Brentwood, MO) and water ad libitum.  The U.S. EPA NHEERL 
Institutional Animal Care and Use Committee (IACUC) approved the protocol. 
 
Preparation of Fe loaded of LA.  LA was suspended in saline at a concentration of 5 mg/ml, 
sonicated for 15 min and vortexed.  The LA suspension was then mixed with an equal 
volume of ferric chloride (FeCl3) (Sigma Aldrich, St. Louis MO) at either 215 µg/ml.  
Samples were incubated at room temperature for 1 hr on a rotator before being centrifuged 
for 15 min at 14,000 rpm.  The pellet was washed 3 times with double distilled water to 
remove non bound Fe before being re-suspended in saline.  Based on previous 
experimentation the amount of Fe associated with the fiber is approximately 16 µg/mg of 
fiber (Shannahan et al. 2011b).  
 
Intratracheal Instillation of Libby Amphibole.  LA fibers were suspended in saline, sonicated 
for 15 minutes in a water bath, and vortex mixed in order to obtain uniform suspension of 
fibers for instillation. To assure that fibers did not settle at the bottom when removing 
suspension for instillation, the suspension was mixed prior to each instillation. Rats 
(n=8/time point) were anesthetized with isoflurane and intratracheally instilled as described 
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previously (Wallenborn et al., 2009) with 300 µl saline only or containing 1 mg 
deferoxamine, 21 µg FeCl3, 0.5 mg of LA, 0.5 mg LA loaded with Fe (FeLA), or 0.5 mg LA 
+ 1 mg deferoxamine (LA + DEF).  
 
Necropsy, Sample Collection, and Analysis.  Four hours or 1 day following instillation rats 
weighed 309 ± 1.46g (Values mean weight ± S.E.) and were anesthetized with an overdose of 
sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, ip).  Animals were 
exsanguinated via the abdominal aorta.   The trachea was then cannulated and the whole lung 
was lavaged with Ca2+/Mg2+ free PBS (pH 7.4, at 37°C) equal to 35 ml/kg body weight 
(representing total lung capacity).  The lung lobes were lavaged three times with the same 
PBS aliquot. The right lung lobes were then removed, placed in liquid nitrogen, and stored at 
-80°C for later RNA isolation.   
 
RNA Isolation and Real-Time Quantitative PCR.  Total RNA was isolated from cells using 
RNeasy micro kits (Qiagen, Valencia, CA), and from caudal lung lobes frozen in liquid 
nitrogen using RNeasy mini kit (Qiagen).  An inflammasome rat specific PCR array was 
used to analyze changes in mRNA expression due to LA exposure via manufacturer’s 
instructions (SA Biosciences, Frederick, MD).  Data were normalized to β –actin as the control 
gene.  Relative fold mRNA expression was calculated considering saline exposed SH rats as 
controls.  
 
Statistical Analysis.  Data are expressed as mean ± S.E. (SH rats, n = 6/ group).  Sigma Stat 
version 3.5 (Systat Software, Inc., Point Richmond, C.A.) was used to determine statistical 
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comparisons via a one-way analysis of variance with exposure as the factor followed by a 
post-hoc comparison using the Holm-Sidak method.  Statistical significance was determined 
when p was found to be less than or equal to 0.05 between treatment groups. 
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4.3  Results 
4.3.1 Activation of genes related to inflammasome  
In order to examine the ability to LA to induce the inflammasome as well as the role 
of Fe, gene expression of inflammasome specific markers were analyzed using SA 
Biosciences rat inflammasome arrays in lungs of rats 4 h post-exposure.  mRNA expression 
of cathepsin B, a known activator of the inflammasome, was induced after LA exposure in 
rats (Figure 4.2).  Furthermore, cathepsin B expression was at control levels when rats were 
exposed to Fe loaded LA and LA + Def.  ASC mRNA expression was also induced following 
LA exposure in rats while exposure to Fe loaded LA and LA+ Def did not induce its 
expression above control levels (Figure 4.2).  Importantly NALP3 mRNA was also elevated 
following LA exposure but remained unchanged due to Fe loading of LA or exposure to LA 
+ Def (Figure 4.2).  All LA exposures induced interleukin-1β (IL-1β) mRNA expression 
(Figure 4.2).  As observed with other genes Fe loaded LA however significantly reduced this 
IL-1 β mRNA expression.  Surprisingly this trend existed also with animals exposed to LA + 
Def.  NfĸB mRNA expression was increased following LA and LA + Def exposure.  Fe 
loading of LA however did not induce NfĸB mRNA expression.  All treatments with LA 
were able to induce mRNA expression of IL-6 compared to controls (Figure 4.2).  Fe loading 
of LA however significantly dampened the induction of IL-6 while LA + Def significantly 
enhanced the induction of IL-6 compared to LA.   
4.3.2  Gene expression of immune and inflammatory cytokines 
 Exposure to LA, Fe loaded LA or LA + Def did not alter pulmonary interferon-γ or 
interleukin-18 (IL-8) mRNA expression (Figure 4.3).  mRNA expression of the eosinophilic 
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chemokine CCL-11 was only up-regulated in rats exposed to LA + Def while expression was 
unchanged in other exposure groups (Figure 4.3).  Even though mRNA expression of CCL-
11 was increased at 4 h eosinophils were not noticeably present in the lavage at 4 or 24 h post 
exposure (data not shown).  mRNA expression of the macrophage cytokines CCL-7, CCL-
12, and CXCL3 were increased after LA exposure (Figure 4.3).  Exposure to Fe loaded of 
LA also increased these cytokines but to a lesser extent compared to LA exposed rats.  In 
general, LA + Def exposure resulted in an exacerbated induction of mRNA expression of 
these cytokines compared to LA.  Pulmonary Cox-2 mRNA expression was increased 
following exposure to Def, LA, Fe loaded LA, and LA +Def compared to controls (Figure 
4.3).  Animals exposed to LA + Def demonstrated significantly enhanced induction of Cox-2 
compared to LA.   
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Figure 4.2   
 
Figure 4.2.  Alterations in mRNA expression of genes related to activation of the 
inflammasome pathway 4 h after exposure to LA, Fe loaded LA, or LA + Def.  * Indicates 
significant difference from saline controls (p<0.05). # Indicates significant difference from 
LA exposed rats (p<0.05). 
 80
Figure 4.3. 
 
Figure 4.3. Immune and inflammatory cytokine mRNA expression 4 h after exposure to LA, 
Fe loaded LA, or LA + Def.  * Indicates significant difference from saline controls (p<0.05). 
# Indicates significant difference from LA exposed rats (p<0.05). 
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4.4  Discussion 
 Chrysotile asbestos and silica exposures have been shown to activate the NALP3 
inflammasome in mice and its activation has been found necessary to the development of 
fibrosis after silica exposure (Dostert et al., 2008). It is not known if physicochemically 
distinct asbestos materials, such as LA might induce inflammation through activation of 
inflammasome complex.  LA exposures have been associated with dose dependent increases 
in asbestosis among Libby, Montana residents (Sullivan, 2007, Moolgavkar et al., 2010).  In 
this study we examined the ability of LA to induce the inflammasome and the role of surface 
available Fe in rats.  Our data show that, like other asbestos materials, LA exposure is 
associated with increases in expression of genes related to the inflammasome pathway that 
that is associated with inflammatory response.  Furthermore, Fe loading of LA diminished 
the induction of many of these inflammasome associated genes and the related inflammatory 
response compared to LA suggesting that surface complexed Fe inhibits LA-induced 
inflammatory response through diminishing inflammasome activity.  Removal of cellular and 
LA-bound Fe by Def increased the inflammatory response induced by LA in the absence of 
increased expression of key inflammasome genes and therefore may enhance inflammation 
through an inflammasome independent mechanism.  Previous studies have demonstrated that 
the activation of the NALP3 inflammasome was dependent on two modes of activation 1) 
internalization of fibers into a phagolysome complex and increases in cathepsin B and 2) the 
production of reactive oxygen species by NADPH oxidase (Dostert et al., 2008).  Our data 
supports these studies, because LA was able to induce cathepsin B mRNA expression and 
our other studies have demonstrated an internalization of LA in alveolar macrophages.  
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Further analysis is required to demonstrate the activation of NADPH oxidase and its possible 
contribution to inflammasome activity. 
 The inflammasome once activated controls the inflammatory cascade through 
directing cleavage of pro-IL-1 β and pro-IL-18.  LA however only was shown to induce IL-1 
β but did not alter IL-18 expression.  IL-18 is known to activate natural killer cells and T 
cells causing a release of interferon-γ thereby initiating an immune response to pathogens.  
Specifically, IL-1β has demonstrated a role in the fibrosis response to asbestos exposure and 
is a well known inflammatory cytokine (Lindroos et al., 1997, Zhang et al., 1993, Kline et 
al., 1993).  This study does not examine the mechanism regulating IL-1β and IL-18 
transcription; however transcriptional activation of IL-1β is postulated to be mediated via 
activation of NADPH oxidase-mediated ROS generation and activation of NFĸB signaling.  
LA specifically increased only in IL-1 β leading to an inflammatory response not genes 
related to a specific immune response such as IL-18 or interferon-γ. 
 Interestingly loading LA with Fe significantly diminished gene expression of many 
inflammasome markers.  This leads us to postulate that catalytically available cellular Fe 
inhibits inflammasome activation. Thus, it is likely that in the absence of readily available 
catalytically active Fe, the Fe binding sites on LA might promote the removal of tightly 
bound Fe from endogenous proteins rendering them more active leading to further activation 
of the inflammasome.  Since fibers are readily internalized by alveolar macrophages in vivo 
we do not believe the loading of Fe decreases the ability of fibers to be engulfed by 
macrophage but decreases its ability to signal once engulfed through complexing endogenous 
Fe.  Treatment of LA with Def further induced the expression of many macrophage cytokines 
compared to LA and Fe loaded LA.  These findings support the conclusion that Def treatment 
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of LA enhances inflammation via an inflammasome independent pathway.  This 
inflammasome independent pathway may be related to increased recruitment and activation 
of alveolar macrophages to the site of exposure.  The increased removal of Fe from protein 
coordination sites by Def treatment may signal for this enhanced inflammatory cell influx.  
Further study into exactly how removal of Fe from LA by Def increases inflammatory cell 
recruitment required.   
Due to the LA sample being a mixture of winchite, richerite, and tremolite one can 
not determine which fiber type is causing inflammasome activation.  Further study would 
require assessing each individual fiber’s ability to induce the inflammasome.  Another 
deficiency in this study is that the whole tissue potion of the lungs were homogenized and 
assessed for inflammasome mRNA expression changes.  This could be diluting the signal as 
epithelial cells have yet to demonstrate inflammasome activity as seen in macrophages (Cruz 
et al., 2007, Hornung et al., 2008).  The next step to this study would be to isolate primary 
alveolar macrophages and analyze gene expression changes in response to fiber exposure and 
the role of surface available Fe.  It is necessary to substantiate gene expression analysis by 
assessing inflammasome specific protein levels after LA exposure and the role of Fe in 
modulating their activity.  Our previous study (Chapter 3) determined that bronchiolar 
epithelial cells exposed to LA exhibited similar modulations in inflammatory response as 
seen in our current analysis of the inflammasome.  This supports the ability of Fe to alter the 
inflammatory response in both cell types however the mechanism governing these effects is 
not clearly understood.  The ability of epithelial cells to possibly activate the inflammasome 
as well as other general mechanisms by which cells activate an inflammatory response 
requires further study.  
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 Overall our data supports the conclusion that LA like other asbestos fibers is able to 
induce the NALP3 inflammasome and cause a specific induction of IL-1 β.  This increase in 
IL-1 β may contribute to the inflammation after exposure and may influence asbestosis 
development.  Fe loading of LA was found to diminish the activity of the inflammasome.  
Def enhancement of LA-induced inflammation may be through an inflammasome 
independent mechanism or through the regulation of a different set of inflammasome genes 
since LA plus Def did not further enhance the transcription of NALP3 genes.  Due to the 
relatively short length of the LA sample it is possible that these fibers are more readily 
engulfed and therefore activate the inflammasome more readily while other longer fibers may 
activate the inflammasome primarily through ROS generation not mediated macrophage fiber 
uptake. 
CHAPTER 5.  THE ROLE OF CARDIOVASCULAR DISEASE-ASSOCIATED IRON 
OVERLOAD IN LIBBY AMPHIBOLE-INDUCED PULMONARY INJURY AND 
INFLAMMATION 
 
5.1 Introduction 
Asbestos exposure in general is known to cause pulmonary toxicity leading to a 
variety of diseases including asbestosis, mesothelioma, and lung cancer.  Miners and 
residents in the town of Libby, Montana have increased incidences of asbestos-related 
diseases, such as asbestosis and mesothelioma, associated with occupational and/or 
environmental exposure to amphibole contamination from a major vermiculite mine (Peipins 
et al. 2003, Sullivan 2007). The Libby amphiboles (LA) are a mixture of winchite, richterite, 
tremolite, and other minerals in prismatic, acicular, and asbestiform morphologies (Meeker et 
al. 2003). Because physicochemically diverse fibers can induce various diseases with varying 
potencies, toxicological studies have begun focusing on how the LA fiber mix might cause 
toxicity differently than fibers that have been studied for decades (Putnam et al., 2008; 
(Duncan et al. 2010). 
Toxicity due to inhalation of asbestos fibers has been linked to the production of 
reactive oxygen species (ROS) both directly by the fibers and indirectly by activation of 
inflammatory cells (Sanchez et al. 2009).  ROS cause cellular damage through oxidation of 
lipids, proteins, and DNA.  This damage leads to activation of cell signaling pathways and 
transcription factors that can cause a variety of alterations in gene expression related to 
antioxidants, apoptosis, cytokines, growth factors, and stress response (Kamp, Weitzman 
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1999).  The inability to clear fibers, such as amphiboles, resulting in their biopersistence 
causes the lung to exist in a state of chronic oxidative stress and inflammation due to the 
prolonged activation of inflammatory cells and the generation of ROS.   
Fe has a considerable role in the production of ROS by asbestos fibers. It has been 
postulated that Fe associated with the surface of fibers has the ability to support Fenton 
reactions using reducing equivalents, such as airway lining ascorbate, thereby generating 
ROS (Ghio et al. 2008).  Furthermore, modulation of the amount of Fe on the surface of the 
fiber alters ROS production and consequently the toxicity of fibers (Gazzano et al. 2007a).  
Chelation of Fe reduces the generation of ROS upon exposure to asbestos in vitro (Kamp et 
al. 1995a) and in vivo (Kamp et al. 1995b).  Asbestos binds endogenous chelatable Fe in vivo 
upon deposition into the airways (Ghio, Churg & Roggli 2004).  Once associated with the 
fiber, this additional Fe from the host may augment toxicity by potentiating ROS production 
(Ghio et al. 2006).  Thus, it is likely that bioavailable host Fe can modify the toxicity of 
asbestos fibers.  
Under oxidative stress, cellular Fe is generated by HO-1 catalyzed degradation of 
heme (Raval, Lee 2010). This process is known to transcriptionally activate production of 
ferritin, an intracellular Fe binding protein which is highly critical in regulating cellular 
oxidative stress and a number of cellular processes catalyzed by Fe, such as the activity of 
mitochondrial aconitase (Gozzelino, Jeney & Soares 2010). Systemically Fe homeostasis is 
maintained by a high abundant extracellular Fe transport protein, transferrin (Kibel, Belovari 
& Drenjancevic-Peric 2008). A number of cell membrane Fe and metal transporters are 
involved in tightly regulating levels of chelatable non-heme Fe (Anderson, Vulpe 2009). In 
many chronic diseases the regulation of Fe homeostasis is disrupted, especially in 
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cardiovascular (CVD), where hemoglobin is vulnerable to degradation by constant sheer 
stress on peripheral vessels (Yasuda, Funakubo & Fukui 2002).  In chronic conditions, 
individuals with CVD exhibit systemic tissue Fe-overload, including the lung (Kruszewski 
2004, Ellervik et al. 2010, Xie et al. 2008). Underlying oxidative stress and a dysregulation 
of Fe homeostasis lead to increased systemic non-heme Fe levels (Kruszewski 2004).  Due to 
the essential role of Fe in catalytic activity of a many proteins it is possible that the disruption 
of Fe homeostasis by its binding to asbestos fibers over time increases the pulmonary toxicity 
more readily in those having Fe-overload.  
 We have recently characterized dysregulation of pulmonary Fe homeostasis in two 
rat models of human cardiovascular diseases; the spontaneously hypertensive (SH) and the 
spontaneously hypertensive heart failure (SHHF) (Shannanan et al., 2010). As with human 
CVD, these rat models, (SHHF>SH) have greater transcriptional activation of lung ferritin at 
mRNA and protein level together with increased HO-1 relative to healthy rats. Also 
associated with these complications SH and SHHF exhibit an increase in chronic 
inflammation, lower antioxidant levels and oxidative stress in their lungs at baseline when 
compared to healthy Wistar Kyoto (WKY) rats (Shannahan et al. 2010). Attributable to the 
ability of asbestos to complex host-tissue Fe, we believe that SH and SHHF, with inherent 
Fe-overload are appropriate for investigating the role of Fe in pulmonary injury caused by 
fibers. We hypothesized that SH and SHHF rats will exhibit greater and prolonged lung 
injury and inflammation upon exposure to LA, relative to healthy WKY rats, due to their 
preexistent dysregulation of Fe homeostasis. To address this hypothesis, we exposed WKY, 
SH, SHHF to LA and examined changes in biomarkers associated with Fe homeostasis, 
inflammation, and oxidative stress.  
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5.2 Materials and Methods 
Libby Amphibole.  The Libby amphibole (LA) sample was collected from the Rainy Creek 
Complex near Libby, Montana in 2007 by the United States Geological Survey and was 
processed to produce inhalable material by Meeker et al., as indicated earlier (Meeker et al. 
2003).  The sample was further size fractionated by water elutriation as described previously 
(Webber et al. 2008) in order to isolate a rat respirable fraction (PM2.5) using a settling 
velocity of 3.4 x 10-4 cm s-1.  Transmission Electron Microscopy showed 97.8% (135/138) of 
elutriated fibers had aspect ratios ≥ 5 consistent with the composition of LA obtained from 
the 2000 sample (Meeker et al. 2003,Webber et al. 2008) and with the composition of LA 
obtained from the PM2.5 elutriated fraction of the 2000 collection (Lowers and Bern, 2009). 
Fiber dimensions, as determined using transmission microscopy of the elutriated LA 2007 
sample were: mean length 4.99µm ± 4.53 and width 0.28µm ± 0.19; median length = 
3.59µm, width = 0.23µm with upper and lower values of length being 0.52µm – 27.30µm 
and width 0.07µm – 1.15µm.  The estimated fiber count for 1 mg LA sample was 218 x 106.  
In comparison to the elutriated LA 2007 sample used in the present study air samples from 
Libby Montana have been shown to contain fibers having a mean length of 7.64µm ± 8.40 
and width 0.51µm ± 0.46, and median length 5.2µm and width 0.39µm with upper and lower 
values of length being 0.5µm – 195µm and width 0.01µm – 10µm; with an aspect ratio of ≥ 
5 (U.S. EPA 2010). The median fiber length being smaller than the mean length suggests that 
there are likely a larger proportion of fibers that are smaller than the mean length. 
 
Animals.  Male, 11-12 week old, healthy WKY, and SH and obese SHHF rats were 
purchased from Charles River Laboratories, Raleigh, NC.  All rats were maintained in an 
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isolated animal room in an Association for Assessment and Accreditation of Laboratory 
Animal Care (AALAC) approved animal facility at 21 +/- 1°C, 50 +/- 5% relative humidity, 
and 12 h light/dark cycle.  Rats were housed (2/cage) in polycarbonate cages containing beta 
chip bedding.  Animals received standard (5001) Purina rat chow (Brentwood, MO) and 
water ad libitum.  The U.S. EPA NHEERL Institutional Animal Care and Use Committee 
(IACUC) approved the protocol. 
 
Intratracheal Instillation of Libby Amphibole.  Since the rat respirable sample of LA was 
prepared using the water elutriation method, a uniform saline suspension of LA for 
intratracheal instillation was achieved by vortexing followed by water bath sonication for 15 
min. The suspension was vortexed prior to each instillation to ensure that fibers did not settle 
at the bottom of the tube.  In order to ensure the fibers did not interact with any biological 
molecules or chemical dispersants of the media prior to landing on the airway surface, we 
decided not to use a biological dispersion media or any other chemicals for preparing the 
instillate. Rats (WKY n=12/time point; SH n=6/time point; SHHF n=6/time point) were 
anesthetized with isoflurane and intratracheally instilled with 300 µl saline containing either 
0, 0.25, or 1.0 mg of LA as described previously (Wallenborn et al. 2009). The 
concentrations selected although high were, in general, consistent with instillation studies 
using other fiber types (Adamson, Bakowska 2001, Hirano, Ono & Aimoto 1988). Doses 
were chosen to assure a response in the lung upon instillation allowing for a comparative 
analysis between strains. Theoretically, a rat will deposit 0.07 mg of fibers during 6 hour 
inhalation at 10mg/m3 based on the assumption that minute volume is 200ml and the 
deposition fraction to pulmonary region is 0.10.  Intratracheal instillation ensured the 
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delivery of exact concentrations of LA into the lung and allowed us to control for likely 
strain-related deposition differences due to their variation in breathing parameters 
(Shannahan et al., 2010).  In our previous study approximately 30% of WKY presented with 
non-pathogenic cardiac hypertrophy (Shannahan et al. 2010).  Therefore WKY group size 
was increased (n=12) to eliminate the data from those with hypertrophic hearts (heart weight 
> 1.3g; normal heart weight ~1g) and still maintain appropriate group sizes for statistical 
comparisons.  
 
Necropsy, Sample Collection, and Analysis.  Rats were weighed (WKY 280 ± 3.46g, SH 283 
± 3.43g, and SHHF 432 ± 4.94g (Values mean weight ± S.E.)) and anesthetized with an 
overdose of sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, ip) 1 
day, 1 week, or 1 month following instillation of LA.  Blood was collected though the 
abdominal aorta into blood collection tubes, which were used for a different study.  Blood 
was then removed from the vasculature of the lung by perfusion of Ca2+/Mg2+ free phosphate 
buffered saline (PBS) via the pulmonary artery to avoid interference in data analysis 
involving Fe-binding proteins and capacities.  
The trachea was then cannulated and the left lung lobe tied off.  The right lung lobes 
were lavaged with Ca2+/Mg2+ free PBS (pH 7.4, at 37°C) equal to 35 ml/kg body weight 
(representing total lung capacity) x 0.6 (right lung capacity being 60% of total lung capacity).  
The lavage volume was normalized for SHHF to WKY rats based on the assumption that the 
lung growth and thus, volumes remained similar at a given age despite the obesity-induced 
increase in body mass of SHHF rats. The lung lobes were lavaged three times with the same 
PBS aliquot. The right lung lobes were then removed, placed in liquid nitrogen, and stored at 
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-80°C for later analysis.  The left lung was fixed at 40% of its total capacity by instillation of 
10% neutral buffered formalin through the trachea and stored in 10% formalin at 4°C until 
processed for histopathology.  
 
Cell Differential and Bronchoalveolar Lavage Fluid (BALF) Analysis.  Aliquots of BALF 
were taken for total cell counts (Coulter Inc., Miami, FL, USA), cell differentials, and 
analyses of lung injury markers.    Cell differentials were conducted by Cytospin preparation 
(Shandon, Pittsburgh, PA), and slides were stained with LeukoStat (Fisher Scientific Co., 
Pittsburgh, PA).  Macrophages and neutrophils were counted under light microscopy and 
quantified based on total cell count. The remaining cell free BALF was evaluated for the 
following: total protein (Coomassie plus Protein Assay Kit, Pierce, Rockford, IL), albumin 
(DiaSorin, Stillwater, MN), lactate dehydrogenase (LDH) activity (Thermo Fischer 
Diagnostics, Middletown, VA), N-acetyl-β-D-glucosaminidase (NAG) activity (Roche 
Diagnostics, Indianapolis IN), γ-glutamyl transferase (GGT) activity (Thermo Fischer 
Diagnostics), and the Fe-binding proteins, ferritin (Kamiya Biomedical Company, Seattle, 
WA) and transferrin (Trf) (DiaSorin, Stillwater, MN).  Total Fe-binding capacity (TIBC) was 
calculated by adding the unsaturated Fe-binding capacity (UIBC) (UIBC Assay, Genzyme 
Diagnostics, Charlottetown, Prince Edward Island, Canada) and the non-heme Fe (Serum Fe-
SL Assay, Genzyme Diagnostics).  All assays were adapted for BALF analysis and ran using 
the Konelab Arena 30 clinical analyzer (Thermo Chemical Lab Systems, Espoo Finland).  
Data were normalized to volume of BALF. 
 One aliquot of BALF was mixed with an equal volume of 6% perchloric acid and 
ascorbate was measured by HPLC (C-18 Bondpack column, Millipore Waters 
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Chromatography, Milford, MA) using amperometric electrochemical detection (Bioanalytical 
Systems, W. Layfayette, IN).  Total glutathione levels were measured using 5,5,9-
dithiobis(2-nitro-benzoic) acid-glutathione disulfide reductase recycling assay via the 
Konelab clinical analyzer (Anderson 1985). 
 
Lung Tissue Analysis.  Ascorbate and glutathione levels were measured in the caudal lung 
lobes.  Individual samples were homogenized in 3% perchloric acid, and supernatants were 
analyzed for ascorbate and glutathione as described above.  Caudal lung lobes were 
homogenized in Tris-HCl buffer (pH 7.4) with protease inhibitors present.  The individual 
samples were then centrifuged (14000 g) for 20 min (4°C) and the supernatant stored at -
80°C.  The supernatant was used to determine total protein content, ferritin, Trf, non-heme 
Fe, total Fe binding capacity (TIBC), and unsaturated Fe-binding capacity (UIBC) as stated 
above.  Data were normalized to total protein content of tissues. 
 
RNA Isolation and Real-Time Quntitative PCR.  Total RNA was isolated from caudal lung 
lobes frozen in liquid nitrogen using RNeasy mini kit (Qiagen, Valencia, CA).  One-step RT-
PCR was carried out using Platinum Quantitative RT-PCR ThermoScript One-Step System 
(Invitrogen, Carlsbad, CA) according to manufacturer’s instructions (Shannahan et al. 2010).  
PCR was performed for 18S ribosomal RNA (Control), macrophage inflammatory protein 
(MIP-2), heme-oxygenase-1 (HO-1), transferrin (Trf), ferritin light chain (FLC), ferritin 
heavy chain (FHC), and divalent metal transporter-1 (DMT-1).  Primers for these mRNA 
were purchased from Applied Biosystems, Inc. (Foster City, CA). Relative fold mRNA 
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expression was calculated for SH and SHHF rats considering the saline exposed WKY values 
as control.  
 
Lung Histopathology.  The right lung lobe was trimmed, embedded in paraffin, sectioned to a 
thickness of approximately 3 microns (transverse), and stained with hematoxylin and eosin 
(H&E).  The lung lesions were evaluated with particular attention to the lesion location (i.e, 
bronchi, terminal bronchi, alveolar duct, alveoli, interstiteum, centriacinar regions, pleura). 
The morphological evaluation took into consideration the characteristics of each 
inflammatory cellular component, i.e., polymorphonuclear cells, macrophages, fibrosis, 
microgranulomas, as well as changes in the alveolar epithelium.  Histopathological changes 
were scored using semiquantitative grading at five levels (0 = normal; 1 = minimal; 2 = mild; 
3 = moderate; 4 = severe) taking into consideration the degree of severity and the type of 
lesion (Shackelford et al. 2002, Nyska et al. 2005).  
 
Statistical Analysis.  Data are expressed as mean ± S.E. (WKY, n = 8-12/ treatment group; 
SH, n = 6/ treatment group; SHHF, n = 6/ treatment group).  Sigma Stat version 3.5 (Systat 
Software, Inc., Point Richmond, C.A.) was used to determine statistical comparisons via a 
two-way analysis of variance with strain and exposure as factors followed by a post-hoc 
comparison using the Holm-Sidak method.  Statistical significance was determined when p 
was found to be less than or equal to 0.05 between treatment groups and strains.  
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5.3 Results 
5.3.1 Pulmonary Inflammation, and Injury 
 In order to quantify inflammation and injury response following LA exposure and to 
determine the baseline strain differences, BALF samples were analyzed for various 
biomarkers. Baseline levels (saline control) of BALF protein were significantly higher in SH 
and SHHF when compared to WKY (SHHF>SH>WKY) (Figure 5.1), consistent with our 
previous study (Shannahan et al. 2010).  Surprisingly, at 1 day post-exposure no increases in 
BALF protein occurred in WKY or SH while SHHF rats exposed to LA demonstrated 
marked variability and decreases compared to strain matched control.  By 1 week, only SH 
rats (with moderate baseline increase in protein relative to WKY) exposed to LA showed 
concentration-dependent increases in total protein which persisted to 1 month. Because of the 
already very high levels at baseline, the LA-induced changes in BALF protein for 1 week and 
one month were not distinguishable in SHHF rats. Albumin levels were consistent with the 
trends demonstrated by total protein at all time points.  GGT activity was significantly 
increased in a concentration-dependent manner and regardless of protein levels in BALF in 
all strains at 1 day; however, the changes in LA-exposed WKY were significantly greater 
when compared to LA-exposed SH and SHHF rats at 1 day and 1 week (Figure 5.1).  At 1 
week through 1 month, GGT activity still remained significantly elevated after 1 mg LA 
exposure in all strains, but the magnitude of effect decreased in a time-dependent manner. 
Concentration-dependent increases in LDH activity were observed at the same level in all 
strains at 1 day (Figure 5.1).  At 1 week and continuing to 1 month, LDH activity remained 
elevated in all strains; however, the increase was more pronounced in SHHF when compared 
WKY. NAG activity, a marker of phagocyte activation increased in a concentration-
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dependent manner after LA exposure in all three strains at 1 day and 1 week with no 
remarkable strain differences and had returned to baseline by 1 month (Figure 5.1).  Despite 
markedly higher baseline BALF protein in SH and SHHF, the baseline levels of these 
enzyme markers in most instances were comparable between strains.   
 All strains exhibited robust neutrophilic influx in response to LA exposure at 1 day 
(Figure 5.2).  Interestingly, SHHF exposed to 1 mg LA had a significantly greater number of 
neutrophils in their BALF compared to WKY receiving the same dose (SHHF>SH>WKY).  
Although to a lesser extent than the 1 day time point, neutrophil increases persisted in SH 
and SHHF rats at 1 week and 1 month (SH>SHHF).  However, in the case of WKY, the 
initial robust increase in neutrophils at 1 day was largely reversed by 1 week.  In WKY, 
numbers of lavageable macrophages decreased at 1 day and 1 month in response to LA.  
BALF macrophages also decreased in SH and SHHF at 1 day, but this effect was less 
remarkable than the effect in WKY.  SH and SHHF exposed to 1 mg LA at 1 week had 
greater numbers of macrophages than controls when compared to dose-matched WKY.  This 
increase in macrophages persisted only in SH through 1 month. The value of total cells in 
each of the three strains reflected changes in macrophages and neutrophils together.  
5.3.2 Fe-Binding Proteins and Capacities in BALF 
 One of the objectives of this study was to evaluate potential strain-related differences 
in non-heme Fe pool in response to acute LA exposure. Therefore, BALF and also lung 
tissue levels of ferritin and transferrin (Trf) at both the protein and transcriptional level, and 
Fe-binding capacities were analyzed.  As we have noted in our previous study, the baseline 
(controls) BALF levels of ferritin and Trf were highly elevated in SH and SHHF when 
compared to WKY.  BALF ferritin protein levels were found to be significantly elevated only 
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in SH and SHHF exposed to LA in a concentration-dependent manner through 1 month 
(Figure 5.3).  At 1 week and 1 month, SH, but not WKY or SHHF exposed to 1 mg LA, 
showed increases in BALF Trf relative to strain matched controls.  The increases in Trf 
might reflect greater vascular protein leakage, as demonstrated by BALF protein leakage, 
since circulating levels of Trf, unlike ferritin, are high as it serves as a major systemic Fe 
transporter protein (Anderson, Vulpe 2009, Ghio et al. 1998). 
The BALF levels of non-heme Fe, as in the case of ferritin and Trf, were also 
significantly elevated at baseline (saline controls) in both SH and SHHF when compared to 
WKY.  Non-heme Fe increased only in SH, but not in WKY or SHHF rats, in a 
concentration-dependent manner at 1 day and 1 week time points (Figure 5.3) which is 
associated with increases in vascular protein leakage.  The non-heme Fe data at 1 month was 
highly variable within and between groups and inconsistent with other time points. We 
presumed that determination of airway lining Fe-binding capacity might allow one to 
understand the role of Fe movement between BALF Fe-binding proteins and inhaled fibers.  
We determined unsaturated and saturated (total) Fe-binding capacities (UIBC and TIBC) in 
BALF.  Although the levels appeared to be high in SH and SHHF, no significant baseline 
strain differences existed in UIBC in the present study (Figure 5.3). This is unlike our 
previous study where SH and SHHF rats had increased unsaturated Fe-binding capacities in 
BALF (Shannahan et al. 2010). The changes in BALF UIBC due to LA exposure were small 
and showed an increase which was significant only in WKY at one month when compared to 
WKY saline control.  In general, TIBC was found to be elevated in control SHHF compared 
to control WKY (Figure 5.3).  LA exposure did not alter TIBC at any time point in any 
strain. 
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5.3.3 Lung Expression of mRNA Markers of Fe Homeostasis, Oxidative Stress, and 
Inflammation 
 To understand the relationship between LA-induced pulmonary injury/inflammation 
and Fe homeostasis, we determined transcriptional levels of genes that regulate heme 
catabolism, Fe transport, Fe storage, oxidative stress and inflammation in rats exposed to 
saline or LA.  As expected, the baseline expression of MIP-2 (a potent neutrophil 
chemoattractant), and HO-1 (a marker of oxidative stress) were markedly elevated in SH and 
SHHF relative to WKY, which supports the baseline differences in neutrophilic inflammation 
between the three strains.  Surprisingly, only WKY increased MIP-2 in a concentration-
dependent manner at 1 day in response to LA, despite neutrophilic inflammation being 
similar in all three strains at 1 day and persistent in SH and SHHF up to 1 month (Figure 
5.4).  No exposure-related induction of HO-1 expression was noted at 1 day in any of the 
strains; on the contrary, its expression was decreased from already high baseline by LA-
exposure in SHHF (Figure 5.4).  At 1 week after 1 mg LA exposure, HO-1 expression was 
increased only in the SH rats. Because ferritin protein is made of a ferritin light chain (FLC) 
and a ferritin heavy chain (FHC), each possessing different kinetic property for binding Fe, 
we determined transcriptional activation of both these subunits.  FHC at all time points and 
FLC mRNA at 1 day and 1 week demonstrated no consistent strain-related baseline 
differences (saline controls), however, at 1 month the expression of FLC in SH and SHHF 
was greatly enhanced at baseline relative to WKY. These baseline alterations suggest a 
disease associated progression in FLC expression. FLC mRNA was not induced after LA 
exposure in any strains at 1 day or 1 week, except for a small but significant rise in SHHF at 
0.25 mg LA dose. However at 1 month its expression increased in WKY as well as SH at 
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high concentration of LA. Surprisingly, SHHF showed a significant decline in its expression 
from already increased baseline, suggesting that less compromised SH retained the capacity 
to sustain LA-induced FLC expression while highly compromised SHHF, lost this ability. 
FHC mRNA expression was elevated in a concentration-dependent manner in only in SHHF 
at 1 day but not at later time points.  No consistent strain or exposure-related differences 
were noted in Trf or divalent metal transporter-1 (DMT-1). 
5.3.4 Fe-Binding Proteins and Capacities in Lung Tissue  
 Lung ferritin protein also exhibited strain related differences at baseline 
(SHHF>SH>WKY), which were unchanged 1 day after exposure to LA.  At 1 week, 
however, only SH rats exposed to 1 mg LA had increased ferritin protein in lung tissue 
compared to saline controls (Figure 5.5).  At 1 month no changes in ferritin levels were 
observed due to exposure in any strain.  Lung Trf protein levels were generally higher at 
baseline in SH and SHHF rats. LA exposure did not affect Trf protein in the lung at any time 
in WKY and SHHF but resulted in a concentration-dependent increase at 1 day in SH rats 
(Figure 5.5).  No major alterations were seen in lung tissue levels of non-Heme Fe, 
unsaturated Fe-binding capacity (UIBC), or total Fe-binding capacity (TIBC) (data not 
shown).   
5.3.5 Antioxidant Levels in BALF and Lung Tissue   
 Alveolar Fe homeostasis and oxidative stress will likely be influenced by antioxidants 
such as ascorbate and glutathione in BALF and lung tissue.  Baseline ascorbate levels in 
BALF were generally lower in SH and SHHF when compared to WKY (Figure 5.6).  SH, 
and to some extent WKY and SHHF, exposed to 0.25 mg of LA at all time points exhibited a 
 99
general decrease in BALF ascorbate when compared to their saline controls; however, most 
of these changes were insignificant except in SH at 1 day.  There were marked variations in 
the baseline levels of lung tissue ascorbate between all three strains at each time point.  
Ascorbate in the lung tissue of SH was decreased due to exposure at 1 day, while WKY and 
SHHF demonstrate no marked changes.  At 1 week lung tissue ascorbate levels were elevated 
in WKY in response to 0.25 mg LA exposure but unchanged in both SH and SHHF.  WKY 
lung tissue ascorbate levels returned to baseline by 1 month while SH still demonstrated 
decreases after exposure.  BALF glutathione levels were undetectable in all strains, while 
lung levels of glutathione were not found to be different between strains at baseline and 
remained unaltered due to LA exposure in all animal models (Figure 5.6). 
5.3.6 Lung Histopathology 
Although the strain related differences in specific biomarkers in lung and BALF were 
apparent, pathologically the LA-induced lesion severity differences could not distinguished 
between strains. Marked histological alterations were noted in all three strains in time- and 
concentration-related manner following LA exposure (Table 5.1).  At 1 day the types of 
lesion characterized by acute alveolar neutrophilic inflammation and cell injury were LA 
concentration-dependent. The distribution of inflammatory foci in the lungs at 1 day was 
centriacinar but multifocal, and generally consisted of neutrophilic influx, associated with 
macrophages present within the lumen of the terminal bronchiole, alveolar duct, and adjacent 
alveoli (Figure 5.7 A, B and C). These changes were associated with minimal alveolar 
hyperplasia, in which the lining alveolar epithelium tended to be cuboidal instead of 
flattened.  No incidences of interstitial fibrosis were observed at 1 day in any strain at either 
dose.  However, at 1 week and at 1 month as shown in Figure 5.7 E and F, all animals 
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developed multifocal interstitial fibrosis and alveolar hyperplasia in a concentration-
dependent manner (Table 5.1 and Figure 5.7 D, E and F).  By 1 month neutrophil-like cells 
were not readily apparent while macrophages persisted within alveoli and interstitium 
(Figure 5.7).  In few rats receiving 1 mg of LA focal granuloma-like formation was noted at 
this time. The severity scores and incidence for each of these pathological indices are given 
in Table 5.1. 
 101
Figure 5.1 
 
 
Figure 5.1.  Temporal changes in BALF protein, albumin, and LDH, NAG and GGT 
activities in WKY, SH and SHHF rats following intratracheal instialltion of saline (control), 
0.25 mg LA, or 1 mg LA. Values are mean ± SE (WKY, n =8-12/group; SH and SHHF, n = 
6/group). * Indicates significant difference within strain in respect to saline controls 
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(p<0.05). # Indicates significant difference from WKY at the same exposure concentration 
(p<0.05). 
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Figure 5.2 
 
 
Figure 5.2.  Alterations in inflammatory cells (total cells, macrophages and neutrophils) in 
BALF of WKY, SH, and SHHF instilled with saline (control), 0.25 mg LA, or 1 mg LA.  
Values are mean ± SE (WKY, n =8-12/group; SH and SHHF, n = 6/group). * Indicates 
significant difference within strain in respect to saline controls (p<0.05). # Indicates 
significant difference from WKY at the same exposure concentration (p<0.05). 
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Figure 5.3 
 
 
 
Figure 5.3. Time-related changes in markers of Fe homeostasis in the BALF of WKY, SH, 
and SHHF intratracheally exposed to saline (control), 0.25 mg LA, or 1 mg LA.  Unsaturated 
Fe-binding capacity (UIBC) is a measurement of the capacity of BALF components to bind 
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catalytically active Fe.  TIBC (total Fe-binding capacity), a calculated value (UIBC + non-
heme Fe), is a measurement of all the Fe currently bound to BALF components.   Values are 
mean ± SE (WKY, n =8-12/group; SH and SHHF, n = 6/group).  *Indicates significant 
difference within strain in respect to saline controls (p<0.05). # Indicates significant 
difference from WKY at the same exposure concentration (p<0.05). 
 
 106
Figure 5.4 
 
 
 
Figure 5.4.  Relative mRNA expressions for markers of inflammation, Fe homeostasis and 
oxidative stress in the lungs of WKY, SH, and SHHF rats exposed to saline (control), 0.25 
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mg LA, or 1 mg LA.  Real-time reverse transcriptase PCR was used for analysis.  MIP-2 
(Macrophage Inflammatory Protein-2), HO-1 (Heme Oxygenase-1), Trf (Transferrin), FLC 
(Ferritin Light Chain), FHC (Ferritin Heavy Chain), and DMT1 (Divalent Metal Transporter 
1). Values are mean ± SE (n = 6/group). * Indicates significant difference within strain in 
respect to saline controls (p<0.05). # Indicates significant difference from WKY at the same 
exposure concentration (p<0.05). 
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Figure 5.5 
 
Figure 5.5. Temporal changes in ferritin and transferrin in the lung tissue of WKY, SH, and 
SHHF rats following single intratracheal instillation of saline (control), 0.25 mg LA, or 1 mg 
LA.  (WKY, n =8-12/group; SH and SHHF, n = 6/group). * Indicates significant difference 
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within strain in respect to saline controls (p<0.05). # Indicates significant difference from 
WKY at the same exposure concentration (p<0.05). 
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Figure 5.6 
 
 
Figure 5.6.  BALF and Lung tissue glutathione and ascrobate in WKY, SH, and SHHF rats 
exposed intratracheally to saline (control), 0.25 mg LA, or 1 mg LA.  Values are mean ± S.E 
(WKY, n =8-12/group; SH and SHHF, n = 6/group). *Indicates significant difference within 
strain in respect to saline controls (p<0.05). # Indicates significant difference from WKY at 
the same exposure concentration (p<0.05). 
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Table 5.1.  Histological evaluation showing the mean severity of lesions after exposure 
to LA in WKY, SH, and SHHF rats. 
 Average Score of Pathology Severity 
 (Number of Animals Affected by Exposure) 
Time 
Point 
Rat 
Strain 
LA 
Conc. 
(mg/rat) 
Animals/ 
 group 
Neutrophils Macrophages Epithelial 
Hyperplasia 
Interstitial 
Fibrosis 
Granuloma 
Formation 
1 Day WKY 0.0 
0.25 
1.0 
10 
10 
11 
0.1 (1) 
0.5 (4) 
2.0 (10) 
0.1 (1) 
0.7 (6) 
1.6 (10) 
0.1 (1) 
0.2 (2) 
0.9 (9) 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
 SH 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
1.0 (6) 
1.0 (6) 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
 SHHF 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
1 
Week 
WKY 0.0 
0.25 
1.0 
11 
10 
11 
0.0 
0.0 
1.0 (11) 
0.0 
1.0 (10) 
2.0 (11) 
0.0 
1.0 (10) 
2.0 (11) 
0.0 
0.0 
1.0 (11) 
0.0 
0.0 
0.0 
 SH 0.0 
0.25 
1.0 
6 
6 
6 
0.2 (1) 
0.0 
1.0 (6) 
0.2 (1) 
1.0 (6) 
2.0 (6) 
0.2 (1) 
1.0 (6) 
2.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
0.0 
 SHHF 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.0 
1.0 (6) 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
1.0 (6) 
2.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
0.0 
1 
Month 
WKY 0.0 
0.25 
1.0 
8 
8 
12 
0.0 
0.0 
0.0 
0.3 (2) 
1.0 (2) 
2.0 (12) 
0.0 
0.0 
1.0 (12) 
0.0 
0.0 
1.0 (11) 
0.0 
0.0 
0.2 (2) 
 SH 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.0 
0.0 
0.0  
1.0 (6) 
2.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
0.3 (2) 
 SHHF 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.0 
0.0 
0.0 
0.0 
2.0 (6) 
0.0 
0.0  
1.0 (6) 
0.0 
0.0 
1.0 (6) 
0.0 
0.0 
0.2 (1) 
 
WKY, SH, and SHHF rats exposed to saline (control) or LA (0.25 or 1.0 mg/rat) were 
examined for pulmonary lesion types and the location.  The number within bracket shows the 
number of rats that are affected per total number of rats examined per group. These lesions 
were classified to reflect alveolar infiltration of neutrophils and macrophages, alveolar 
epithelial hyperplasia, and interstitial fibrosis.  Note that within the time points studied in the 
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present experiment, no pleural thickening, inflammation or fibrosis were noted. Lesions were 
graded on a scale of increasing severity from 1-4 and the mean severity of lesions reflect the 
average score per animal.  
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Figure 5.7 
 
 
 
Figure 5.7. Time related histological alterations in the lung following a single intratracheal 
instillation of LA in WKY rats demonstrated after H & E staining. The photomicrographs for 
WKY rats 1 day and 1 month post-exposure to saline, 0.25, and 1.0 mg LA are shown. A and 
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D: Representative histological sections of lungs from WKY rats exposed to saline at 1 day 
and 1 month, respectively. B and E: Histological sections of lungs from WKY rats exposed 
to 0.25 mg LA at 1 day and 1 month, respectively. C and F:  Histological sections of lungs 
from WKY rats exposed to 1.0 mg LA at 1 day and 1 month, respectively.  Red arrows 
denote alveolar neutrophilic influx, green arrows show intra alveolar macrophage 
accumulation, blue arrows indicate alveolar hyperplasia, and black arrows interstitial fibrosis.  
All images are at X 20 magnification. 
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5.4 Discussion 
 The ROS generation and toxicity of asbestos fibers has been shown to be increased by 
surface-complexed Fe and also by binding of tissue-associated Fe (Kamp et al. 1995b, 
Governa et al. 1999, Gazzano et al. 2007b). In this study, we postulated that genetically-
predisposed rat models with CVD-associated pulmonary Fe-overload would show greater 
pulmonary injury and inflammation following LA exposure when compared to healthy WKY 
rats due to increased availability of endogenous Fe to complex with LA.  While initial 
inflammatory response to LA was only slightly exacerbated in SHHF, we found that there 
was a greater persistency of inflammation in SH and SHHF relative to WKY. This was 
associated with changes in Fe homeostasis biomarkers with a general increase in Fe binding 
proteins only in SH and SHHF rats suggesting that more readily available endogenous 
protein-complexed Fe might be released over time to bind LA fibers thus, causing 
persistency in inflammation. The formation of ferruginous-bodies over asbestos fibers is 
known to occur with persistent inflammation over a long period of time in humans (Ghio et 
al., 2003).   
MIP-2, which is a major neutrophil chemotectic factor in rats (Smartt et al. 2010), has 
been shown to be increased in epithelial and mesothelial cells in vitro, and in the pleural 
lavage of F344 rats following asbestos exposure (Hill et al., 2003; Driscoll et al., 1998). 
WKY were able to mount an acute and largely reversible inflammatory response 
(neutrophilic influx) with the reversible induction of MIP-2 mRNA, which was associated 
with activation of alveolar macrophages (increased NAG activity in BALF).  However, SH 
and SHHF, despite their initial robust neutrophilic inflammation at 1 day, did not transiently 
increase expression of MIP-2. Antioxidant deficiency in alveolar lining might result in earlier 
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MIP-2 induction in SH and SHHF rats. Ascorbate, a key antioxidant of airway lining and the 
first line of defense, was lower at baseline in SH and SHHF and not increased following LA 
exposure when compared to WKY.  Early initial oxidant stress might have triggered MIP-2 
expression prior to 1-day in SH and SHHF while it was delayed in WKY due to availability 
of sufficient ascorbate in the airway lining. Our subsequent studies have shown induction of 
MIP-2 at 4 hours in SH rats following LA exposure (Shannahan et al., 2011a).  
Exposure to asbestos has been shown to cause acute pulmonary inflammation 
following intratracheal instillation and inhalation exposure in animals and has been 
postulated to contribute to chronic diseases (Dostert et al. 2008, Fattman et al. 2006).  The 
predominance of neutrophilic inflammation acutely after LA exposure is expected based on 
the physicochemical nature of inhaled fibers as observed in earlier studies (Putnam et al. 
2008, Dorger et al. 2002). In the present study however, the mechanisms mediating this 
inflammatory response was likely different between healthy and Fe-overloaded CVD models 
because only WKY transiently increased MIP-2 mRNA in response to LA exposure at 1 day 
while only SH and SHHF demonstrated changes in Fe regulatory proteins.  The observation 
that neutrophilic influx was more persistent in SH and SHHF compared to WKY exposed to 
LA suggests that they may be more sensitive to developing chronic active inflammation 
associated with lung disease.  
Biomarkers of Fe homeostasis were significantly elevated at baseline and also 
changed in response to LA in only in SH and SHHF relative to WKY. Specifically, the 
expression of FHC, which is considered important in sequestering Fe during acute 
inflammation/injury (Koorts and Viljoen 2007) was induced only acutely and only in SHHF 
rats in an LA concentration-dependent manner which was accompanied by increases in 
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BALF ferritin. FLC, which is known to be induced with chronic Fe-overload, was increased 
later in SH and SHHF at baseline consistent with its role in long-term baseline inflammation. 
However, unlike SH and WKY, the inability of SHHF to transcribe FLC in response to LA at 
1 month when baseline expression is already very high, suggests that more severe Fe-
overload might impair their ability to further increase ferritin which can lead to increases in 
the availability of catalytically active Fe and thus, might contribute to chronic inflammation 
and injury following LA exposure. Increases in BALF ferritin were associated with an 
increased non-heme Fe and Trf in SHHF at baseline and also following LA exposure. These 
data further support the hypothesis that increased mobility of endogenous Fe from its protein-
bound form in rat models of CVD-associated Fe-overload and their inability to maintain 
normal Fe homeostasis likely contribute to persistent inflammation and exacerbated 
pulmonary disease. 
Heme oxygenase-1 (HO-1) is an inducible enzyme which catabolizes heme into labile 
Fe, carbon monoxide, and biliverdin (Driscoll et al. 1998, Gozzelino, Jeney & Soares 2010).  
The labile Fe released from HO-1 induces ferritin production, which binds and stores Fe, 
thereby reducing oxidative stress and thus plays an important role in the antioxidant response 
to Fe-mediated ROS generation.  The regulation of HO-1 as well as its other downstream 
effects lacks sufficient study.  However, it is thought that induction of HO-1 may be biphasic, 
peaking rapidly initially after exposure and then again induced months after.  In our study, 
only SH rats exposed to LA were able to induce HO-1 mRNA expression at 1 week which 
accompanied elevations in BALF and lung ferritin protein but not mRNA suggesting that 
transcriptional activation might have occurred in the course of 1 week. The increased 
baseline expression of HO-1 coincided with high baseline levels of ferritin protein and 
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mRNA in SHHF rats. Interestingly, SHHF, already high in baseline expression, showed an 
inhibition of HO-1 expression at 1 day due to LA exposure.  Since mice lacking the ability to 
induce HO-1 are more susceptible to the cytotoxic effects of ROS and inflammation 
(Kapturczak et al. 2004, Poss, Tonegawa 1997), it is possible that the SHHF might be more 
vulnerable to injury and chronic exacerbation due to inhibition of HO-1 after LA exposure.  
However, acute transcriptional activation of FHC despite inhibition HO-1 due to LA 
exposure suggests a complex mechanism of regulating oxidative stress and Fe homeostasis in 
the SHHF.  The availability of Fe in the CVD models may cause an inhibition of HO-1 
transcription through poorly understood mecahanisms of negative feedback regulation.   
Asbestos fibers are known to cause acute oxidative stress and inflammation which 
persists over time and contributes to chronic fibrosis, granuloma and lung cancer. We show 
the presence of inflammation at all times and fibrosis at 1 week and 1 month following a 
single dose of LA in all rat strains which leads to focal granuloma formation in few animals 
at 1 month. Although it is believed that environmentally relevant low-level exposures over a 
long period of time are not associated with lung inflammation, and fibrosis following 
asbestos exposure in humans, it has not been experimentally demonstrated. In animals, 
inflammation develops as soon as 3 days following inhalation of asbestos at occupationally-
relevant concentrations (earliest determined) leading to pulmonary fibrosis over longer 
duration (Sabo-Attwood et al. 2005, Dostert et al. 2008).  The persistence of inflammation as 
evidenced by increases in BALF cellularity and histological alterations suggests a persistent 
immune cell response, critical in chronic pulmonary disease, especially in rats with 
underlying Fe-overload.  
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There are limitations in generalizing the role of Fe-overload in LA-induced lung 
injury. The genetic rat models of CVD-associated Fe-overload may not exactly mimic the 
mechanisms of Fe-overload in humans. While intratracheal instillation allows us to precisely 
control the exposure dose, it will produce a one time bolus effect which may not be apparent 
with inhalation, where exposure continues with concurrent compensatory response. Because 
the fiber length in the LA mix used in this study is relatively shorter than other asbestos 
materials such as amosite and crocidolite, it is likely that the major portion of LA would have 
been phagocytosed by alveolar macrophages. Thus, the pattern of lung injury caused by LA 
could be very different from other fibers that are not phagocytosed. However, we have noted 
that, as in case of other fiber types, LA can bind exogenous Fe (Shannahan et al., 2011). Due 
to the difference in fiber characteristics, the kinetics of clearance of LA fibers might be 
different from other long fibers. The clearance of LA is also likely different in different rat 
models and can influence the degree of lung response.  
Conclusions  
In conclusion, SH and especially SHHF demonstrated changes at baseline in markers 
of Fe homeostasis, oxidative stress, and inflammation relative to WKY.  Acute exposure to 
LA induced transient pulmonary inflammation and MIP-2 expression in WKY without 
increases in markers of Fe homeostasis (ferritin) and oxidative stress (HO-1).  However, in 
SHHF, and to some extent in SH, LA exposure caused more persistent inflammation over 1 
week and 1 month, which was associated with marked changes in biomarkers of iron 
homeostasis with a generalized increases in ferritin. These findings suggest the involvement 
of endogenous Fe metabolism in more persistent pulmonary inflammation seen in SH and 
SHHF, which may be critical in their susceptibility to chronic asbestos-related disease.
CHAPTER 6.  SUB-CHRONIC PULMONARY PATHOLOGY, IRON-OVERLOAD 
AND TRANSCRIPTIONAL ACTIVITY AFTER LIBBY AMPHIBOLE EXPOSURE 
IN RAT MODELS OF CARDIOVASCULAR DISEASE 
 
6.1 Introduction 
Residents and miners in Libby, Montana were exposed to a mixture of amphibole 
type asbestos fibers containing winchite, richerite, tremolite, and other minerals in prismatic, 
acicular, and asbestiform morphologies during the town’s extensive vermiculite mining 
(Sullivan, 2007, Meeker et al., 2003, Whitehouse et al., 2008, Moolgavkar et al., 2010).  
Epidemiological studies have shown a dose-dependent correlation between Libby amphibole 
(LA) exposure and the incidences of asbestos-induced diseases such as asbestosis, lung 
cancer, and mesothelioma in this population (Sullivan, 2007, Moolgavkar et al., 2010, 
Putnam et al., 2008). Exposure to LA has also been associated with increased autoimmune 
disease in residents (Noonan et al., 2006).  These diseases are known to develop years to 
decades after exposure to asbestos and are possibly due to the bio-persistency of amphibole 
fibers within the lung causing prolonged inflammation and oxidative stress resulting in 
diverse pulmonary diseases based upon genetic differences (Bernstein et al., 2003, Bernstein 
et al., 2005).  
 Asbestos is able to produce reactive oxygen species (ROS) through Fenton reactions 
facilitated by surface available metals such as iron (Fe).  Interestingly asbestos and silica can 
associate endogenous Fe after inhalation exposure forming Fe-rich asbestos bodies on the 
surface of the fibers (Ghio et al., 2004).   This Fe once bound to the surface of asbestos
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 maintains the capability to redox cycle enhancing the fiber’s ability to produce ROS when 
incubated with the appropriate reducing equivalents (Ghio et al., 2006).  It has been 
postulated that this Fe once bound would enhance the ability of asbestos to produce ROS and 
thereby exacerbate toxicity (Gazzano et al., 2007, Gazzano et al., 2007, Ghio et al., 1992, 
Hardy and Aust, 1995).  Our previous studies have established that LA can bind Fe and that 
this Fe is redox active in an acellular environment (Shannahan et al. 2011a).  However we 
also have demonstrated that Fe loading of LA inhibits the acute inflammatory response in 
vitro in cells and in vivo in rats.  Furthermore by increasing the cellular catalytically active Fe 
pool in vitro the acute inflammatory response after LA exposure was also reduced. The role 
of Fe in the progression of the chronic diseases induced by LA and other asbestos materials 
however is unknown.   
 Increased tissue Fe-overload may increase bioactive and protein bound Fe levels and 
affect the inflammatory response necessary for compensatory mechanisms to be induced 
following an environmental insult. Individuals with chronic diseases such as thalassemia, 
diabetes, arthritis, cancer, and cardiovascular disease (CVD) have been shown to exist in a 
state of systemic Fe-overload (Abdalla et al., 2011, Sen et al., 2011, Allen, 2010, Toyokuni, 
2011). Humans with CVD are known to exist in a state of systemic Fe-overload, 
inflammation, and oxidative stress (Kruszewski, 2004, Ellervik et al., 2010), which may 
influence their susceptibility to asbestos-induced diseases. We have previously characterized 
the underlying pulmonary disease present in two accepted rat models of human CVD the 
spontaneously hypertensive (SH) rat and the spontaneously hypertensive heart failure 
(SHHF) rat (Shannahan et al., 2010).  We determined that both the SH and SHHF existed in 
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a state of pulmonary Fe-overload, inflammation and oxidative stress compared to control 
normotensive Wistar Kyoto (WKY).  
Recently, we have shown that an acute exposure to LA in rat models of CVD-
associated Fe-overload (SH and SHHF) resulted in the lack of exacerbation of inflammation 
despite increases in Fe binding proteins and their transcription (Shannahan et al., 2011b). 
Already high baseline inflammation together with dysregulated Fe homeostasis might 
diminish the acute inflammogenic response to additional insults.  In this continuing study, we 
hypothesized that prolonged presence of LA in the lungs of SH and SHHF rats will cause 
further accumulation of fiber-associated Fe, and aberrant tissue repair leading to diversified 
pathological alterations.  Furthermore we postulated that examining the transcriptional 
activity of the whole lung genome might allow additional insights into the role of Fe in the 
progression of lung disease in these models. Because CVD, diabetes and cancer are prevalent 
in humans and are associated with the highest mortality and global health burden, 
understanding the role of Fe-overload becomes significant in environmental exposures such 
as the one experienced by residents of Libby, Montana.  
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6.3 Materials and Methods 
Libby Amphibole.  The Libby amphibole (LA) sample was collected from the Rainy Creek 
Complex near Libby, Montana in 2007 by the United States Geological Survey and was 
processed to produce inhalable material by Meeker et al., as indicated earlier (Meeker et al., 
2003).  The sample was further size fractionated by water elutriation as described previously 
(Webber et al., 2008) in order to isolate a rat respirable fraction (PM2.5) using a settling 
velocity of 3.4 x 10-4 cm s-1.   
 
Animals.  Male, 11-12 week old, healthy WKY, and SH and obese SHHF rats were 
purchased from Charles River Laboratories, Raleigh, NC.  All rats were maintained in an 
isolated animal room in an Association for Assessment and Accreditation of Laboratory 
Animal Care (AALAC) approved animal facility at 21 +/- 1°C, 50 +/- 5% relative humidity, 
and 12 h light/dark cycle.  Rats were housed (2/cage) in polycarbonate cages containing beta 
chip bedding.  Animals received standard (5001) Purina rat chow (Brentwood, MO) and 
water ad libitum.  The U.S. EPA NHEERL Institutional Animal Care and Use Committee 
(IACUC) approved the protocol. 
 
Intratracheal Instillation of Libby Amphibole.  Since the rat respirable sample of LA was 
prepared using the water elutriation method, a uniform saline suspension of LA for 
intratracheal instillation was achieved by vortexing followed by water bath sonication for 15 
min. The suspension was vortexed prior to each instillation to ensure that fibers did not settle 
at the bottom of the tube.  In order to ensure the fibers did not interact with any biological 
molecules or chemical dispersants of the media prior to landing on the airway surface, we 
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decided not to use a biological dispersion media or any other chemicals for preparing the 
instillate. Rats (WKY n=12/time point; SH n=6/time point; SHHF n=6/time point) were 
anesthetized with isoflurane and intratracheally instilled with 300 µl saline containing either 
0.0, 0.25, or 1.0 mg of LA as described previously (Wallenborn et al., 2009). The 
concentrations selected although high were, in general, consistent with instillation studies 
using other fiber types (Adamson and Bakowska, 2001, Hirano et al., 1988). Doses were 
chosen to assure a response in the lung upon instillation allowing for a comparative analysis 
between strains. Theoretically, a rat will deposit 0.07 mg of fibers during 6 hour inhalation at 
10mg/m3 based on the assumption that minute volume is 200ml and the deposition fraction to 
pulmonary region is 0.10.  Intratracheal instillation ensured the delivery of exact 
concentrations of LA into the lung and allowed us to control for likely strain-related 
deposition differences due to their variation in breathing parameters (Shannahan et al., 2010).  
In our previous study approximately 30% of WKY presented with non-pathogenic cardiac 
hypertrophy (Shannahan et al., 2010).  Therefore WKY group size was increased (n=12) to 
eliminate the data from those with hypertrophic hearts (heart weight > 1.3g; normal heart 
weight ~1g) and still maintain appropriate group sizes for statistical comparisons.  
 
Necropsy, Sample Collection, and Analysis.  Rats were weighed and anesthetized with an 
overdose of sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, ip) 1 
day, 1 week, 1 month, or 3 months following instillation of LA.  Blood was collected through 
the abdominal aorta into blood collection tubes, which were used for a different study.  Blood 
was then removed from the vasculature of the lung by perfusion of Ca2+/Mg2+ free phosphate 
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buffered saline (PBS) via the pulmonary artery to avoid interference in data analysis 
involving Fe-binding proteins and capacities.  
The trachea was then cannulated and the left lung lobe tied off.  The right lung lobes 
were lavaged with Ca2+/Mg2+ free PBS (pH 7.4, at 37°C) equal to 35 ml/kg body weight 
(representing total lung capacity) x 0.6 (right lung capacity being 60% of total lung capacity).  
The lavage volume for SHHF despite their increased body weight was kept same as the mean 
volume of WKY rats based on the assumption that the lung growth will remain similar at a 
given age in both strains despite the obesity-induced increase in body mass of SHHF rats. 
The lung lobes were lavaged three times with the same PBS aliquot. The right lung lobes 
were then removed, placed in liquid nitrogen, and stored at -80°C for later analysis.  The left 
lung was fixed at 40% of its total capacity by instillation of 10% neutral buffered formalin 
through the trachea and stored in 10% formalin at 4°C until processed for histopathology.  
 
Cell Differential and Bronchoalveolar Lavage Fluid (BALF) Analysis.  Aliquots of BALF 
were taken for total cell counts (Coulter Inc., Miami, FL, USA), cell differentials, and 
analyses of lung injury markers.  Cell differentials were conducted by Cytospin preparation 
(Shandon, Pittsburgh, PA), and slides were stained with LeukoStat (Fisher Scientific Co., 
Pittsburgh, PA).  Macrophages and neutrophils were counted under light microscopy and 
quantified based on total cell count. The remaining cell free BALF was evaluated for the 
following: total protein (Coomassie plus Protein Assay Kit, Pierce, Rockford, IL), albumin 
(DiaSorin, Stillwater, MN), and the Fe-binding proteins, ferritin (Kamiya Biomedical 
Company, Seattle, WA) and transferrin (Trf) (DiaSorin, Stillwater, MN).  All assays were 
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adapted for BALF analysis and ran using the Konelab Arena 30 clinical analyzer (Thermo 
Chemical Lab Systems, Espoo Finland).  Data were normalized to volume of BALF. 
 
Statistical Analysis of BALF Data.  Data are expressed as mean ± S.E. (WKY, n = 8-12/ 
treatment group; SH, n = 6/ treatment group; SHHF, n = 6/ treatment group).  Sigma Stat 
version 3.5 (Systat Software, Inc., Point Richmond, C.A.) was used to determine statistical 
comparisons via a two-way analysis of variance with strain and exposure as factors followed 
by a post-hoc comparison using the Holm-Sidak method.  Statistical significance was 
determined when p was found to be less than or equal to 0.05 between treatment groups and 
strains.  
 
Lung Histopathology.  The right lung lobe from each animal was trimmed, embedded in 
paraffin, sectioned to a thickness of approximately 3 microns (transverse), and stained with 
hematoxylin and eosin (H&E), Perls Prussian blue, or Masson’s trichrome.  The lung lesions 
were evaluated with particular attention to the lesion location (i.e, bronchi, terminal bronchi, 
alveolar duct, alveoli, interstiteum, centriacinar regions, pleura). The morphological 
evaluation took into consideration the characteristics of each inflammatory cellular 
component, i.e., polymorphonuclear cells, macrophages, fibrosis, microgranulomas, as well 
as changes in the alveolar epithelium.  Lesions were also evaluated for Perls Prussian blue 
staining for ferric Fe content and Masson’s Trichrome for collagen in order to understand 
modulation of pulmonary Fe content and progression of fibrosis.  Histopathological changes 
were scored using semiquantitative grading at five levels (0 = normal; 1 = minimal; 2 = mild; 
3 = moderate; 4 = severe) taking into consideration the degree of severity and the type of 
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lesion (Shackelford et al., 2002), (Nyska et al., 2005).  In order to verify pathological 
changes and possible chronic progression of lesion development after LA exposure the study 
was repeated in 36 SHHF rats examining lung pathology 3 months and 6 months post-
exposure. SHHF rats were instilled with saline containing 0.0, 0.25, or 1.0 mg of LA and 
necropsies were performed 3 or 6 months later for detailed pathological evaluation.  This 
additional study substantiated the findings of the 3 month study and demonstrated the 
presence but not progression of fibrotic and proliferative lesions after LA exposure (Data not 
shown).  
 
Immunohistochemistry.  Due to the presence of focal hyperplasic changes in SHHF rats, 5-
micron lung sections were cut from parrifin embedded lung blocks from these rats exposed to 
0.0, 0.25 and 0.5 mg LA and were were immunohistochemically stained for epithelial cell 
markers in order to determine the origin of the hyperplastic changes within LA-induced lung 
lesions.  The hydrated lung sections were first incubated with 3% hydrogen peroxide to block 
endogenous peroxidase. These sections were blocked with the appropriate blocking reagents 
and then incubated with primary antibodies specific for Surfactant Protein-A (sc-7699), Clara 
Cell Protein-10 (sc-9772), and the Cytokeratins 10 (sc-58720), and 14 (sc-53253) Santa Cruz 
Biotechnology Inc., Santa Cruz CA.), and Cytokeratin 19 (CRC946) (Cell Marque 
Corporation, Rocklin, CA).  Biotinylated secondary antibodies were used with peroxidase-
conjugated streptavidin to detect cellular localization of proteins of interest. Positive control 
slides using known reactive tissues and negative control slides in which the primary antibody 
was omitted were also prepared.  A board certified pathologist then evaluated the slides. 
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Gene Array.  Total RNA was isolated from caudal lung lobes frozen in liquid nitrogen using 
RNeasy mini kit (Qiagen, Valencia, CA).  RNA integrity was assessed by the RNA 6000 
LabChip® kit using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).  We 
examined global gene expression changes in rat lung tissue using the Affymetrix platform 
(Rat Genome 230 2.0 Array).  Gene expression changes were assessed after exposure to LA 
(1.0 mg/rat & 0.0 mg/rat) at 3 months post-exposure in each strain. 
There were 6 samples per group and gene expression in each sample was assayed on 
separate chips.  Biotin-labeled cRNA was produced from 15 µg total RNA using an 
Affymetrix “IVT-express labeling kit (cat# 901228).   Total cRNA was then quantified using 
a Nano-Drop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and 
evaluated for quality after fragmentation on a 2100 Bioanalyzer. Following overnight 
hybridization at 45oC to Affymetrix 430_2 GeneChips in an Affymetrix Model 640 
GeneChip hybridization oven, the arrays were washed and stained using an Affymetrix 450 
fluidics station as recommended by the manufacturer and scanned on an Affymetrix Model 
3000 (7G) scanner.  After scanning, raw data (Affymetrix .cel files) were obtained using 
Affymetrix Command Console Operating Software (version 3.0).  This software also 
provided summary reports by which array QA metrics were evaluated including average 
background, average signal, and 3’/5’ expression ratios for spike-in controls, β-actin, and 
GAPDH.   
 
Gene Array Data Analysis.  The resulting CEL files were loaded into Rosetta Resolver and 
normalized with the Rosetta error-model.  Differentially expressed probesets were 
determined within Rosetta Resolver using a one-way ANOVA with a Benjamini-Hochberg 
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multiple test correction (false discovery rate set at 0.05).  Each of the five treatments 
(including SHR saline and SHHF saline) was contrasted to WKY- saline as the control.  The 
resulting five lists of DEGs were combined to generate a master list.   Venn diagrams were 
generated from this master list of DEGs for LA induced changes relative to each strain’s 
control using Rosetta Resolver. 
 
Functional Analysis.  For a global assessment of impacted Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways, the master list was submitted to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) (Huang da et al., 2009) for analysis.  P-
values from this analysis were used to generate a heatmap of KEGG pathways.   
All genes were filtered to meet the criteria of intensity greater than or equal to 30 and 
had a fold change greater than 1.5 or less than or equal to -1.5.  Functional lists of genes were 
constructed from KEGG pathway genes: inflammation, and cell cycle control.  Inflammation 
genes were assembled from KEGG pathways: 4060, 4062, 4070, 4310, 4510, 4514, 4520, 
4620, 4621, and 4670.    Cell cycle control genes were assembled from KEGG pathways:  
4115, 5200, 5215, 5217, 5222, and 5223.    For each of the functional lists, genes that were 
on the pathway-specific list and on the master list were submitted to Eisen’s Cluster (Eisen et 
al., 1998) for hierarchical clustering.  The genes were median centered with average linkage.  
The resulting cluster was displayed using Treeview (Eisen et al., 1998). Two other functional 
lists, growth and fibrosis, were obtained from NetAffx 
(http://www.affymetrix.com/estore/analysis/index.affx).  The lists were combined and the 
genes that were on both the growth and fibrosis and were clustered with Eisen’s Cluster and 
displayed with Treeview.    
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6.3 Results 
6.3.1 Libby Amphibole Characterization 
Fiber characterization parameters were recently published (Shannahan et al. 2011b).  
In brief, based on transmission electron microscopy, fiber dimensions, of the elutriated LA 
2007 sample were: mean length 4.99µm ± 4.53 and width 0.28µm ± 0.19; median length = 
3.59µm, width = 0.23µm with upper and lower values of length being 0.52µm – 27.30µm 
and width 0.07µm – 1.15µm.  The estimated fiber count for 1 mg LA sample was 218 x 106.  
In comparison to the elutriated LA 2007 sample used in the present study air samples from 
Libby Montana have been shown to contain fibers having a mean length of 7.64µm ± 8.40 
and width 0.51µm ± 0.46, and median length 5.2µm and width 0.39µm with upper and lower 
values of length being 0.5µm – 195µm and width 0.01µm – 10µm; and an aspect ratio of ≥ 5 
(U.S. EPA 2010). The median fiber length being smaller than the mean length suggests that a 
larger proportion of fibers are likely smaller than the mean length. Transmission Electron 
Microscopy of LA obtained from the 2000 sample similar to one used in the present study 
showed that 97.8% (135/138) of elutriated fibers had aspect ratios ≥ 5 (Meeker et al., 2003, 
Webber et al., 2008), Lowers and Bern, 2009).  
6.3.2 Pulmonary Inflammation, and Injury as Determined using BALF 
 In order to quantify inflammation and injury response following LA exposure, BALF 
samples were analyzed for various biomarkers. It was anticipated that some of the BALF cell 
parameters might not actually reflect the long-term inflammatory changes in the lung and 
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therefore, extensive pathological analysis was done (see below) for all three strains. Baseline 
levels (saline control) of BALF protein and albumin were significantly higher in SH and 
SHHF when compared to WKY (SHHF>SH>WKY) (Figure 6.1), based on our previous 
study (Shannahan et al., 2010). Only SHHF exposed to 1 mg LA demonstrated elevated 
BALF protein at 3 months, however, because of the variable and high levels at baseline, it 
was difficult to ascertain if this increase was related to LA exposure.  The recovery of 
alveolar macrophages in BALF was unchanged after LA exposure in all strains despite 
increased cellularity and presence of fiber-laden macrophages.  As seen at earlier time points, 
neutrophils were significantly increased at baseline in SHHF compared to SH and WKY 
while LA-induced increases in neutrophils were noted during1day through 1 month 
(Shannahan et al., 2011) time points and were largely reversed by the 3 months in all strains. 
Baseline levels (saline control) of BALF ferritin and transferrin were significantly higher in 
SHHF when compared to WKY (SHHF>SH>WKY) (Figure 6.1) suggesting an underlying 
state of CVD associated Fe-overload. However, at 3 months after LA exposure the increases 
noted during earlier time points (Shannahan et al., 2010) were largely reversed.   
6.3.3 Histological Evaluation for H&E, Collagen, and Ferric Fe Staining 
 Histological analysis of H&E stained lung tissue sections for the 1 day, 1 week and 1 
month time points have been recently reported (Shannahan et al., 2011b). In this paper we 
examined pathological lesions from 3 month H&E slides and also performed trichrome 
staining for collagen and Perls blue staining for ferric Fe from lung tissue sections obtained 
at 1 week, 1 month and 3 month time points to understand the time course of the 
development of fibrosis and accumulation of ferric Fe in all three strains. All strains 
demonstrated interstitial fibrosis after exposure to LA shown by trichrome staining for 
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collagen (Table 6.1 and Figure 6.2).  More intense fibrotic foci were apparent in terminal 
bronchiolar areas where fibers likely accumulate. Pathology scoring of the staining intensity 
showed concentration- and time-related increases over 1 week to 3 month time points 
suggesting progression of fibrotic lesions.  However, no strain-related differences could be 
ascertained from comparative analysis of trichrome staining. Control WKY and SH did not 
stain for ferric Fe while a few spontaneous alveolar macrophages stained positive in SHHF 
(Table 6.1).  No discernible changes in Perls blue staining were apparent between control and 
exposed rats at 1 week time point. At 3 months only a few macrophages stained positive for 
ferric Fe in WKY and SH rats exposed to high concentration of LA.  However, the SHHF 
had a greatly exacerbated number macrophages stain positive for Fe compared to WKY and 
SH (SHHF>SH>WKY) (Table 6.1 and Figure 6.2).  These Fe positive macrophages could be 
noticed around the lesion areas. Interestingly alveolar macrophages appeared to internalize 
LA at 1 week post-exposure and fibers remained visible in macrophages 3 months post-
exposure (Figure 6.2).   
6.3.4 Immunohistochemical Evaluation         
 One important observation made in 3 month H&E stained slides of SHHF was the 
presence of atypical hyperplastic lesions (Figure 6.3).  These hyperplastic lesions were only 
present in LA-exposed SHHF rats and were highly focal. These lesions appeared to be dose 
dependent (saline 0/0 lesion incidence; 0.25 mg LA 2/6 lesion incidence; 1 mg LA 4/6 lesion 
incidence).  The lesions were located at or near terminal bronchioles and consisted of 
atypical stacking of cells with the appearance of interstitial cellular aggregation.  The 
experiment was repeated for verification by additional 5 step sections from each animal.  In 
order to determine the cellular origin of these hyperplastic cells and determine the possible 
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presence of squamation, several cytokeratin and epithelial cell markers were examined 
immunohistochemically.  These lesions were negative for the squamous epithelial markers 
cytokeratin 10 and 14 (Figure 6.3).  Lesions however stained positive for 1) the bronchiolar 
epithelial cell markers, cytokeratin 19, a clara cell and 2) the alveolar type II cell marker 
surfactant protein A, and 3) the clara cell specific marker, clara cell 10 (Figure 6.3).  Based 
on the evaluation of these markers we designated these atypical hyperplastic lesions to be of 
bronchiolar epithelial cell origin.  To determine the further progression of hyperplastic 
changes over time additional animals instilled at the same dose levels were held out to 3 and 
6 months post-exposure to LA.  This experiment verified the presence of atypical 
hyperplastic lesions in SHHF at 3 months.  At 6 months post-exposure to LA atypical 
hyperplastic lesions were present but did not progress in severity from what was observed at 
3 months (Data not shown).  Unlike the 3 month time point, one focal spontaneous lesion 
showing typical hyperplastic epithelium was found in a control SHHF at 6 months, however 
LA exposed SHHF demonstrated a clear increase in the incidences of hyperplastic lesions 
that were atypical. 
6.3.5 Gene Expression Analysis 
 We compared the gene expression profiles in all strains exposed to 1.0 mg of LA 
compared to controls in order to determine genes and pathways that still remained altered at 
3 months post-exposure to LA.  We presumed that a snapshot of expression analysis later in 
the course of lung injury but prior to progression of lung disease might allow us to identify 
signature patterns that will provide insight into the relationship between acute injury and 
chronic asbestos-related disease. Further we anticipated that this would allow determination 
of potential mechanistic differences between healthy and cardiovascular compromised Fe-
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overload animals. Baseline strain differences were remarkable and primarily involved genes 
related to immune regulation, inflammation and disease condition. Surprisingly, a large 
number of genes were still differentially expressed at 3 months especially in WKY and SH 
rats after a single intratracheal instillation of LA when compared to saline controls; however 
major strain differences were noted. It was apparent from the Venn diagram of LA-induced 
changes in each strain that WKY and SH had thousands genes changed due to LA at 3 month 
while SHHF showed minimum changes (only 180 genes significantly altered after LA 
exposure) (Figure 6.4). The Venn diagram demonstrated only 15 genes that were modified in 
common between all three strains in response to LA exposure at 3 months (Figure 6.4).  The 
SH rats demonstrated the highest number total of genes changed after LA exposure 
(SH>WKY>SHHF) with more down regulated compared to the WKY and SHHF (Figure 
6.4).   
In order to understand relative strain differences and LA effect in parallel, we 
compared the mean expression values of WKY-saline control to the mean expression values 
of WKY-LA, SH-saline, SH-LA, SHHF-saline, SHHF-LA and determined relative fold 
differences. Although with marked intensity differences, most of the baseline gene changes 
seen in SH and SHHF relative to WKY are in the same direction (up or down) as those seen 
in WKY after LA exposure. It is difficult to ascertain specific mechanistic insight from this, 
however one can speculate that LA exposure over a long period of time in WKY is 
associated with an effect on the trancriptome activity of the lung likely reflective of 
underlying pathology at baseline in SH and SHHF.  Based on the list of DEGs for each 
contrast, the pathways significantly altered due to baseline strain differences or LA exposure 
are depicted in the heat map shown in Figure 6.5.  The green and black colors show no effect 
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while the red color show pathways with genes significantly altered. The review of KEGG 
pathways identified processes involving lipid and steroid metabolism, glycolysis, 
inflammation, leukocyte migration, cell cycle control, oxidative phosphorylation, diabetes 
and many more to be altered due to baseline strain differences and after LA exposure (Figure 
6.5). The glutathione metabolism pathway was significantly changed only in WKY exposed 
to LA. Similarly, only WKY exposed to LA demonstrated an effect on pathways related to 
oxidative phosphorylation and tumor suppression signaling (Figure 6.5).  SH rats exposed to 
LA demonstrated an effect on pathways assigned to cancer after exposure while SHHF had 
this pathway affected significantly at baseline as well as after LA exposure (Figure 6.5).  
SHHF exposed to LA also had other pathways related to cell proliferation altered including 
basal cell carcinoma while the p53 signaling pathway was affected only in WKY (Figure 
6.5).        
Cluster analysis of DEGs that changed in the same direction in all three strains with 
LA exposure and those that did not, revealed insights into specific genes within processes 
that were still affected by LA exposure and how each strain responded differently. 
Hierarchical clustering of genes identified within selected KEGG pathways was performed to 
understand the strain-related directional changes in gene expression belonging to specific 
processes. As indicated in Figure 6.6, many genes related to inflammation were induced 
markedly at baseline in SH and to some degree in SHHF relative to WKY. The expression 
levels of the same genes were increased more readily after LA exposure in WKY, and to a 
lesser extent in SHHF but had a tendency to be inhibited in SH. (Figure 6.6, cluster 1).  
Notable examples of genes within this cluster included NfĸB, tumor necrosis factor, and a 
variety of interleukins.  Figure 6.6, cluster 2 shows genes that are expressed at high levels in 
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WKY at baseline relative to baseline expression in SH and SHHF. These genes remained 
unchanged in WKY but tended to be inhibited from their already low baseline in SH and 
SHHF after LA exposure (Figure 6.6).  Many of these genes involved chemokines such as 
Cxcl-14, and CCl-5, suggesting that some genes that regulate inflammatory response to LA 
tended to be inhibited in SH and SHHF but not WKY.  A third cluster within Figure 6.6, 
cluster 3 contained genes involved in neutrophil chemotaxis that are expressed at high levels 
in SH and SHHF at baseline compared to WKY (Figure 6.6). Since this analysis was done at 
3-months post-exposure, this data together with the return of neutrophils to baseline in all 
respective strains suggests that no active neutrophilic influx is occurring in the lung at this 
time and that baseline neutrophil inflammation associated with underlying CVD is still 
persisting in SH and SHHF. 
 The other differential expression pattern that was apparent from the clustering 
involved cell cycle control genes. We noted remarkable strain difference at baseline and 
following LA exposure in the expression of genes involved in cell cycle control (Figure 6.7).  
Genes expressed at high levels in the lungs of SH and SHHF at baseline including matrix 
metalloproteinase-9 and some oncogenes are separated in cluster 1 of Figure 6.7.  These 
genes in cluster 1 seem to be induced in WKY after LA but are inhibited in SH and SHHF 
rats (Figure 6.7).   A few cell cycle control and growth arrest genes are expressed at lower 
levels at baseline in SH and SHHF when compared to WKY-saline (Figure 6.7, cluster 2).  
These genes in cluster 2 are inhibited only in SH and SHHF after LA exposure while 
remaining unchanged in WKY (Figure 6.7). Figure 6.7, cluster 3 includes genes such as 
tumor suppressor genes and growth receptors that are induced only in WKY 3 months 
following LA exposure (Figure 6.7). 
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 Since the process of fibrosis has been shown to progressively occur after asbestos 
exposure, we postulated that this process would still be active at 3 months post-exposure to 
LA based on the persistency of amohibole-type fibers in the lung. We thus examined 
differentially expressed genes in order to gain further insight into fibrotic and proliferative 
changes seen after LA exposure. There were strain related differences in expression of genes 
involved in cell growth and fibrosis at baseline and in response to LA exposure.  Figure 6.8, 
cluster 1 identifies genes that are expressed at high levels in WKY and SH at baseline 
(WKY>SH) and are reduced in SH following LA exposure.  These genes include 
transforming growth factor-α, and endoglin, a receptor involved in transforming growth 
factor signaling (Figure 6.8).  Figure 6.8, cluster 2 shows genes that are expressed at high 
levels at baseline in SH and are induced in WKY but inhibited in SH following LA exposure.  
These genes include platelet derived growth factor receptor-α, pim-1 an inflammatory 
cytokine, and TIMP-1 an inhibitor of matrix metalloproteinases (Figure 6.8).  Figure 6.8, 
cluster 3 contains genes that are induced primarily in WKY and SHHF following exposure to 
LA.  Genes in this cluster include inducible transforming growth factor-β, and cytochrome B-
245 β otherwise known as NOX-2 (Figure 6.8).   
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Figure 6.1 
 
 
Figure 6.1.  Alterations in BALF protein, albumin, macrophages, neutrophils, ferritin, and 
transferrin  in WKY, SH and SHHF rats following intratracheal instillation of saline 
(control), 0.25 mg LA, or 1 mg LA. Values are mean ± SE (WKY, n =8-12/group; SH and 
SHHF, n = 6/group). * Indicates significant difference within strain in respect to saline 
controls (p<0.05). # Indicates significant difference from WKY at the same exposure 
concentration (p<0.05). 
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Table 6.1 Histological evaluation showing the staining of lesions for ferric Fe and collagen 
after exposure to LA in WKY, SH, and SHHF rats. 
 Average Score 
(Number of Animals Affected by 
Exposure) 
Time 
Point 
Rat 
Strain 
LA 
Concentration 
(mg/rat) 
Animals/ 
 group 
Perls Blue Staining 
for Ferric Iron 
Trichrome Staining 
for Collagen 
1 
Week 
WKY 0.0 
0.25 
1.0 
5 
6 
6 
0.0  
0.0  
0.3 (2) 
0.0  
1.0 (6)  
1.0 (6) 
 SH 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.0  
0.3 (2) 
0.2 (1) 
1.0 (6) 
1.0 (6) 
 SHHF 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.8 (4) 
0.8 (4) 
0.0 
1.0 (6) 
1.2 (6) 
1 
Month 
WKY 0.0 
0.25 
1.0 
5 
5 
5 
0.0 
0.0 
0.0  
0.0  
1.0 (5) 
0.8 (4)  
 SH 0.0 
0.25 
1.0 
6 
6 
5 
0.0  
0.0 
1.0 (4) 
0.0  
0.8 (5) 
1.0 (6) 
 SHHF 0.0 
0.25 
1.0 
6 
6 
6 
0.3 (2) 
1.5 (6) 
1.7 (6) 
0.0  
1.0 (6) 
1.2 (6) 
3 
Month 
WKY 0.0 
0.25 
1.0 
5 
6 
5 
0.0 
0.0 
0.4 (2) 
0.0 
1.0 (6) 
1.7 (5) 
 SH 0.0 
0.25 
1.0 
6 
6 
6 
0.0 
0.5 (2) 
0.8 (3) 
0.0 
0.8 (5) 
1.5 (6) 
 SHHF 0.0 
0.25 
1.0 
6 
5 
6 
0.3 (2) 
0.6 (2) 
1.7 (6) 
0.0  
0.8 (5) 
2.0 (6) 
 
WKY, SH, and SHHF rats exposed to saline (control) or LA (0.25 or 1.0 mg/rat) were 
examined for pulmonary collagen deposition and ferric iron (Fe) accumulation using 
Masson’s trichrome and Perls Blue staining respectively.  The number within bracket shows 
the number of rats that are affected per total number of rats examined per group.  Collagen 
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deposition and ferric Fe accumulation were graded on a scale of increasing severity from 1-4 
and the mean severity of lesions reflect the average score per animal. 
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Figure 6.2 
 
 
 
Figure 6.2.  Time-related collagen deposition, ferric iron (Fe) alterations and alveolar 
macrophage fiber uptake in the lung following a single intratracheal instillation of LA in 
SHHF rats. The photomicrographs of lung tissue sections of SHHF rats 1 week, 1 month, and 
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3 months post-exposure to 1.0 mg LA are shown. A and B: Representative sections of lung 
stained for collagen using Masson’s Trichrome stain from SHHF rats exposed to 1.0 mg LA 
at 1 week, and 3 months, respectively.  Images are at X 20 magnification.  C and D: 
Representative sections of lung stained for ferric Fe using Perls Blue stain from SHHF rats 
exposed to 1.0 mg LA at 1 week, and 3 months, respectively.  Images are at X 60 
magnification.  E and F: Representative sections of lung using phase contrast microscopy to 
focus on alveolar macrophage uptake of LA in SHHF rat exposed to 1.0 mg LA at 1 week 
and 3 months, respectively.  Images are at X 40. 
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Figure 6.3 
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Figure 6.3.  Immunohistochemical characterization of atypical hyperplastic lesions in SHHF 
at 3 months after a single instillation of 1.0 mg LA.  A:  Representative image of H & E 
stained lung section from SHHF exposed to 1.0 mg LA 3 month post-exposure demonstrating 
the presence of an atypical hyperplastic lesion.  B and C:  Lung sections 
immunohistochemically stained for the squamous cell markers cytokeratins 10 and 14 
respectively from SHHF exposed to 1.0 mg LA 3 months post-exposure.   D:  Lung sections 
immunohistochemically stained for the bronchiolar cell marker cytokeratins 19 from SHHF 
exposed to 1.0 mg LA 3 months post-exposure.   E:  Lung sections immunohistochemically 
stained for surfactant protein-A, a marker of alveolar type II and clara cells from SHHF 
exposed to 1.0 mg LA 3 months post-exposure.  F:  Lung sections immunohistochemically 
stained for the clara cell marker, clara cell 10 from SHHF exposed to 1.0 mg LA 3 months 
post-exposure.  All images are at X 20 magnification. 
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Figure 6.4 
 
 
 
Figure 6.4.  A Venn diagram of differentially expressed genes (DEGs) comparing WKY, SH, 
and SHHF rats 3 months following intratracheal instillation exposure to 1.0 mg LA compared 
to strain matched saline controls.  The table shows the direction of changes in differentially 
expressed genes for each strain.  
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Figure 6.5 
 
 
 
Figure 6.5.  DAVID KEGG pathway specific pulmonary gene expression heat map analyzing 
global expression changes comparing WKY, SH, and SHHF rats 3 months following 
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intratreacheal instillation exposure to 1.0 mg LA normalized to control WKY exposed to 
saline. Black indicates a similar number of genes are activated and the pathway is not altered 
compared to control (WKY saline).  Green indicates that the pathway lacks activation of 
many genes compared to control (WKY saline).  Red indicates the pathway was significantly 
altered (p ≤ 0.05) and contains genes that were activated within the pathway compared to 
control (WKY saline).  This is based on the list of differentially expressed genes (DEGs) for 
each contrast. 
 148
Figure 6.6 
 
 
 
Figure 6.6.  Clustering of inflammation specific pulmonary genes comparing WKY, SH and 
SHHF rats 3 months after intratracheal instillation exposure of 1.0 mg LA.  Differentially 
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expressed genes (DEGs) related to inflammation were assembled from KEGG pathways: 
4060, 4062, 4070, 4310, 4510, 4514, 4520, 4620, 4621, and 4670.  All genes were filtered to 
meet the criteria of intensity greater than or equal to 30 and had a fold change greater than 
1.5 or less than or equal to -1.5.  Genes were then hierarchically clustered using Eisen’s 
Cluster Analysis, were median centered with average linkage, and viewed using Treeview.  
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Figure 6.7 
 
 
 
Figure 6.7.  Clustering of cell cycle control specific pulmonary genes comparing WKY, SH 
and SHHF rats 3 months after intratracheal instillation exposure of 1.0 mg LA.  Differentially 
expressed genes (DEFs) related to cell cycle control were assembled from KEGG pathways: 
4115, 5200, 5215, 5217, 5222, and 5223.  All genes were filtered to meet the criteria of 
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intensity greater than or equal to 30 and had a fold change greater than 1.5 or less than or 
equal to -1.5.  Genes were then hierarchically clustered using Eisen’s Cluster Analysis, were 
median centered with average linkage, and viewed using Treeview.  
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Figure 6.8 
 
 
 
Figure 6.8.  Clustering of growth factor and fibrosis specific pulmonary gene expression 
comparing WKY, SH and SHHF rats 3 months after intratracheal instillation exposure of 1.0 
mg LA.  Functional lists for genes related to growth and fibrosis, were obtained from 
NetAffx (http://www.affymetrix.com/estore/analysis/index.affx). All genes were filtered to 
meet the criteria of intensity greater than or equal to 30 and had a fold change greater than 
1.5 or less than or equal to -1.5.  Genes were then hierarchically clustered using Eisen’s 
Cluster Analysis, were median centered with average linkage, and viewed using Treeview.  
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6.4 Discussion 
The molecular mechanisms of acute inflammation that lead to chronic fibrosis or lung 
cancer after asbestos exposure remains elusive despite decades of research. Fiber-associated 
Fe has been postulated to play a role in the inflammatory process; however, its influence on 
chronic pathological outcome is unknown. The literature is controversial regarding the role 
of Fe overload and chronic disease susceptibility. Studies have demonstrated that the 
accumulation of Fe at tumor sites is a consequence due to tumor-associated inflammation and 
oxidative stress (Kukulj et al., 2010).  Other studies however have shown that Fe is causal in 
tumor progression postulating that the availability of Fe promotes ROS generation, which 
leads to cancer through oxidation and damage of DNA (Hu et al., 2010, Toyokuni, 2011).  
We have recently have shown that rat models of CVD-associated Fe-overload do not show an 
exacerbation of acute LA-induced inflammation and that this acute inflammatory response 
induced by LA is reduced by Fe despite its ability to generate ROS (Shannahan et al. 2011a, 
Shannahan et al. 2011b). In this study we postulated that exposure of SH and SHHF rats to 
LA due to their underlying CVD and associated pulmonary Fe-overload would result in 
further accumulation of Fe in the lung and differential pathological outcomes over a longer 
period of time (3 and 6 months). We further hypothesized that a snapshot analysis of lung 
gene expression signatures in control and LA-exposed rats, 3 months post-exposure, would 
allow us to delineate the relationship between acute injury and long-term occurrence of 
pathology, and the role of CVD-associated Fe-overload.   
Here we show that pulmonary fibrosis progresses to a similar degree in all three 
strains over 3 months after LA exposure despite differences in expression of genes related to 
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fibrosis in all three strains.  Fe accumulation was also found in fiber-laden alveolar 
macrophages and was highly exacerbated in SHHF. Surprisingly, only SHHF developed 
atypical hyperplastic lesions of bronchiolar origin in response to LA. The overall 
transcriptional activity supports the development of hyperplastic lesions in SHHF and 
underlying chronic inflammation. However, the role of key genes in given processes is 
difficult to ascertain from expression analysis.   
Persistent systemic inflammation and Fe-overload are the hallmark features of 
chronic diseases in humans and in animals, however it is not known if they are consequence 
of the disease or causal (Yao and Rahman, 2011, O'Byrne, 1996).   We have shown that SH 
and SHHF due to their genetic predisposition to CVD have increased baseline inflammation 
as characterized by increased presence of neutrophils, and Fe-overload that relates to the 
severity of of disease (SHHF>SH) (Shanahan et al. 2010). In this study we hypothesized that 
pulmonary gene expression patterns might be different in SH and SHHF rats having 
increased presence of neutrophils at baseline and may relate to inflammation and pathology 
induced by LA.  Genes involved in inflammatory processes mediated by NFkB and other 
signaling pathways were generally up-regulated at baseline in both SH and SHHF relative to 
WKY, along with several metabolic and pathological processes. 
Gene expression analysis revealed that the LA effect on inflammatory genes that 
regulate innate immunity is still evident at 3 months post-exposure in WKY but less so in 
SHHF and SH with suppressed acquired immunity genes at baseline (Figure 6.6 cluster 1). 
This pattern of response suggests that SH and SHHF 3 months after LA exposure are unable 
to sustain increased inflammatory gene expression despite their elevated baseline lung 
neutrophils. This may be related to their already high baseline expression and an inability to 
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further up-regulate inflammatory genes or temporal differences in gene expression between 
strains.   
Persistent inflammatory response in the case of asbestos exposure leads to pulmonary 
fibrosis at the terminal bronchiolar region of the lung, coinciding with the site of fiber 
deposition (Brody et al., 1981).  Despite gene expression pattern differences between strains 
our study demonstrates similar degrees of fibrotic lesions in the lung. Even though the LA-
induced neutrophilic influx had subsided in all three strains at 3 months, the inflammatory 
gene expression still remained induced in WKY compared to SH and SHHF who express 
these genes at high level at baseline. We speculate that the increased inflammatory gene 
expression was necessary for progressing to fibrosis in all strains regardless of how the gene 
expression is increased (LA exposure in WKY and high baseline in SH and SHHF). We 
further postulate that LA-induced inflammation and fibrosis-related gene expression might 
have been dampened because of the Fe that accumulated within fiber-laden macrophages in 
Fe-overloaded SHHF. Underlying genetic differences may also be involved in differential 
regulation of inflammation and fibrosis. 
Unlike long thin fibers that remain intercalated at the terminal bronchiolar region, the 
shorter fibers are likely to be readily phagocytozed by alveolar macrophages (Bernstein et 
al., 2010).  In vitro studies have shown that epithelial cells can take up relatively short LA 
fibers (Duncan et al., 2010). Light microscopy examinations with phase contrast revealed the 
presence of LA fibers within alveolar macrophages at 3 months suggesting that these fibers 
are taken up by alveolar macrophages and are not cleared from the lung. Amosite fibers of a 
similar length to LA have been shown to be engulfed by alveolar macrophages in vivo 
(Bernstein et al., 2010).  Furthermore, the half life of these fibers have been shown to be 
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greater than 90 days suggesting that some of these fibers within macrophages will remain in 
the lung for the lifetime of the animal.  The ability of alveolar macrophages to engulf but not 
clear the LA fibers may result in chronic inflammation within the lung affecting disease 
progression.    
The enhanced progressive accumulation of Fe within fiber laden alveolar 
macrophages in the SHHF supports the hypothesis that the increased availability of cellular 
Fe increases the accumulation of Fe at the site of fiber deposition within the lung. Coating of 
endogenous Fe on the surface of fibers has been shown in mice and in humans after exposure 
(Ghio et al., 2006, Ghio et al., 2009).  We have shown that LA binds Fe in an acellular 
system in minutes (Shannahan et al. 2011a). Here we show that, as in humans and mice, LA 
likely associates cellular Fe in rats and that this process is rapid in rats with underlying Fe-
overload.  Furthermore, our previous study with LA (Shannahan et al., 2011a) and another 
study with quartz (Ghiazza et al., 2011) have shown that the bio-availability of catalytically 
active Fe may reduce the inflammatory response following fiber exposure.  This supports the 
conclusion that possibly the Fe-overload conditions seen in SH and SHHF might reduce the 
inflammatory gene induction caused by LA due to accumulation of Fe at the site of fiber 
deposition.   
Surprisingly, only the SHHF developed atypical hyperplastic lesions at 3 months and 
6 months post-exposure to LA.  These proliferative lesions likely originated form bronchiolar 
epithelial cells and did not involve squamation based on immunohostochemical detection of a 
series of cell specific markers. Unlike the typical hyperplastic changes seen in the 
bronchiolar epithelial and alveolar type II cells after asbestos induced lung fibrosis (Robledo 
et al., 2000, Crouch, 1990), the hyperplastic changes seen in LA-exposed SHHF were 
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classified as atypical based on the stacking of hyperplastic cells; but were not classified as 
adenomatous. Such atypical lesions have been noted in bronchoalveolar neoplasia and 
atypical adenomatous hyperplasia of the lung in humans and have been associated with 
genetic changes in the EGF receptor (Kitamura and Okudela, 2010, McIntire et al., 2010).  
Case studies with asbestos exposure have shown the coexistence of atypical adenomatous 
hyperplasia, primary lung adenocarcinoma and pleural mesothelioma (Thomas et al., 2004, 
Tsuzuki et al., 2008). Because these lesions in SHHF rats at 3 months did not progress over 6 
months, it is difficult to ascertain their significance. However, these findings allow us to 
speculate that SHHF might have genetic traits that predispose them earlier to asbestos-
induced lung cancer development.  
We presumed that analysis of expression of inflammatory cytokines, growth factors 
and cell cycle control genes would allow for insights into the proliferative lesions seen only 
the in SHHF rat model. We noted that the cellular processes involving cell cycle control, and 
growth were differentially affected in all three strains. TP53 a key tumor suppressor gene 
was induced only in WKY exposed to LA.  The loss of function of the tumor suppressor 
gene, TP53 has been implicated in the development of lung cancer and cellular proliferation 
following asbestos exposure (Morris et al., 2004). C-Fos, a member of AP-1 oncogene 
family, which is implicated in cell motility and invasion (Han et al., 2010) and the FBJ 
oncogene were upregualted only in LA-exposed SHHF. The EGF receptor has been 
implicated in adenomatus hyperplastic cell growth (Adiseshaiah et al., 2008) and was also 
increased in SHHF.  A number of cellular processes as determined based on pathway 
analysis using KEGG indicated significant changes in pathways in cancer, and basal cell 
carcinoma development, especially in SHHF. This may facilitate the proliferative phenotype 
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seen in the SHHF after LA exposure.  Baseline high levels of oxidative stress and 
inflammation demonstrated by SHHF also may influence their increased sensitivity to 
develop proliferative lesions compared to other animal strains.  Thus, the SHHF may be an 
appropriate model to study proliferative changes following asbestos exposure due to the high 
number of incidences seen in this study.  
There are limitations of the study that concern the interpretation of findings: 1) 
Animal models have genetic CVD which may influence their susceptibility to LA more so 
than Fe-overload. 2) The use of intratracheal instillation, while allowing precise control for 
pulmonary dose, might produce a one time high response relative to inhalation where injury 
and compensatory processes occur simultaneously. 3) The temporality of gene expression 
patterns was not considered. 4) The analysis of whole lung tissue expression might reduce 
actual changes seen at the site of lesion. 5) Due to LA being shorter than other well studied 
fibers, the kinetics of retention and the effect on the pulmonary cells might be different.  
 In conclusion, we report that LA exposure is associated with progressive fibrosis and 
increased gene expression for inflammatory markers and fibrosis in all three strains, however 
the accumulation of Fe within fiber-laden macrophages is primarily seen in SHHF. The 
SHHF was found to develop atypical hyperplastic lesions that presented with cellular 
stacking and were of bronchiolar cell origin. Transcriptional analysis of lung tissue revealed 
LA-induced changes in inflammation, immune regulation and number of pathological and 
metabolic processes, however, with remarkable strain-related differences.  Genes involved in 
Fe homeostasis did not remain altered at 3 months following LA exposure. Key regulatory 
genes of cell cycle control and growth were differentially affected in all three strains, 
however; specific cancer-related processes were significantly altered only in SHHF. Thus, 
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disease associated Fe-overload might result in increased accumulation of Fe at the site of 
fiber deposition, however, this might not be causal in susceptibility to induce proliferative 
changes. 
CHAPTER 7.  OVERALL CONCLUSIONS AND SIGNIFICANCE 
 
 
These studies taken together demonstrate the role of iron (Fe) in Libby amphibole 
(LA) asbestos-induced lung inflammation in healthy and cardiovascular disease (CVD) 
compromised rats with Fe-overload.  It has been postulated that increased amounts of Fe on 
the surface of asbestos would potentiate the production of reactive oxygen species (ROS) by 
fibers and thereby enhance inflammation and toxicity.  The link between the ability of Fe to 
generate ROS and the enhancement of the toxicity of a variety of pollutants has been 
proposed.  No systematic approaches, however, have been taken to understand if the injury 
and inflammatory responses are exacerbated when Fe levels are increased.  The literature 
provides conflicting evidence of the role of Fe due to differences in the experimental 
approaches.  Fe can be catalytically active and is ubiquitously present in the ambient air, our 
diet, and tissues.  Thus, the understanding of its role in toxicity after environmental 
exposures to particles and fibers is fundamental and necessary.  In order to make our research 
questions and experiments more relevant to humans and applicable to diseases associated 
with environmental exposures, we systematically evaluated the role of Fe in fiber-induced 
lung inflammation in healthy and CVD compromised rat models with Fe-overload.   
To understand the role of Fe in asbestos toxicity and the progression of lung diseases, 
it is necessary to integrate findings from epidemiology, human, animal, in vitro, and acellular 
chemical studies.  Often, integration of results from various types of studies is difficult.  
Human and animal studies have demonstrated an ability of asbestos to bind Fe after exposure
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(Shen et al., 2000, Gibbs et al., 1994, Ghio et al., 2004, Pascolo et al., 2011).  Furthermore, 
fibers coated with Fe have been shown to generate increased ROS compared to fibers without 
additional Fe in acellular systems.  Based on these independent studies, it was postulated that 
endogenous Fe on the surface of fibers could enhance ROS production and toxicity (Governa 
et al., 1999, Ghio et al., 2006, Lund et al., 1994, Ghio et al., 1992).  Further studies 
examining fibers with different Fe contents also showed this trend (Gazzano et al., 2007, 
Srivastava et al., 2010).   
 Our research supports the conclusion that LA fibers bind exogenous Fe, and with 
increased levels of Fe, the fibers become more redox active in an acelllular system.  This 
increased redox activity due to associated Fe, however, does not seem to be the mechanism 
responsible for the acute inflammatory response demonstrated after fiber exposure in cells 
and in vivo. Rather, the increased bioavailability of cellular Fe to bind fibers and also the 
fiber-associated Fe are responsible for inhibiting the acute inflammatory response to fibers.  
These findings were confirmed in animal models with CVD-associated Fe-overload (SH and 
SHHF rats) that demonstrated reduced inflammatory gene expression compared to a healthy 
model (WKY).  Furthermore, the ability of LA to associate endogenous Fe in vivo was 
validated by the prominent accumulation of Fe in fiber-laden macrophages in Fe-overloaded 
SHHF rats. 
Fe is the most abundant metal in the environment and is an essential metal for living 
organisms.  Fe is required for basic biological functions such as transporting and releasing 
oxygen in our tissues, electron transport, energy metabolism, and DNA synthesis and repair.  
Although it is likely that other essential metals can bind fibers in vivo and modulate 
biological processes, Fe is of the most biological interest.  The importance of Fe is due to 
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high endogenous levels and the stability constant for its complexation with the fiber is higher 
than any other cation found within the body. Furthermore, Fe is abundant within our 
environment and is a key component of many air pollutants.  The ability of Fe to facilitate 
Fenton reactions in vivo can make it a promoter of oxidative stress.  As Fe is highly redox 
active, its endogenous levels are tightly regulated within the body by the Fe transporters and 
binding proteins such as lactoferrin, transferrin, and ferritin.  Lactoferrin and transferrin are 
Fe transport proteins responsible for the binding of free Fe and its transport into cells.  
In contrast to transferrin and lactoferrin’s role in Fe transport, ferritin is the body’s 
primary Fe storage protein and is useful in determining an organism’s Fe status.  Ferritin 
consists of a combination of two subunits: ferritin heavy chain and ferritin light chain.  
Ferritin heavy chain is responsible for sequestration of Fe by oxidation, while the light chain 
is responsible for the storage of Fe.  According to where it is in the body and its function, the 
proportion of each subunit is different.  Light chain rich ferritins are associated with 
conditions of Fe-overload and are known to release Fe very slowly.  Heavy chain rich 
ferritins are known to be associated with inflammatory responses as the body prepares to 
quickly bind Fe that is released due to oxidative damage to heme-containing proteins and 
catabolism of heme groups by HO-1    
In environmental exposures, Fe has been postulated to play a key role in the 
inflammatory response induced by inhaled fibers and silicates including asbestos.  Human 
exposure to asbestos has been shown to cause the development of lung cancer, the fibrotic 
condition asbestosis, and mesothelioma.  Individuals in the town of Libby, Montana who 
were exposed for years both occupationally and environmentally to an amphibole mixture 
(winchite, richerite, and tremolite) during mining of asbestos-contaminated vermiculite 
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(Meeker et al., 2003), have recently shown increased incidences of asbestos-related diseases 
(Peipins et al., 2003, Sullivan, 2007).  Similar to other asbestos fiber-types, the chemical 
formula of fibers in the LA sample contains Fe which can redox cycle and produce ROS, as 
well as silicon which has been shown with other fibers to facilitate the association of 
endogenous Fe.      
  Our acellular studies support these findings in that LA could bind Fe and this 
additional Fe rendered them more redox active.  However, our in vitro and in vivo studies 
demonstrated that having additional Fe bound on the surface of the fibers inhibited the 
inflammatory response compared to unmodified fibers.  Recently, this mechanism has also 
been shown to be true for quartz-induced inflammation (Ghiazza et al., 2011).  We believe 
the reason for this disconnect between the acellular studies and the cell and animal toxicity 
studies is the high concentration of Fe and reducing equivalents present in the acellular 
experiments to promote Fenton chemistry.  However, this is unlikely in a live cell where 
mechanisms exist to inhibit abbarent ROS production.    
 We postulated that Fe might reduce the inflammatory response by inhibiting the 
activity of the inflammasome as other asbestos fibers have recently been shown to induce 
inflammation through this pathway.  The inflammasome is a multiprotein complex known to 
initiate the inflammatory cascade following exposure to a variety of stimuli.  Asbestos fibers 
have shown an ability to specifically induce the NALP3 inflammasome (Dostert and Petrilli, 
2008, Dostert et al., 2008) while NALP3 knockout mouse models have been shown to be 
protected from the development of silicosis following exposure to silica (Cassel et al., 2008).  
For the first time, our study demonstrates the activation of the inflammasome after LA 
exposure and the ability of Fe to transcriptionally inhibit signaling targets of this pathway 
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involved in acute inflammation (Chapter 4).  Furthermore, at 3 months post-LA exposure, 
expression of genes involved in the inflammasome pathway, while still up-regulated in 
healthy rats seem unaltered in rats with Fe-overload.  Our findings support the role of Fe in 
activation of inflammasome-mediated signaling in rat models of Fe-overload.  This altered 
activation of the inflammasome in Fe-overload models may contribute to the differential 
inflammatory response seen after exposure and may cause variations in susceptibility to 
asbestos exposure.   
Importantly, in Chapter 3 we use IL-8 as a marker of inflammagenic response to LA 
in a bronchiolar epithelial cell line, while in Chapter 4 we use IL-1β, an inflammatory 
response marker produced by alveolar macrophages following inflammasome activation.  We 
find that Fe similarly alters the inflammatory response in both cell types as demonstrated by 
altered induction of IL-8 and IL-1β.  Induction of IL-8 has currently not been found to be due 
to activation of the inflammasome.  These findings support the conclusion that there may be 
a general mechanism by which Fe alters the inflammatory response such as differential 
activation or expression of transcription factors such as Nf-ĸB.  The ability of Fe to modulate 
inflammation in different cell types via unique or similar mechanisms requires further study. 
 Although inflammation orchestrated by integration of a variety of signaling pathways 
is needed by the body, it can also be detrimental if not properly regulated.  Our studies 
demonstrate modifications in the acute inflammation induced by asbestos due to the 
bioavailability of Fe.   A robust inflammatory response may be needed to stimulate 
appropriate repair mechanisms.  On the other hand, if this inflammatory response does not 
resolve or is too intense, there could be non-reversible damage to the lung and lead to the 
progression of diseases.  SHHF had persistent high baseline inflammation but did not 
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demonstrate an ability to further induce inflammatory gene expression comparable to WKY.  
Historical evidence suggests that the inflammatory response is a delicate balance. During the 
flu pandemic of 1918, younger healthy individuals were curiously more susceptible to the 
morbidity and mortality caused by the flu (Hsieh et al., 2006).  This was later found to be 
related to their robust inflammatory response after contracting the flu.  Older individuals who 
commonly were at risk for mortality from the flu were found to survive due to their 
reduced/weakened inflammatory response.  Because older people are likely to have Fe-
overload, one can postulate that this Fe reduces the inflammatory response to inhalable 
pathogens and air pollutants. 
 Many chronic diseases including diabetes, thalasemmia, cancer, and CVD are 
associated with not only inflammation and oxidative stress, but also systemic Fe-overload 
(Galanello et al., 2010, Allen, 2010, Kruszewski, 2004, Ellervik et al., 2010).  The 
examination of rat models of CVD in Chapter 1 demonstrates pulmonary inflammation, 
oxidative stress, and Fe-overload. Therefore, we believe that these models were appropriate 
for the study of CVD-associated Fe-overload and its consequences in air pollution exposures.  
The sheer stress caused by elevated blood pressure in these models is thought to contribute to 
the release of Fe from hemoglobin resulting in systemic Fe-overload. It is not known if these 
increases in tissue Fe levels are causal or a consequence of the underlying disease.  This 
increased systemic Fe is thought to contribute to the systemic oxidative stress and 
inflammation seen in these individuals and rat models.  The SH and SHHF rats used in our 
studies have not been fully genotyped and are polygenetic models of CVD.  The response of 
these animal models to LA might also be influenced by genetic abnormalities in these models 
that do not pertain to the underlying state of Fe-overload. This causes an increased variability 
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in their responses to asbestos and other inhalable pollution exposures, giving an accurate 
depiction of the continuum of responses seen in the human subpopulation of CVD.   
    The ability of LA to bind Fe is not unique to this fiber type as other fibers have shown 
an ability to bind Fe.  It has been postulated in other studies that macrophages are the source 
of Fe for the formation of ferruginous bodies on fibers (Koerten et al., 1986).  Specifically, it 
has been hypothesized that inflammatory macrophages that are recruited to the lung after 
fiber exposure are the source of Fe (Birgegard and Caro, 1984).  This postulation is based on 
more abundant Fe in the inflammatory macrophage compared to resident lung macrophages 
due to uptake of damaged erythrocytes.  The time required to form ferruginous bodies after 
exposure is not known, but some individuals are known to more readily deposit Fe on fibers.  
This variation in deposition of Fe on fibers has been thought to be related to differences in 
individual body Fe burden. Our data are consistent with this assumption and show that SHHF 
with Fe-overload accumulate Fe in fiber-laden macrophages as early as 3 months whereas 
other strains with less tissue Fe show minimal accumulation.  
Chapter 3 demonstrates that in the presence of increased Fe levels, the inflammatory 
effect of LA is reduced.   Interestingly, our findings in Chapter 6 not only support this by 
showing that animals with Fe-overload have a decreased LA-induced inflammatory gene 
expression, but also showing that animals with disease associated Fe-overload more readily 
coated fibers with Fe.  This finding supports our hypothesis that the endogenous loading of 
Fe is dependent on the bio-availability of Fe and that individuals with CVD-associated Fe-
overload more readily coat fibers.  This also validates the increases seen in Chapter 5 of 
markers of Fe homeostasis in response to the enhanced movement of Fe in the SHHF.  This 
finding may explain why often individuals with chronic diseases demonstrate reduced 
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inflammatory responses to particle exposures. Since accumulation of essential transition 
metals including Fe has been noted at the site of pathology and systemically, one might 
speculate on the role of these metals in the development of aberrant cell-cycle control and 
proliferative changes based on the increased hyperplastic lesions seen only in LA exposed 
SHHF.  However, this association of Fe-overload in LA-exposed SHHF and the lack of 
inflammatory gene expression must be cautiously interpreted since numerous genetic 
abnormalities and the baseline presence of lung inflammation might also contribute to the 
lack of inflammatory gene induction in these rats.   
In humans asbestos is known to cause a specific cancer of the pleural region of the 
lung well-known as mesothelioma.  It is postulated that the migration of macrophages loaded 
with short fibers through lymphatics to pleural surface is involved in calcification and 
mesothelioma of the pleura.  Rats after intratracheal instillation have also demonstrated the 
movement of short chrysotile fibers to the pleural region (Viallat et al., 1986).  Chronic 
inhalation studies of amosite and chrysotile have also demonstrated this translocation to the 
pleural region in hamsters and rats (Mast et al., 1994, McConnell et al., 1999).  These 
studies, however, demonstrated strain specific differences with the hamster demonstrating 
greater translocation of fibers compared to rats and also pleural fibrosis and mesothelioma 
that were unseen in rats (Gelzleichter et al., 1999).  Thus, the rat is not considered the 
preferred model for the study of mesothelioma (Rodelsperger and Woitowitz, 1995) and the 
absence of pleural changes in our LA exposure studies appears to be a deficiency with our 
chosen rat models.  Epidemiology, however, has determined a relationship between 
occupational and environmental exposure to LA and increased incidences of mesothelioma 
(Moolgavkar et al., 2010).  Donaldson et al., 2010 hypothesized that the fibers that are more 
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biopersistent could move from the alveolar spaces to the pleural region and could eventually 
lead to carcinogenesis.  Studies have also shown that injection of asbestos into the pleural 
region of rats can cause pleural changes, supporting this hypothesis (Hu et al., 2010, Cullen 
et al., 2002).  Based on this hypothesis, the lack of pleural changes seen in our studies could 
be attributable to 1) a shorter timeframe after a single bolus instillation which may not have 
been long enough to see translocation of fibers to the pleura and 2) the lack of sensitivity of 
rats to the translocation of fibers.  
 In accordance with several other studies, we demonstrate progressive and 
concentration-dependent fibrotic changes in all rat strains exposed to LA.  The development 
fibrosis after LA exposure has also been recently noted in Fisher 344 rats (Padilla-Carlin et 
al. 2011). The development of proliferative lesions, however, is unique to the SHHF. The 
development of the fibrosis has also been noted after exposure to crocidolite (Robledo et al., 
2000).  Furthermore, it is known that other asbestos fibers deposit within the terminal 
bronchiolar region of the lung after acute inhalation exposure (Brody et al., 1981).  The 
fibrotic foci in all three strains and the proliferative lesions in SHHF were concentrated at the 
terminal bronchiolar junctions, indicating that the injury and disease occur at the site of fiber 
deposition in the lung. (Robledo et al., 2000; Crouch, 1990).   
The findings in SHHF, but not WKY or SH, of increased atypical hyperplasia and Fe 
accumulation within fiber-laden macrophages at 3 months post exposure prompted us to 
further examine the transcriptional activity of the lung using gene expression arrays.  The 
results obtained from gene expression arrays do not allow the confirmation of a specific 
hypothesis, but serve as a hypotheses generating tool and provide insights into observed 
pathological findings.  We postulated that a snap shot of global gene expression at the time 
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when these lesions begin to appear would allow us to get an insight into the role of Fe 
accumulation in the development of hyper plastic lesions in LA-exposed SHHF.  While the 
Fe accumulation in macrophages and the development of atypical hyperplastic lesions are 
temporally associated in SHHF, one must also consider the role of underlying chronic 
baseline oxidative stress and inflammation and genetic abnormalities that contribute to the 
disease in interpretation of findings observed from gene expression patterns.  
Even though genes regulating numerous metabolic and pathological processes have 
been noted to be abnormal at baseline in both SH and SHHF rats, it was surprising to note 
that the pathways involved in tumorogenesis were more altered in SHHF both at baseline and 
following LA exposure.  TP53, an extensively characterized and a major tumor suppressor 
gene, was induced only in WKY exposed to LA, but not in SHHF that developed 
hyperplastic lesions.  SHHF also was shown to have increased KRAS expression at baseline 
and a lack of cell-cycle control gene expression compared to WKY, supporting pathological 
findings.  The lack of LA-induced changes in genes regulating Fe homeostasis suggests that 
Fe accumulation in animals with this Fe-overload condition may not be directly related to 
proliferative changes in the lungs of LA-exposed SHHF.  Rather, the persistent inhibition of 
inflammatory gene induction likely due to Fe accumulation in LA-exposed SHHF might 
relate to their susceptibility to develop hypeplastic lesions. The SHHF seemed to be 
susceptible to the development of these lesions after asbestos exposure compared to the other 
animal models, possibly making the SHHF an appropriate model for the study of asbestos-
induced cell proliferation.  It would be of interest to determine if these proliferative lesions 
were unique to fiber exposure or could be repeated with other pollutant exposures.     
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The speculation that inhibition of inflammation by Fe might result in aberrant cell-
cycle control and proliferation in SHHF goes against the common notion that inflammation is 
the key factor in development of cancer.  Here, we try to go beyond the boundaries of the 
experimental results in postulating that the presence of chronic inflammation as a result of 
genetic predisposition, but not the inflammation induced by environmental insult might cause 
increased susceptibility to develop cancer.  Rather, the inability to mount a robust 
inflammation as suggested earlier may predispose one to increased susceptibility through 
failing to initiate appropriate repair mechanisms.  Future studies should examine the role of 
Fe accumulation at the site of disease and its contribution to regulation of cell-cycle control.   
The role of Fe in the development of these hyperplastic lesions is unclear as 
indicated.  In the literature, there are conflicting views about the role of Fe in proliferative 
changes leading to tumor progression.  Studies have demonstrated increased levels of Fe at 
tumor sites; however, it is unclear if this accumulation of Fe is causal or a consequence of 
tumor development.  Many studies believe that the ability of Fe to redox cycle and produce 
ROS may contribute to the oxidative damage to DNA (Hu et al., 2010, Schurkes et al., 2004, 
Toyokuni, 2011).  Others believe that the accumulation of Fe is due to tumor associated 
oxidative stress and inflammation (Kukulj et al., 2010).  Our work at this time is unable to 
provide any insight into the role of Fe in cancer development, as we only assessed acute and 
sub-chronic time points and the proliferative lesions that did develop were not found to be 
progressive.   
This work lays the foundation for multiple future research questions.  Further 
assessment of the toxicity induced by other materials known to bind Fe would be of interest 
in order to determine if the availability of endogenous Fe modifies the inducible injury and 
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inflammation.  We determined in our studies that the movement of Fe from cellular Fe pools 
was important in modulating the inflammatory response, however, it is necessary to 
understand specifically the pool of Fe that is susceptible to Fe sequestration by the fiber.  We 
postulated in our studies that the fiber would initially take up Fe from the catalytically active 
Fe pool.  Furthermore, we hypothesized that in the situation when no catalytically active 
cellular Fe is available to bind to inhaled fibers, the removal of Fe from more tightly bound 
protein coordination complexes would occur and may cause a different injury outcome.  
Future studies tracking the movement of Fe from the pools need to be done in order to 
understand specifically which pool this Fe is coming from and its biological implications.  
Due to the chronic nature of asbestos-induced diseases and the inability of many fibers to be 
removed from the lung, the implications of chronic Fe-overload requires further evaluation.  
Another future direction is the use of calculating Fe binding potentials for fibers with 
different physiochemical properties and assessing relative toxicities.  This would allow for 
the determination of correlations between the ability of fibers to associated endogenous Fe 
and a fiber toxic potential given the host endogenous Fe concentrations remain constant.  The 
use of different animal models of variable Fe regulation would also be of interest to study.  
All experiments we designed used a one-time intratracheal instillation of asbestos in order to 
control dosing between animal models with different minute volumes.  However, studies 
assessing episodic inhalation exposures over a long period of time would be more realistic in 
mimicking the human exposure scenario. 
We believe that this project, overall, has scientifically contributed to the field of 
toxicology.  First, our project characterized the pulmonary disease states in commonly used 
rat models of CVD.  We also were able to characterize a highly human relevant form of 
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asbestos, the LA sample, and determined its ability to associate Fe.  We further determined a 
unique mechanism by which the acute inflammatory response may be mediated after fiber 
exposure and its inhibition by Fe.  Lastly, we assessed the role of Fe and its contribution to 
LA-induced pulmonary disease susceptibility in models of Fe overload and demonstrated that 
Fe binds LA in vivo. 
Since asbestos-induced diseases and the mechanisms of induction have been studied 
for decades but many aspects still remain unknown, the continued examination of asbestos 
toxicity is needed, as newer technologies for the evaluation of toxicity are made available.  
The information obtained from high throughput studies involving diverse animal models 
could allow us to determine how acute inflammation induced by asbestos or other pollutants 
can lead to the development of lung cancer and other diseases.  These research findings may 
have implications influencing the treatment and prevention of asbestos-induced diseases. 
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